Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
66 "Cells"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Reviews
Basic and Translational Research
Article image
Redefining β-Cell Function in Type 2 Diabetes Mellitus: From Comprehensive Assessment to Precision Medicine
YongKyung Kim, Joon Ha, Jun Sung Moon
Diabetes Metab J. 2026;50(2):235-252.   Published online March 1, 2026
DOI: https://doi.org/10.4093/dmj.2026.0034
  • 432 View
  • 48 Download
AbstractAbstract PDFPubReader   ePub   
The global surge in type 2 diabetes mellitus (T2DM) requires a thorough understanding of pancreatic β-cell dysfunction, which remains a central determinant of the disease. However, the evaluation of β-cell insulin secretory capacity is often challenging in clinical practice due to its inherent complexity. This review presents a comprehensive technical overview of diverse assessment methodologies, ranging from conventional fasting-based indices and glucose tolerance tests to advanced mathematical modeling and artificial intelligence-driven approaches. A detailed examination of the methodological strengths and limitations of these various tools is provided to guide their appropriate clinical application. Furthermore, we explore the clinical implications of these assessments in enhancing diagnostic accuracy and tailoring therapeutic strategies. Particular emphasis is placed on the pivotal role of β-cell function evaluation in predicting and achieving diabetes remission—an emerging clinical priority. By integrating the technical landscape of β-cell assessment with practical applications, this review provide a structured framework for optimizing T2DM management and improving long-term patient outcomes.
Basic and Translational Research
Article image
Heterogeneity and Clinical Relevance of Human Adipose Stromal and Progenitor Cells
Maxi Albert, Khansa Nalir, Jiawei Zhong, Lucas Massier
Diabetes Metab J. 2026;50(2):217-234.   Published online March 1, 2026
DOI: https://doi.org/10.4093/dmj.2025.1182
  • 516 View
  • 49 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Adipose stromal and progenitor cells (ASPCs) represent the largest cell population in human white adipose tissue (WAT). Despite their abundance, ASPC heterogeneity remains less well characterized compared to adipocytes or immune cells. Recent single-cell transcriptome studies provide unprecedented resolution of ASPC diversity and function. This review summarizes state-of-the-art approaches, including high-resolution single-cell methods, classical lineage and functional assays, to define ASPC populations. By systematically comparing recent datasets, we identify evidence for at least eight distinct ASPC-subtypes, which demonstrate specific marker genes and putative functional diversity. Along the adipogenic trajectory, these include uncommitted multipotent progenitors, intermediate and committed preadipocytes, and premature adipocytes. Additional populations comprise specialized anti-adipogenic, profibrotic, inflammatory, and fibroblast-like ASPCs. Other cell types are not consistently detected across studies, reflecting both biological and methodological variability, and the need for further validation studies. Better understanding of ASPC heterogeneity may improve the clinical assessment of metabolic disorders and support their treatment. We further discuss subtype-specific (dys)functions linked to fibrosis, inflammation and impaired adipogenesis and describe their increased abundance in metabolic disease. Together, this review integrates current knowledge on ASPC heterogeneity and highlights its clinical relevance, aiming to provide a unified framework for future studies on WAT remodeling and metabolic dysfunction.
Original Articles
Basic and Translational Research
Article image
Abnormally Elevated PKCδ Delays Diabetic Wound Healing by Inhibiting the GAD1-GABA Pathway
Peiliang Qin, Peng Zhou, Yating Huang, Binbin Long, Ruikang Gao, Bingjie Zhu, Yiqing Li, Qin Li
Received August 4, 2024  Accepted May 29, 2025  Published online September 8, 2025  
DOI: https://doi.org/10.4093/dmj.2024.0450    [Epub ahead of print]
  • 5,695 View
  • 59 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Diabetic foot ulcer (DFU) represents a challenging complication of diabetes mellitus, characterized by slow healing processes. Protein kinase C delta (PKCδ) has been identified as a significant factor in the pathogenesis of various diabetic complications, including DFU. However, the precise underlying mechanisms remain to be fully elucidated.
Methods
Human umbilical vein endothelial cells (HUVECs) were cultivated under high glucose conditions and PKCδ was knocked down by siRNA. The proliferation, migration, and tube formation of HUVECs were detected. A metabolomics sequencing was done to identify potential metabolites contributing to the changes. HUVECs proliferation, migration, tube formation, and apoptosis were detected after regulating the production of selected metabolite. And finally, the effect of the metabolite on diabetic wound healing was detected.
Results
In vitro, knockdown of PKCδ upregulated glutamate decarboxylase 1 (GAD1) expression and gamma-aminobutyric acid (GABA) levels, which enhanced proliferation, migration, and tube formation and suppressed apoptosis of HUVECs under high glucose conditions. Interestingly, inhibition of GAD1 in normal glucose-treated HUVECs resulted in decreased proliferation, migration, tube formation, and increased apoptosis. Furthermore, in vivo experiments demonstrated that topical administration of GABA accelerated the healing of diabetic wounds in streptozotocin-induced type 2 diabetes mellitus mice, manifested as higher angiogenesis and proliferation.
Conclusion
The inhibition of GAD1-GABA pathway by PKCδ suppresses the proliferation, migration, tube formation and promotes the apoptosis of endothelial cells under high glucose and leads to delayed diabetic wound healing.
Basic and Translational Research
Article image
High-Fat Diet-Fed Kcnq1 Mutant Mice Have Reduced Pancreatic β-Cell Mass via Gene-Environment Interaction
Shun-ichiro Asahara, Hiroyuki Inoue, Yuka Ihara, Kyoko Teruyama, Asuka Imai, Chisako Hara, Mizuki Hara, Masako Seike, Aisha Yokoi, Nozomi Kido, Hirotaka Suzuki, Ayumi Kanno, Yuka Inaba, Hitoshi Watanabe, Go Shioi, Maki Kimura-Koyanagi, Michihiro Matsumoto, Hiroshi Inoue, Keiichi I. Nakayama, Wataru Ogawa, Masato Kasuga, Yoshiaki Kido
Diabetes Metab J. 2026;50(1):77-89.   Published online July 30, 2025
DOI: https://doi.org/10.4093/dmj.2024.0790
  • 2,526 View
  • 75 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
The potassium voltage-gated channel subfamily Q member 1 (KCNQ1) gene has recently received much attention as a candidate susceptibility gene for type 2 diabetes mellitus, especially in Asian populations. We previously reported that Kcnq1 mutant mice exhibit reduced insulin secretion and hyperglycemia due to a decrease in pancreatic β-cell mass. Through in vivo and in vitro analyses, we ascertained that this mechanism is the result of the downregulation of the non-coding RNA ‘Kcnq1ot1,’ which is expressed in the paternal allele of the Kcnq1 gene region, causing an increase in the expression of the cell cycle inhibitor cyclin dependent kinase inhibitor 1C (Cdkn1c). It was found that decreased Kcnq1ot1 expression resulted in pancreatic β-cell failure; however, the degree of pancreatic β-cell volume reduction was not severe.
Methods
We induced obesity in Kcnq1ot1 truncation mice by feeding them a high-fat diet and evaluated pancreatic β-cell mass.
Results
In the present study, we reveal that CCAAT/enhancer binding protein beta (C/EBPβ), which is expressed at higher levels in pancreatic β-cells in obese individuals, further increases the expression of Cdkn1c, which is upregulated by the Kcnq1 gene mutation. We found that simultaneous Cdkn1c hypomethylation and C/EBPβ overexpression in pancreatic β-cells causes a synergistic decrease in pancreatic β-cell mass.
Conclusion
This finding suggests that the synergistic effect of genetic factors such as Kcnq1 gene mutations and environmental factors such as obesity and overeating, which lead to increased expression of C/EBPβ, contribute to the regulation of pancreatic β-cell mass. This study is the first to show that the Kcnq1 gene is related to pancreatic β-cell mass through genetic-environment interactions.
Basic and Translational Research
Article image
Interleukin 33 Promotes Liver Sinusoidal Endothelial Cell Dysfunction and Hepatic Fibrosis in Diabetic Mice
Huimin Chen, Chao Gao, Li Mo, Xingzhu Yin, Li Chen, Bangfu Wu, Ying Zhao, Xueer Cheng, Chanhua Liang, Bichao Xu, Dongyan Li, Yanyan Li, Ping Yao, Yuhan Tang
Diabetes Metab J. 2025;49(6):1204-1218.   Published online May 22, 2025
DOI: https://doi.org/10.4093/dmj.2024.0532
  • 3,827 View
  • 169 Download
  • 1 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Interleukin 33 (IL33) drives liver fibrosis, and individuals with type 2 diabetes mellitus are more likely advanced to liver fibrosis. However, the role of IL33 in diabetic liver fibrosis remains unclear, prompting our investigation.
Methods
We developed a diabetes model in wild-type, IL33−/−, and suppression of tumorigenicity 2 (ST2−/−, IL33 receptor) mice. Furthermore, wild-type diabetic mice were injected with IL33 neutralizing antibody (αIL33). We also co-cultured human liver endothelial cells and human hepatic stellate cells to identify the role of IL33 in high palmitic acid and high glucose conditions.
Results
Hepatic collagen deposition was increased in diabetic mice, which was alleviated by IL33 knockout, ST2 knockout, or administration of αIL33. Also, αIL33 treatment blunted liver sinusoidal endothelial cell (LSEC) dysfunction and inflammation during diabetic liver fibrosis progression. Recombinant IL33 (rIL33) treatment aggravated autophagy disruption in the presence of palm acid and high glucose in LSECs, which was blunted by autophagy agonist rapamycin administration and ERK/MAPK inhibitor PD98059 treatment. Hepatic stellate cell line LX-2 co-cultured with rIL33-pretreated LSECs displayed augmented activation, which was also attenuated by rapamycin or PD98059 pretreated.
Conclusion
IL33 drives LSEC dysfunction and promotes diabetic hepatic fibrosis, thus a potential therapeutic target for diabetic liver fibrosis.

Citations

Citations to this article as recorded by  
  • Sappanone A, a potential natural inhibitor of PI3K, alleviates metabolic dysfunction-associated steatohepatitis in experimental models
    Xi Qiao, Qian Li, Ruiqi Fan, Yujie Cheng, Qingxuan Zeng, Huan Xue, Xiaoli Zhang, Yi Zhang, Yunfeng Liu
    Biochemical Pharmacology.2025; 242: 117305.     CrossRef
  • Cell-specific roles of autophagy in liver fibrosis: implications for targeted pharmacotherapy
    Chibo Liu, Huan Yang, Yongjie Liu, Min An, Zhiyong Weng, Lihua Li
    Annals of Medicine.2025;[Epub]     CrossRef
Review
Basic and Translational Research
Article image
Metabolic Sparks in the Liver: Metabolic and Epigenetic Reprogramming in Hepatic Stellate Cells Activation and Its Implications for Human Metabolic Diseases
Yeon Jin Roh, Hyeonki Kim, Dong Wook Choi
Diabetes Metab J. 2025;49(3):368-385.   Published online May 1, 2025
DOI: https://doi.org/10.4093/dmj.2025.0195
  • 5,789 View
  • 171 Download
  • 4 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   ePub   
The liver plays a fundamental role in metabolic homeostasis, integrating systemic fuel utilization with the progression of various metabolic diseases. Hepatic stellate cells (HSCs) are a key nonparenchymal cell type in the liver, which is essential for maintaining hepatic architecture in their quiescent state. However, upon chronic liver injury or metabolic stress, HSCs become activated, leading to excessive extracellular matrix deposition and pro-fibrotic signaling, ultimately positioning them as key players in liver pathology. Emerging evidence highlights the critical roles of metabolic reprogramming and epigenetic regulation in HSCs activation. HSCs activation is driven by both intrinsic fuel metabolism reprogramming and extrinsic metabolic cues from the microenvironment, while the metabolic intermediates actively reshape the epigenetic landscape, reinforcing fibrogenic transcriptional programs. In this review, we summarize recent advances in understanding how metabolic and epigenetic alterations drive HSCs activation, thereby shaping transcriptional programs that sustain fibrosis, and discuss potential therapeutic strategies to target these interconnected pathways in human metabolic diseases.

Citations

Citations to this article as recorded by  
  • Breaking Glycolysis Barriers to Immunotherapy with Nanomedicines
    Miya Zhang, Yanhong Ren, Jiaping Li, Jiaji Yu, Qianqi Li, Heng Zhao, Zheng Wang, Xiaoyuan Chen, Junjie Cheng
    ACS Nano Medicine.2026; 1(1): 149.     CrossRef
  • Burden of MASLD and liver fibrosis: evidence from Phenome India cohort
    Meghana Arvind, Anshul Verma, Sreeshma Raj K, Satyartha Prakash, Vignesh S. Kumar, Mohammad Azhar Uddin, Ayushi Narayan, Mamta Rathore, Nancy Rawat, Ankita Sahu, Yogesh Kumar, Pulkit Hasmukhbhai Leuva, Monika Sharma, Rajesh S, Dwaipayan Saha, Ankita Mridh
    The Lancet Regional Health - Southeast Asia.2026; 45: 100723.     CrossRef
  • Beyond Organ-Specific Therapies: A Unified Approach to Multi-Organ Fibrosis
    Ziyan Pan, Shadi Zerehpoosh, Shu-Chi Wang, Necati Örmeci, Won Kim, Mohammed Eslam
    Drug Design, Development and Therapy.2026; Volume 20: 1.     CrossRef
  • Hepatic stellate cell-specific miR-214 expression alleviates liver fibrosis without boosting steatosis and inflammation
    Fangqing Zhao, Xuan Niu, Ge Song, Lijie Wang, Yisheng Fu, Shuwen Li, Xinxin Gu, Qingkun Wang, Jiao Luo
    Journal of Translational Medicine.2025;[Epub]     CrossRef
  • PPARs in molecular pathogenesis and drug treatment of type 2 diabetes-related MASLD
    Amedeo Lonardo, Ralf Weiskirchen
    Exploration of Digestive Diseases.2025;[Epub]     CrossRef
Sulwon Lecture 2024
Basic and Translational Research
Article image
Overcoming β-Cell Dysfunction in Type 2 Diabetes Mellitus: CD36 Inhibition and Antioxidant System
Il Rae Park, Yong Geun Chung, Kyu Chang Won
Diabetes Metab J. 2025;49(1):1-12.   Published online January 1, 2025
DOI: https://doi.org/10.4093/dmj.2024.0796
  • 12,368 View
  • 482 Download
  • 10 Web of Science
  • 11 Crossref
AbstractAbstract PDFPubReader   ePub   
Type 2 diabetes mellitus (T2DM) is marked by chronic hyperglycemia, gradually worsening β-cell failure, and insulin resistance. Glucotoxicity and oxidative stress cause β-cell failure by increasing reactive oxygen species (ROS) production, impairing insulin secretion, and disrupting transcription factors such as pancreatic and duodenal homeobox 1 (PDX-1) and musculoaponeurotic fibrosarcoma oncogene family A (MafA). Cluster determinant 36 (CD36), an essential glycoprotein responsible for fatty acid uptake, exacerbates oxidative stress and induces the apoptosis of β-cells under hyperglycemic conditions through pathways involving ceramide, thioredoxin-interacting protein (TXNIP), and Rac1-nicotinamide adenine dinucleotide phosphate oxidase (NOX)-mediated redoxosome formation. Targeting CD36 pathways has emerged as a promising therapeutic strategy. Oral hypoglycemic agents, such as metformin, teneligliptin, and pioglitazone, have shown protective effects on β-cells by enhancing antioxidant defenses. These agents reduce glucotoxicity via mechanisms such as suppressing CD36 expression and stabilizing mitochondrial function. Additionally, novel insights into the glutathione antioxidant system and its role in β-cell survival underscore its therapeutic potential. This review focuses on the key contribution of oxidative stress and CD36 to β-cell impairment, the therapeutic promise of antioxidants, and the need for further research to apply these findings in clinical practice. Promising strategies targeting these mechanisms may help preserve β-cell function and slow T2DM progression.

Citations

Citations to this article as recorded by  
  • Small‐Molecule Sarco/Endoplasmic Reticulum Ca2+‐ATPase Activators Reverse Methylglyoxal‐Induced Inhibition through Nonantioxidant Mechanisms
    Carlos Cruz‐Cortés, Silvia Micháliková, Petronela Rezbáriková, L. Michel Espinoza‐Fonseca, Jana Viskupičová
    ChemMedChem.2026;[Epub]     CrossRef
  • Bone Marrow Mesenchymal Stromal Cells and Their Derived Extracellular Vesicles Protect Pancreatic Beta‐TC‐6 Cells From Hypoxia‐Induced Injury via miR‐539‐3p‐Mediated Downregulation of CD36 Expression
    Na Lin, Yaoyao Liang, Minying Tang, Fei Liu, Liuyan Chen, Lvying Wu, Yunfeng Fu, Zhuoyu Li, Lingfeng Zhu, Jin Chen, Yuelin Zhang
    Stem Cells International.2026;[Epub]     CrossRef
  • Potential Involvement of PI3K/AKT Signaling Pathway in the Protective Effects of Rhinacanthus nasutus Against Diabetic Nephropathy-Induced Oxidative Stress
    Junyu Liu, Yehao Lin, Xudong Yi, Min Zhang, Pharkphoom Panichayupakaranant, Joseph Buhagiar, Haixia Chen
    Antioxidants.2026; 15(2): 252.     CrossRef
  • Amylin and parameters of carbohydrate and lipid metabolism in patients with type 2 diabetes mellitus in the Azerbaijani population
    Z.G. Akhmedova, D.I. Kagramanova
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2026; 22(1): 35.     CrossRef
  • Polygonatum sibiricum polysaccharides enhance pancreatic β-cell function in diabetic zebrafish by mitigating mitochondrial oxidative damage via the AMPK-SIRT1 pathway
    Fan Lin, Wenjing Yu, Ping Li, Shuyao Tang, Yitong Ouyang, Liya Huang, Di Wu, Shaowu Cheng, Zhenyan Song
    Frontiers in Nutrition.2025;[Epub]     CrossRef
  • Melatonin Improves Lipid Homeostasis, Mitochondrial Biogenesis, and Antioxidant Defenses in the Liver of Prediabetic Rats
    Milena Cremer de Souza, Maria Luisa Gonçalves Agneis, Karoliny Alves das Neves, Matheus Ribas de Almeida, Geórgia da Silva Feltran, Ellen Mayara Souza Cruz, João Paulo Ferreira Schoffen, Luiz Gustavo de Almeida Chuffa, Fábio Rodrigues Ferreira Seiva
    International Journal of Molecular Sciences.2025; 26(10): 4652.     CrossRef
  • From Glucotoxicity to Lung Injury: Emerging Perspectives on Diabetes-Associated Respiratory Complications
    Hongmei Yu, Jie Liu, Xiaojuan He
    Lung.2025;[Epub]     CrossRef
  • Quercetin as an Anti-Diabetic Agent in Rodents—Is It Worth Testing in Humans?
    Tomasz Szkudelski, Katarzyna Szkudelska, Aleksandra Łangowska
    International Journal of Molecular Sciences.2025; 26(15): 7391.     CrossRef
  • Preclinical Evaluation of 2-Aminobenzothiazole Derivatives: In Silico, In Vitro, and Preliminary In Vivo Studies as Diabetic Treatments and Their Complications
    Natalia Reyes-Vallejo, Miguel Valdes, Adelfo Reyes-Ramírez, Juan Andres Alvarado-Salazar, Alejandro Cruz, Erik Andrade-Jorge, Jessica Elena Mendieta-Wejebe
    Molecules.2025; 30(16): 3427.     CrossRef
  • Metal organic frameworks (MOFs) synthesis and their use as a loading agent in oxidative stress-based diseases
    Muhammad Saqib Saif, Sana Batool, Yusra Majeed, Asadullah, Tuba Tariq, Li Haitao, Yanjun Duan, Ghazala Mustafa, Murtaza Hasan
    Journal of Environmental Chemical Engineering.2025; 13(5): 118725.     CrossRef
  • Synergism of Synthetic Sulfonamides and Natural Antioxidants for the Management of Diabetes Mellitus Associated with Oxidative Stress
    Ancuța Dinu (Iacob), Luminita-Georgeta Confederat, Ionut Dragostin, Ionela Daniela Morariu, Dana Tutunaru, Oana-Maria Dragostin
    Current Issues in Molecular Biology.2025; 47(9): 709.     CrossRef
Brief Report
Type 1 Diabetes
Article image
In Vivo Differentiation of Endogenous Bone Marrow-Derived Cells into Insulin-Producing Cells Using Four Soluble Factors
Seung-Ah Lee, Subin Kim, Seog-Young Kim, Jong Yoen Park, Hye Seung Jung, Sung Soo Chung, Kyong Soo Park
Diabetes Metab J. 2025;49(1):150-159.   Published online October 24, 2024
DOI: https://doi.org/10.4093/dmj.2024.0174
  • 4,079 View
  • 158 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Four soluble factors—putrescine, glucosamine, nicotinamide, and signal transducer and activator of transcription 3 (STAT3) inhibitor BP-1-102—were shown to differentiate bone marrow mononucleated cells (BMNCs) into functional insulin-producing cells (IPCs) in vitro. Transplantation of these IPCs improved hyperglycemia in diabetic mice. However, the role of endogenous BMNC regeneration in this effect was unclear. This study aimed to evaluate the effect of these factors on in vivo BMNC differentiation into IPCs in diabetic mice. Mice were orally administered the factors for 5 days, twice at 2-week intervals, and monitored for 45–55 days. Glucose tolerance, glucose-stimulated insulin secretion, and pancreatic insulin content were measured. Chimeric mice harboring BMNCs from insulin promoter luciferase/green fluorescent protein (GFP) transgenic mice were used to track endogenous BMNC fate. These factors lowered blood glucose levels, improved glucose tolerance, and enhanced insulin secretion. Immunostaining confirmed IPCs in the pancreas, showing the potential of these factors to induce β-cell regeneration and improve diabetes treatment.

Citations

Citations to this article as recorded by  
  • Kinetics of respiratory burst and its regulation in bone marrow granulocytes of diabetic db/db mice
    Valentina G. Safronova, Alsu R. Dyukina, Irina V. Tikhonova, Andrey A. Grinevich
    Free Radical Biology and Medicine.2025; 240: 80.     CrossRef
Original Article
Basic and Translational Research
Article image
NG2-Glia Cause Diabetic Blood-Brain Barrier Disruption by Secreting MMP-9
Xiaolong Li, Yan Cai, Zhu Zhong, Maolin Li, Dong Huang, Zhifei Qiao, Hongli Zhou, Zuo Zhang, Jiyin Zhou
Diabetes Metab J. 2026;50(1):47-61.   Published online July 23, 2024
DOI: https://doi.org/10.4093/dmj.2023.0342
  • 6,361 View
  • 207 Download
  • 2 Web of Science
  • 6 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Disorders of the blood-brain barrier (BBB) arising from diabetes mellitus are closely related to diabetic encephalopathy. Previous research has suggested that neuron-glia antigen 2 (NG2)-glia plays a key role in maintaining the integrity of the BBB. However, the mechanism by which NG2-glia regulates the diabetic BBB remains unclear.
Methods
Type 2 diabetes mellitus (T2DM) db/db mice and db/m mice were used. Evans-Blue BBB permeability tests and transmission electron microscopy techniques were applied. Tight junction proteins were assessed by immunofluorescence and transmission electron microscopy. NG2-glia number and signaling pathways were evaluated by immunofluorescence. Detection of matrix metalloproteinase-9 (MMP-9) in serum was performed using enzyme-linked immunosorbent assay (ELISA).
Results
In T2DM db/db mice, BBB permeability in the hippocampus significantly increased from 16 weeks of age, and the structure of tight junction proteins changed. The number of NG2-glia in the hippocampus of db/db mice increased around microvessels from 12 weeks of age. Concurrently, the expression of MMP-9 increased in the hippocampus with no change in serum. Sixteen- week-old db/db mice showed activation of the Wnt/β-catenin signaling in hippocampal NG2-glia. Treatment with XAV-939 improved structural and functional changes in the hippocampal BBB and reduced MMP-9 secretion by hippocampal NG2-glia in db/db mice. It was also found that the upregulation of β-catenin protein in NG2-glia in the hippocampus of 16-week-old db/db mice was significantly alleviated by treatment with XAV-939.
Conclusion
The results indicate that NG2-glia can lead to structural and functional disruption of the diabetic BBB by activating Wnt/β-catenin signaling, upregulating MMP-9, and degrading tight junction proteins.

Citations

Citations to this article as recorded by  
  • Blood and imaging biomarkers of blood-brain barrier disruption in diabetic individuals with cognitive impairment
    Luyao Qiao, Xiaoping Tang, Jiaxing Peng, Qing Xie, Mengqian Wu, Xinyue Chen, Zhenyu Tang
    Aging Clinical and Experimental Research.2026;[Epub]     CrossRef
  • Potential role of ghrelin in neuroprotection and cognitive function: implications for diabetic cognitive impairment
    Yuhan Zhang, Ruihua Zhang, Xin Wang, Leilei Shi, Hongzhe Zhu, Jiping Liu
    PeerJ.2025; 13: e18898.     CrossRef
  • Persisting blood–brain barrier disruption following cisplatin treatment in a mouse model of chemotherapy-associated cognitive impairment
    Roland Patai, Boglarka Csik, Adam Nyul-Toth, Rafal Gulej, Kiana Vali Kordestan, Siva Sai Chandragiri, Santny Shanmugarama, Stefano Tarantini, Peter Mukli, Anna Ungvari, Andriy Yabluchanskiy, Zoltan Ungvari, Anna Csiszar
    GeroScience.2025; 47(3): 3835.     CrossRef
  • Diabetes Differentially Alters Glial Cells in Different Brain Regions
    Rashmi Kumari, Lisa Willing, Patricia J. McLaughlin
    Diabetology.2025; 6(3): 16.     CrossRef
  • Quetiapine Reverses the Behavior and Myelination in Alcohol-Exposed Gestational Diabetes Mellitus Offspring Mice via ERK1/2 Signaling
    Dong Huang, Maolin Li, Zhifei Qiao, Hongli Zhou, Zuo Zhang, Jiyin Zhou
    Biological and Pharmaceutical Bulletin.2025; 48(3): 323.     CrossRef
  • Protection against stroke-induced blood-brain barrier disruption by Guanxinning injection and its active-component combination via TLR4/NF-κB/MMP9-mediated neuroinflammation
    Siwen Fan, Hongying Du, Yixin Yao, Huanyi Wang, Min Zhang, Xuliu Shi, Jiankun Yan, Li Peng, Guangxu Xiao, Shuang He, Ming Lyu, Yan Zhu
    Phytomedicine.2025; 147: 157162.     CrossRef
Reviews
Metabolic Risk/Epidemiology
Article image
Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome
Scott L. Friedman
Diabetes Metab J. 2024;48(2):161-169.   Published online January 26, 2024
DOI: https://doi.org/10.4093/dmj.2023.0240
  • 12,024 View
  • 520 Download
  • 24 Web of Science
  • 27 Crossref
AbstractAbstract PDFPubReader   ePub   
Metabolic dysfunction-associated steatotic (fatty) liver disease (MASLD), previously termed non-alcoholic fatty liver disease, is a worldwide epidemic that can lead to hepatic inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). The disease is typically a component of the metabolic syndrome that accompanies obesity, and is often overlooked because the liver manifestations are clinically silent until late-stage disease is present (i.e., cirrhosis). Moreover, Asian populations, including Koreans, have a higher fraction of patients who are lean, yet their illness has the same prognosis or worse than those who are obese. Nonetheless, ongoing injury can lead to hepatic inflammation and ballooning of hepatocytes as classic features. Over time, fibrosis develops following activation of hepatic stellate cells, the liver’s main fibrogenic cell type. The disease is usually more advanced in patients with type 2 diabetes mellitus, indicating that all diabetic patients should be screened for liver disease. Although there has been substantial progress in clarifying pathways of injury and fibrosis, there no approved therapies yet, but current research seeks to uncover the pathways driving hepatic inflammation and fibrosis, in hopes of identifying new therapeutic targets. Emerging molecular methods, especially single cell sequencing technologies, are revolutionizing our ability to clarify mechanisms underlying MASLD-associated fibrosis and HCC.

Citations

Citations to this article as recorded by  
  • Use of Artificial Intelligence-Assisted Histopathology for Evaluation of Sex-Specific Progression and Regression of Hepatocellular Carcinoma Related to Metabolic Dysfunction-Associated Fatty Liver Disease
    Ke Yin, Yuyun Song, Ran Fei, Xu Cong, Baiyi Liu, Zilong Wang, Xin Ai, Minjun Liao, Yayun Ren, Kutbuddin Akbary, Wei Wang, Qiang Yang, Xiao Teng, Nan Wu, Huiying Rao, Xiaoxiao Wang, Feng Liu
    Diagnostics.2026; 16(2): 234.     CrossRef
  • The Effect of GLP-1 Agonists on Patients with Metabolic-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis
    Denisia Adelina Tornea, Christian Goldis, Alexandru Isaic, Alexandru Catalin Motofelea, Alexandra Christa Sima, Tudor Ciocarlie, Andreea Crintea, Razvan Gheorghe Diaconescu, Nadica Motofelea, Adrian Goldis
    Pharmaceutics.2026; 18(1): 86.     CrossRef
  • Metabolic Syndrome in Focus: Emerging Causes, New Diagnostic Approaches and Criteria, and Long-Term Health Consequences
    Michalina Loson-Kawalec, Piotr Sawina, Anna Kowalczyk, Estera Pazek, Dorota Szydłowska, Julia Pawlowska, Dawid Boczkowski, Aleksandra Wielochowska, Dawid Szymanski, Mateusz Podkanowicz, Maciej Majchrzak, Tomasz Dolata, Weronika Majchrowicz, Patrycja Dadyn
    Cureus.2026;[Epub]     CrossRef
  • Activating the Osteoblastic USP26 Pathway Alleviates Multi‐Organ Fibrosis by Decreasing Insulin Resistance
    Jiyuan Tang, Wenkai Ye, Liang He, Zhou Dan, Leilei Chang, Zijie You, Yuanyue Jiang, Guoqing Tang, Lianfu Deng, Changwei Li
    Advanced Science.2026;[Epub]     CrossRef
  • Liver Fibrosis and the Risks of Impaired Cognition and Dementia: Mechanisms, Evidence, and Clinical Implications
    Mohamad Jamalinia, Ralf Weiskirchen, Amedeo Lonardo
    Medical Sciences.2026; 14(1): 44.     CrossRef
  • The Gut–Liver Axis in MASLD: From Host–Microbiome Crosstalk to Precision Therapeutics
    Ji Zhou, Bowen Zhu, Ziqian Bing, Tingting Wang, Yue Zhao
    Microorganisms.2026; 14(2): 471.     CrossRef
  • Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma
    Daniel Neureiter, Tobias Kiesslich, Matthias Ocker
    Medical Sciences.2026; 14(1): 110.     CrossRef
  • Metabolic liver imaging: What you need to know
    Luigi Asmundo, Amirkasra Mojtahed, Samay Prakash, Theodore T. Pierce, Jingwei Wei, Angelo Vanzulli
    Digestive and Liver Disease.2026;[Epub]     CrossRef
  • Valorizing Agro‐Food Waste for Nutraceutical Development: Sustainable Approaches for Managing Metabolic Dysfunction‐Associated Steatotic Liver Disease and Related Co‐Morbidities
    Laura Comi, Claudia Giglione, Fationa Tolaj Klinaku, Federico Pialorsi, Valentina Tollemeto, Maria Zurlo, Antonio Seneci, Paolo Magni
    Food Frontiers.2025; 6(2): 670.     CrossRef
  • The Triad of Risk: Linking MASLD, Cardiovascular Disease and Type 2 Diabetes; From Pathophysiology to Treatment
    Eleni Michalopoulou, John Thymis, Stamatios Lampsas, George Pavlidis, Konstantinos Katogiannis, Dimitrios Vlachomitros, Eleni Katsanaki, Gavriella Kostelli, Sotirios Pililis, Loukia Pliouta, Aikaterini Kountouri, Ioannis S. Papanikolaou, Vaia Lambadiari,
    Journal of Clinical Medicine.2025; 14(2): 428.     CrossRef
  • Role of triggering receptor expressed on myeloid cells 2 in the pathogenesis of non-alcoholic fatty liver disease
    Li-Hui Zhang, Su-Tong Liu, Qing Zhao, Xiao-Yan Liu, Tong Liu, Qiang Zhang, Ming-Hao Liu, Wen-Xia Zhao
    World Journal of Hepatology.2025;[Epub]     CrossRef
  • Efficacy of measuring natural killer-activating receptor ligands to predict the pathogenesis of metabolic dysfunction-associated steatotic liver disease
    Jun Arai, Akinori Okumura, Satoshi Kimoto, Kazumasa Sakamoto, Tomoya Kitada, Rena Kitano, Tadahisa Inoue, Sayaka Nishimura, Noriko Inden, Yukiko Muraki, Naoya Kato, Kiyoaki Ito
    Hepatology International.2025; 19(4): 836.     CrossRef
  • Metabolic Sparks in the Liver: Metabolic and Epigenetic Reprogramming in Hepatic Stellate Cells Activation and Its Implications for Human Metabolic Diseases
    Yeon Jin Roh, Hyeonki Kim, Dong Wook Choi
    Diabetes & Metabolism Journal.2025; 49(3): 368.     CrossRef
  • Extracellular Vesicle-Mediated Network in the Pathogenesis of Obesity, Diabetes, Steatotic Liver Disease, and Cardiovascular Disease
    Joonyub Lee, Won Gun Choi, Marie Rhee, Seung-Hwan Lee
    Diabetes & Metabolism Journal.2025; 49(3): 348.     CrossRef
  • Trends and visualization analysis of research on MASLD-Related hepatocellular carcinoma: a bibliometric analysis
    Hongkun Yin, Xusheng Zhang, Qi Wang
    Discover Oncology.2025;[Epub]     CrossRef
  • Elucidating the mechanistic interplay of AMPK and Nrf2 in MASLD: A focus on dietary phytochemical modulation of lipid and redox homeostasis
    Cindy H.J. Yu, H.P. Vasantha Rupasinghe
    Biochemical and Biophysical Research Communications.2025; 777: 152300.     CrossRef
  • Notch signaling in metabolic diseases: A key regulator and potential target
    Zhaoqing Xi, Junxia Zhang, Mingwei Bao
    Biochemical and Biophysical Research Communications.2025; 781: 152492.     CrossRef
  • Role of ChREBP–PPARα–FGF21 Axis in Metabolic Dysfunction of MASLD
    Karina Mireya Palacios Girón, Zamira Helena Hernandez Nazara, Montserrat Maldonado-González, Erika Martínez-López, Martha P. Sánchez Muñoz, Carlos Alfredo Bautista López, Ma. Soledad Aldana Aguiñaga, Jose Alfredo Dominguez-Rosales, Belinda Vargas-Guerrero
    International Journal of Molecular Sciences.2025; 26(23): 11425.     CrossRef
  • Prognostic Impact of Metabolic Syndrome and Steatotic Liver Disease in Hepatocellular Carcinoma Using Machine Learning Techniques
    Sergio Gil-Rojas, Miguel Suárez, Pablo Martínez-Blanco, Ana M. Torres, Natalia Martínez-García, Pilar Blasco, Miguel Torralba, Jorge Mateo
    Metabolites.2024; 14(6): 305.     CrossRef
  • Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
    Na Young Lee, Myeung Gi Choi, Eui Jin Lee, Ja Hyun Koo
    Archives of Pharmacal Research.2024; 47(6): 558.     CrossRef
  • New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?
    Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, Krizia Pocino, Gian Ludovico Rapaccini, Gabriele Ciasca, Umberto Basile, Valeria Carnazzo
    Journal of Personalized Medicine.2024; 14(8): 798.     CrossRef
  • AI Digital Pathology Using qFibrosis Shows Heterogeneity of Fibrosis Regression in Patients with Chronic Hepatitis B and C with Viral Response
    Feng Liu, Yameng Sun, Dean Tai, Yayun Ren, Elaine L. K. Chng, Aileen Wee, Pierre Bedossa, Rui Huang, Jian Wang, Lai Wei, Hong You, Huiying Rao
    Diagnostics.2024; 14(16): 1837.     CrossRef
  • Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation
    Harrison T. Muturi, Hilda E. Ghadieh, Suman Asalla, Sumona G. Lester, Getachew D. Belew, Sobia Zaidi, Raziyeh Abdolahipour, Abhishek P. Shrestha, Agnes O. Portuphy, Hannah L. Stankus, Raghd Abu Helal, Stefaan Verhulst, Sergio Duarte, Ali Zarrinpar, Leo A.
    Molecular Metabolism.2024; 88: 102010.     CrossRef
  • The impact of traditional Chinese medicine and dietary compounds on modulating gut microbiota in hepatic fibrosis: A review
    Xingting Xue, Hongbing Zhou, Jiaxing Gao, Xinghua Li, Jia Wang, Wanfu Bai, Yingchun Bai, Liya Fan, Hong Chang, Songli Shi
    Heliyon.2024; 10(19): e38339.     CrossRef
  • Beneficial Effects of Tyrosol and Oleocanthal from Extra Virgin Olive Oil on Liver Health: Insights into Their Mechanisms of Action
    Daniela Gabbia
    Biology.2024; 13(10): 760.     CrossRef
  • Kisspeptin Alleviates Human Hepatic Fibrogenesis by Inhibiting TGFβ Signaling in Hepatic Stellate Cells
    Kavita Prasad, Dipankar Bhattacharya, Shams Gamal Eldin Shams, Kimberly Izarraras, Tia Hart, Brent Mayfield, Maryjka B. Blaszczyk, Zhongren Zhou, Utpal B. Pajvani, Scott L. Friedman, Moshmi Bhattacharya
    Cells.2024; 13(19): 1651.     CrossRef
  • Novel Strategies Enhancing Bioavailability and Therapeutical Potential of Silibinin for Treatment of Liver Disorders
    Michal Selc, Radka Macova, Andrea Babelova
    Drug Design, Development and Therapy.2024; Volume 18: 4629.     CrossRef
Basic Research
Article image
Rediscovering Primary Cilia in Pancreatic Islets
Eun Young Lee, Jing W. Hughes
Diabetes Metab J. 2023;47(4):454-469.   Published online April 28, 2023
DOI: https://doi.org/10.4093/dmj.2022.0442
  • 10,386 View
  • 337 Download
  • 11 Web of Science
  • 12 Crossref
AbstractAbstract PDFPubReader   ePub   
Primary cilia are microtubule-based sensory and signaling organelles on the surfaces of most eukaryotic cells. Despite their early description by microscopy studies, islet cilia had not been examined in the functional context until recent decades. In pancreatic islets as in other tissues, primary cilia facilitate crucial developmental and signaling pathways in response to extracellular stimuli. Many human developmental and genetic disorders are associated with ciliary dysfunction, some manifesting as obesity and diabetes. Understanding the basis for metabolic diseases in human ciliopathies has been aided by close examination of cilia action in pancreatic islets at cellular and molecular levels. In this article, we review the evidence for ciliary expression on islet cells, known roles of cilia in pancreas development and islet hormone secretion, and summarize metabolic manifestations of human ciliopathy syndromes. We discuss emerging data on primary cilia regulation of islet cell signaling and the structural basis of cilia-mediated cell crosstalk, and offer our interpretation on the role of cilia in glucose homeostasis and human diseases.

Citations

Citations to this article as recorded by  
  • Glucagon secretion by pancreatic alpha-cells requires an intact tubulin-cytoskeleton-primary cilium axis
    Elena Casanueva-Álvarez, Alba Sanz-González, Alicia Vilas, Patricia Cámara-Torres, Magalie A. Ravier, Sara Eslava-Alcon, M. Carmen Duran-Ruiz, Cristina M. Ramírez, Peristera-Ioanna Petropoulou, Teresa Rodriguez-Calvo, Beatriz Merino, Germán Perdomo, Irene
    Molecular Medicine.2026;[Epub]     CrossRef
  • Molecular mechanisms of the obesity associated with Bardet‐Biedl syndrome: An update
    Bang‐Hua Zhong, Ning Nie, Ming Dong
    Obesity Reviews.2025;[Epub]     CrossRef
  • ciBAR1 loss in mice causes laterality defects, pancreatic degeneration, and altered glucose tolerance
    Eunice N Kim, Feng-Qian Li, Ken-Ichi Takemaru
    Life Science Alliance.2025; 8(2): e202402916.     CrossRef
  • Synchronized temporal-spatial analysis via microscopy and phosphoproteomics (STAMP) of quiescence
    Mohammad Ovais Azizzanjani, Rachel E. Turn, Anushweta Asthana, Karen Y. Linde-Garelli, Lucy Artemis Xu, Leilani E. Labrie, Mohammadamin Mobedi, Peter K. Jackson
    Science Advances.2025;[Epub]     CrossRef
  • Roles of primary cilia in cell death
    Sheng Chen, Chao Chen, Mingjue Chen, Feiyun Li, Chao Xie, Zengwu Shao, Guozhi Xiao
    Oral Science and Homeostatic Medicine.2025; 1(3): 9610030.     CrossRef
  • The NME7 Gene Is Involved in the Kinetics of Glucose Processing
    Daniela Vejražková, Josef Včelák, Markéta Vaňková, Petra Lukášová, Michaela Svojtková, Tereza Grimmichová, Hana Kvasničková, Andrea Tura, Lucie Šedová, Ondřej Šeda, Kateřina Škultéty, Běla Bendlová
    International Journal of Molecular Sciences.2025; 26(19): 9821.     CrossRef
  • The role of the primary cilium in thyroid function and dysfunction with implications for thyroid disease
    Inés Martín-Lacave, Victoria Vázquez-Román, Beatriz Pérez-Fernández, José María Fernández-Santos
    Histochemistry and Cell Biology.2025;[Epub]     CrossRef
  • Genome-wide association study and trans-ethnic meta-analysis identify novel susceptibility loci for type 2 diabetes mellitus
    Asma A Elashi, Salman M Toor, Umm-Kulthum Ismail Umlai, Yasser A Al-Sarraj, Shahrad Taheri, Karsten Suhre, Abdul Badi Abou-Samra, Omar M E Albagha
    BMC Medical Genomics.2024;[Epub]     CrossRef
  • Reduced Nephrin Tyrosine Phosphorylation Enhances Insulin Secretion and Increases Glucose Tolerance With Age
    Casey R Williamson, Nina Jones
    Endocrinology.2024;[Epub]     CrossRef
  • Beta-Hydroxybutyrate Promotes Basal Insulin Secretion While Decreasing Glucagon Secretion in Mouse and Human Islets
    Risha Banerjee, Ying Zhu, George P Brownrigg, Renata Moravcova, Jason C Rogalski, Leonard J Foster, James D Johnson, Jelena Kolic
    Endocrinology.2024;[Epub]     CrossRef
  • Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus
    Shengnan Huang, Fangfang Li, Chunhua Quan, Dan Jin
    Gut Microbes.2024;[Epub]     CrossRef
  • Beta cell primary cilia mediate somatostatin responsiveness via SSTR3
    Samantha E. Adamson, Zipeng A. Li, Jing W. Hughes
    Islets.2023;[Epub]     CrossRef
Basic Research
Article image
Regulation of Cellular Senescence in Type 2 Diabetes Mellitus: From Mechanisms to Clinical Applications
Kanako Iwasaki, Cristian Abarca, Cristina Aguayo-Mazzucato
Diabetes Metab J. 2023;47(4):441-453.   Published online March 6, 2023
DOI: https://doi.org/10.4093/dmj.2022.0416
  • 17,251 View
  • 720 Download
  • 27 Web of Science
  • 29 Crossref
AbstractAbstract PDFPubReader   ePub   
Cellular senescence is accelerated by hyperglycemia through multiple pathways. Therefore, senescence is an important cellular mechanism to consider in the pathophysiology of type 2 diabetes mellitus (T2DM) and an additional therapeutic target. The use of drugs that remove senescent cells has led to improvements in blood glucose levels and diabetic complications in animal studies. Although the removal of senescent cells is a promising approach for the treatment of T2DM, two main challenges limit its clinical application: the molecular basis of cellular senescence in each organ is yet to be understood, and the specific effect of removing senescent cells in each organ has to be determined. This review aims to discuss future applications of targeting senescence as a therapeutic option in T2DM and elucidate the characteristics of cellular senescence and senescence-associated secretory phenotype in the tissues important for regulating glucose levels: pancreas, liver, adipocytes, and skeletal muscle.

Citations

Citations to this article as recorded by  
  • Active ingredients, nutrition values and health-promoting effects of aboveground parts of rhubarb: a review
    Pengwang Wang, Zheng Liu, Bin Ma, Lingzhuo An, Luyao Zhang, Xia Li, Lanping Guo, Wenyuan Gao
    Food Science and Biotechnology.2026; 35(1): 39.     CrossRef
  • Senescence-regulating agents remodel mesenchymal stem cell-schwann cell circuitry for diabetic bone regeneration
    An Lao, Yiting Sun, Weiqi Li, Yu Zhuang, Ziyang Liu, Chenci Xu, Xiangbing Wu, Linhu Ge, Kaili Lin, Jianyong Wu, Jing Mao, Jiaqiang Liu
    Biomaterials.2026; 326: 123656.     CrossRef
  • Differential Activation of p53‐Lamin A/C and p16‐Rb‐Mediated Senescence Pathways in Trophoblasts From Pregnancies Complicated by Type A2 Gestational Diabetes Mellitus
    Leena Kadam, Kaylee Chan, Kylia Ahuna, Nicole E. Marshall, Leslie Myatt
    The FASEB Journal.2026;[Epub]     CrossRef
  • Renal podocyte senescence in human obesity detected by urinary extracellular vesicles
    Lei Zhang, Mina Al-Saeedi, Aleksandar Denic, Kyra L. Jordan, Ning Yang, Fei Yuan, Xiangyang Zhu, Ailing Xue, Hui Tang, Alfonso Eirin, Amir Lerman, Mary Fidler, LaTonya J. Hickson, Andrew D. Rule, Aleksandra Kukla, Lilach O. Lerman
    eBioMedicine.2026; 124: 106116.     CrossRef
  • AQP1 mediates pancreatic β cell senescence induced by metabolic stress through modulating intracellular H2O2 level
    Qihui Yan, Haifeng Zhang, Yunxiao Ma, Lin Sun, Zhiyue Chen, Yinbei Zhang, Weiying Guo
    Free Radical Biology and Medicine.2025; 226: 171.     CrossRef
  • Targeting the hypothalamic MC4 receptor: A novel approach to senolytic therapy?
    Youn Ju Kim, Joo Hyun Lim, Eun Ran Kim
    Medical Hypotheses.2025; 195: 111551.     CrossRef
  • Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function
    Atenea A. Perez-Serna, Daniel Guzman-Llorens, Reinaldo S. Dos Santos, Laura Marroqui
    Biomedicines.2025; 13(1): 223.     CrossRef
  • Cellular Senescence in Health, Disease, and Lens Aging
    Ying Qin, Haoxin Liu, Hongli Wu
    Pharmaceuticals.2025; 18(2): 244.     CrossRef
  • Recent Advances in Anti‐Aging Therapeutic Strategies Targeting DNA Damage Response and Senescence‐Associated Secretory Phenotype‐Linked Signaling Cascade
    Jawad Nadeem, Razia Sultana, Amna Parveen, Sun Yeou Kim
    Cell Biochemistry and Function.2025;[Epub]     CrossRef
  • Anti-senescence therapies: a new concept to address cardiovascular disease
    Stevan D Stojanović, Thomas Thum, Johann Bauersachs
    Cardiovascular Research.2025; 121(5): 730.     CrossRef
  • Taurine Alleviates Pancreatic β‐Cell Senescence by Inhibition of p53 Pathway
    Baomin Wang, Ziyan Wang, Yumei Yang, Melody Yuen Man Ho, Runyue Yang, Huizi Yang, Siyi Liu, Huige Lin, Kenneth King Yip Cheng, Xiaomu Li
    Journal of Diabetes.2025;[Epub]     CrossRef
  • New Insights into the Role of Cellular Senescence and Its Therapeutic Implications in Ocular Diseases
    Junying Wu, Xiuxing Liu, Yidan Liu, Wenru Su, Yehong Zhuo
    Bioengineering.2025; 12(6): 563.     CrossRef
  • Microgravity Therapy as Treatment for Decelerated Aging and Successful Longevity
    Nadine Mozalbat, Lital Sharvit, Gil Atzmon
    International Journal of Molecular Sciences.2025; 26(13): 6544.     CrossRef
  • Hesperetin Alleviates Bleomycin‐Induced Pulmonary Fibrosis by Modulating Cellular Senescence and Promoting Impaired Autophagy in a CISD2‐Dependent Manner
    Qi Lin, Wenjie Fan, Ziyi Chen, Bin Chen, Chaofeng Zhang
    The FASEB Journal.2025;[Epub]     CrossRef
  • Anti-Senescence Effect of Inhibiting Sodium-Glucose Cotransporter 2 and α-Glucosidase in a Type 2 Diabetes Mellitus Animal Model
    Serin Hong, Byung Soo Kong, Hyunsuk Lee, Young Min Cho
    Diabetes & Metabolism Journal.2025; 49(6): 1229.     CrossRef
  • Glycemic status-dependent proteomic signatures of biological aging for health risk prediction
    Jiang Li, Jie Li, Xiaoqin Xu, Yuefeng Yu, Wenqi Shen, Ying Sun, Yanqi Fu, Xiao Tan, Ningjian Wang, Yingli Lu, Bin Wang
    GeroScience.2025;[Epub]     CrossRef
  • Comparative effects of aerobic exercise, resistance exercise and yoga on metabolic profile and cellular ageing in type 2 diabetes mellitus
    Subham, Radhika Jindal, Shyam Sunder Sharma, Harleen Uppal, Sujatha George, Renuka Sharma
    Indian Journal of Physiology and Pharmacology.2025; 0: 1.     CrossRef
  • Amide Alkaloids as Privileged Sources of Senomodulators for Therapeutic Purposes in Age-Related Diseases
    Mazzarine Dotou, Aurore L’honoré, Roba Moumné, Chahrazade El Amri
    Journal of Natural Products.2024; 87(3): 617.     CrossRef
  • Study on the Pathogenesis of Cell Senescence in Non-Alcoholic Fatty Liver
    丽媛 黄
    Medical Diagnosis.2024; 14(01): 76.     CrossRef
  • Senescent adipocytes and type 2 diabetes – current knowledge and perspective concepts
    Weronika Kruczkowska, Julia Gałęziewska, Mateusz Kciuk, Adrianna Gielecińska, Elżbieta Płuciennik, Zbigniew Pasieka, Lin-Yong Zhao, Yi-Jin Yu, Damian Kołat, Żaneta Kałuzińska-Kołat
    Biomolecular Concepts.2024;[Epub]     CrossRef
  • New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions
    Kyriazoula Chatzianagnostou, Melania Gaggini, Adrian Suman Florentin, Ludovica Simonini, Cristina Vassalle
    International Journal of Molecular Sciences.2024; 25(11): 6218.     CrossRef
  • Benefits of Quercetin on Glycated Hemoglobin, Blood Pressure, PiKo-6 Readings, Night-Time Sleep, Anxiety, and Quality of Life in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
    Aikaterini E. Mantadaki, Manolis Linardakis, Maria Tsakiri, Stella Baliou, Persefoni Fragkiadaki, Elena Vakonaki, Manolis N. Tzatzarakis, Aristidis Tsatsakis, Emmanouil K. Symvoulakis
    Journal of Clinical Medicine.2024; 13(12): 3504.     CrossRef
  • Insulin Resistance in Women Correlates with Chromatin Histone Lysine Acetylation, Inflammatory Signaling, and Accelerated Aging
    Christina M. Vidal, Jackelyn A. Alva-Ornelas, Nancy Zhuo Chen, Parijat Senapati, Jerneja Tomsic, Vanessa Myriam Robles, Cristal Resto, Nancy Sanchez, Angelica Sanchez, Terry Hyslop, Nour Emwas, Dana Aljaber, Nick Bachelder, Ernest Martinez, David Ann, Ver
    Cancers.2024; 16(15): 2735.     CrossRef
  • Quercetin Intake and Absolute Telomere Length in Patients with Type 2 Diabetes Mellitus: Novel Findings from a Randomized Controlled Before-and-After Study
    Aikaterini E. Mantadaki, Stella Baliou, Manolis Linardakis, Elena Vakonaki, Manolis N. Tzatzarakis, Aristides Tsatsakis, Emmanouil K. Symvoulakis
    Pharmaceuticals.2024; 17(9): 1136.     CrossRef
  • Body Composition and Senescence: Impact of Polyphenols on Aging-Associated Events
    Tanila Wood dos Santos, Quélita Cristina Pereira, Isabela Monique Fortunato, Fabrício de Sousa Oliveira, Marisa Claudia Alvarez, Marcelo Lima Ribeiro
    Nutrients.2024; 16(21): 3621.     CrossRef
  • Loxenatide Alleviates High Glucose-Induced Pancreatic β-Cell Senescence via Regulating the PERK/eIF2α Pathway
    Junfang Yuan, Yuzhong Wang, Defeng Wang, Han Yan, Ning Wang
    Hormone and Metabolic Research.2024; 56(12): 890.     CrossRef
  • Insulin Sensitivity Controls Activity of Pathogenic CD4+ T Cells in Rheumatoid Arthritis
    Malin C. Erlandsson, Eric Malmhäll-Bah, Venkataragavan Chandrasekaran, Karin M. E. Andersson, Lisa M. Nilsson, Sofia Töyrä Silfverswärd, Rille Pullerits, Maria I. Bokarewa
    Cells.2024; 13(24): 2124.     CrossRef
  • The Effect of Long-Term Passage on Porcine SMCs’ Function and the Improvement of TGF-β1 on Porcine SMCs’ Secretory Function in Late Passage
    Yan-Yan Zheng, Ze-Nan Hu, Zheng Liu, Yi-Chen Jiang, Ren-Peng Guo, Shi-Jie Ding, Guang-Hong Zhou
    Foods.2023; 12(14): 2682.     CrossRef
  • Exploring the Relationship between Cellular Senescence Markers and Aging-Related Diseases
    怡 罗
    Advances in Clinical Medicine.2023; 13(08): 12298.     CrossRef
Original Article
Basic Research
Article image
Hyperglycemia-Suppressed SMARCA5 Disrupts Transcriptional Homeostasis to Facilitate Endothelial Dysfunction in Diabetes
Ju Wang, Hui Zhou, Jinhua Shao, Shu Zhang, Jing Jin
Diabetes Metab J. 2023;47(3):366-381.   Published online March 6, 2023
DOI: https://doi.org/10.4093/dmj.2022.0179
  • 5,972 View
  • 129 Download
  • 4 Web of Science
  • 4 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Dysfunction of vascular endothelial cells (ECs) plays a central role in the pathogenesis of cardiovascular complications in diabetes. SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SMARCA5) is a key regulator of chromatin structure and DNA repair, but its role in ECs remains surprisingly unexplored. The current study was designed to elucidate the regulated expression and function of SMARCA5 in diabetic ECs.
Methods
SMARCA5 expression was evaluated in ECs from diabetic mouse and human circulating CD34+ cells using quantitative reverse transcription polymerase chain reaction and Western blot. Effects of SMARCA5 manipulation on ECs function were evaluated using cell migration, in vitro tube formation and in vivo wound healing assays. Interaction among oxidative stress, SMARCA5 and transcriptional reprogramming was elucidated using luciferase reporter assay, electrophoretic mobility shift assay and chromatin immunoprecipitation.
Results
Endothelial SMARCA5 expression was significantly decreased in diabetic rodents and humans. Hyperglycemia-suppressed SMARCA5 impaired EC migration and tube formation in vitro, and blunted vasculogenesis in vivo. Contrarily, overexpression of SMARCA5 in situ by a SMARCA5 adenovirus-incorporated hydrogel effectively promoted the rate of wound healing in a dorsal skin punch injury model of diabetic mice. Mechanistically, hyperglycemia-elicited oxidative stress suppressed SMARCA5 transactivation in a signal transducer and activator of transcription 3 (STAT3)-dependent manner. Moreover, SMARCA5 maintained transcriptional homeostasis of several pro-angiogenic factors through both direct and indirect chromatin-remodeling mechanisms. In contrast, depletion of SMARCA5 disrupted transcriptional homeostasis to render ECs unresponsive to established angiogenic factors, which ultimately resulted in endothelial dysfunction in diabetes.
Conclusion
Suppression of endothelial SMARCA5 contributes to, at least in part, multiple aspects of endothelial dysfunction, which may thereby exacerbate cardiovascular complications in diabetes.

Citations

Citations to this article as recorded by  
  • From waste to wonder: exploring the hypoglycemic and anti-oxidant properties of corn processing by−products
    Xiaoqian Yang, Yuelong Wang, Jingfeng Li, Yuxing Tai, Kunping Yang, Jingwei Lv, Jiaming Sun, Hui Zhang
    Frontiers in Chemistry.2024;[Epub]     CrossRef
  • E3 ubiquitin ligase RNF180 mediates the ALKBH5/SMARCA5 axis to promote colon inflammation and Th17/Treg imbalance in ulcerative colitis mice
    Kailing Wang, Fan Liu, Budumu Muchu, Jiawen Deng, Jing Peng, Yan Xu, Fujun Li, Miao Ouyang
    Archives of Pharmacal Research.2024; 47(7): 645.     CrossRef
  • USP3 promotes DNA damage response and chemotherapy resistance through stabilizing and deubiquitinating SMARCA5 in prostate cancer
    Sheng Li, Situ Xiong, Zhongqi Li, Lin Yang, Hailang Yang, Jing Xiong, Wang Pan, Ju Guo, Songhui Xu, Bin Fu
    Cell Death & Disease.2024;[Epub]     CrossRef
  • Overexpression of Chromatin Remodeling Factor SRG3 Down-Regulates IL1β-Expressing M1 Macrophages and IL17-Producing T Cells in Adipose Tissues
    Jungmin Jeon, Sung Won Lee, Hyun Jung Park, Yun Hoo Park, Tae-Cheol Kim, Sujin Lee, Seyeong Lee, Luc Van Kaer, Seokmann Hong
    International Journal of Molecular Sciences.2024; 25(21): 11681.     CrossRef
Reviews
Basic Research
Article image
Heterogeneity of Islet Cells during Embryogenesis and Differentiation
Shugo Sasaki, Takeshi Miyatsuka
Diabetes Metab J. 2023;47(2):173-184.   Published online January 12, 2023
DOI: https://doi.org/10.4093/dmj.2022.0324
  • 9,898 View
  • 322 Download
  • 5 Web of Science
  • 6 Crossref
AbstractAbstract PDFPubReader   ePub   
Diabetes is caused by insufficient insulin secretion due to β-cell dysfunction and/or β-cell loss. Therefore, the restoration of functional β-cells by the induction of β-cell differentiation from embryonic stem (ES) and induced-pluripotent stem (iPS) cells, or from somatic non-β-cells, may be a promising curative therapy. To establish an efficient and feasible method for generating functional insulin-producing cells, comprehensive knowledge of pancreas development and β-cell differentiation, including the mechanisms driving cell fate decisions and endocrine cell maturation is crucial. Recent advances in single-cell RNA sequencing (scRNA-seq) technologies have opened a new era in pancreas development and diabetes research, leading to clarification of the detailed transcriptomes of individual insulin-producing cells. Such extensive high-resolution data enables the inference of developmental trajectories during cell transitions and gene regulatory networks. Additionally, advancements in stem cell research have not only enabled their immediate clinical application, but also has made it possible to observe the genetic dynamics of human cell development and maturation in a dish. In this review, we provide an overview of the heterogeneity of islet cells during embryogenesis and differentiation as demonstrated by scRNA-seq studies on the developing and adult pancreata, with implications for the future application of regenerative medicine for diabetes.

Citations

Citations to this article as recorded by  
  • Pancreatic β-cell remodeling in health and aging: Lessons from rodents and humans
    Radwan Darwish, Yasmine Alcibahy, Sangeeta Dhawan, Alexandra E. Butler, Abu Saleh Md Moin
    Ageing Research Reviews.2025; 110: 102815.     CrossRef
  • Single-cell RNA sequencing in studies of type 1 diabetes mellitus: modern state-of-the-art and technical peculiarities
    Azat Vadimovich Abdullatypov, Olga Valentinovna Glushkova, Ekaterina Sergeevna Petriaikina, Viktor Pavlovich Bogdanov, Dmitry Vyacheslavovich Tabakov, Vasilii Eduardovich Akimov, Vladimir Sergeevich Yudin, Anton Arturovich Keskinov, Sergey Mikhailovich Yu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Imeglimin enhances α-to-β reprograming mediated by PDX1 in β-cell ablated islets
    Rei Fujishima, Tomomi Taguchi, Naoya Shimizu, Agena Suzuki, Wataru Hagiwara, Shiori Ito, Satomi Takebe, Mitsuko Inoue, Takeshi Miyatsuka
    Biochemical and Biophysical Research Communications.2025; 790: 152886.     CrossRef
  • Transcriptional and temporal heterogeneity of developing α cells revealed by single-cell RNA sequencing
    Naoya Shimizu, Tomomi Taguchi, Miwa Himuro, Iichiro Shimomura, Francis C. Lynn, Hirotaka Watada, Shugo Sasaki, Takeshi Miyatsuka
    Biochemical and Biophysical Research Communications.2025; 792: 152996.     CrossRef
  • Investigation of the motif activity of transcription regulators in pancreatic β-like cell subpopulations differentiated from human induced pluripotent stem cells
    Eric Leclerc, Mikhail Pachkov, Lisa Morisseau, Fumiya Tokito, Cecile Legallais, Rachid Jellali, Masaki Nishikawa, Amar Abderrahmani, Yasuyuki Sakai
    Molecular Omics.2024; 20(10): 654.     CrossRef
  • Newly discovered knowledge pertaining to glucagon and its clinical applications
    Dan Kawamori, Shugo Sasaki
    Journal of Diabetes Investigation.2023; 14(7): 829.     CrossRef
Pathophysiology
Article image
Endoplasmic Reticulum Stress and Dysregulated Autophagy in Human Pancreatic Beta Cells
Seoil Moon, Hye Seung Jung
Diabetes Metab J. 2022;46(4):533-542.   Published online July 27, 2022
DOI: https://doi.org/10.4093/dmj.2022.0070
  • 11,698 View
  • 327 Download
  • 22 Web of Science
  • 21 Crossref
AbstractAbstract PDFPubReader   ePub   
Pancreatic beta cell homeostasis is crucial for the synthesis and secretion of insulin; disruption of homeostasis causes diabetes, and is a treatment target. Adaptation to endoplasmic reticulum (ER) stress through the unfolded protein response (UPR) and adequate regulation of autophagy, which are closely linked, play essential roles in this homeostasis. In diabetes, the UPR and autophagy are dysregulated, which leads to beta cell failure and death. Various studies have explored methods to preserve pancreatic beta cell function and mass by relieving ER stress and regulating autophagic activity. To promote clinical translation of these research results to potential therapeutics for diabetes, we summarize the current knowledge on ER stress and autophagy in human insulin-secreting cells.

Citations

Citations to this article as recorded by  
  • The Role of Crosstalk Between the Unfolded Protein Response and Autophagy in Diseases Associated with Sympathetic Nervous System Imbalance: Mechanisms and Therapeutic Perspectives
    Bo Xu, Yi Yang, Renjun Wang
    International Journal of Molecular Sciences.2026; 27(3): 1282.     CrossRef
  • POTENSI HIDROLISAT PROTEIN IKAN DALAM KONTROL GLUKOSA DARAH DAN NAFSU MAKAN PADA OBESITAS UNTUK MENCEGAH DIABETES MELITUS TIPE 2: LITERATURE REVIEW
    Herlina Hapsari, Etika Ratna Noer, Fitriyono Ayustaningwarno
    Journal of Nutrition College.2026; 15(1): 60.     CrossRef
  • Ambient air fine particulate matter (PM10 and PM2.5) and risk of type 2 diabetes mellitus and mechanisms of effects: a global systematic review and meta-analysis
    Salah Azizi, Mohammad Hadi Dehghani, Ramin Nabizadeh
    International Journal of Environmental Health Research.2025; 35(6): 1413.     CrossRef
  • Crosstalk between autophagy and other forms of programmed cell death
    Huaiyuan Wang, Xiran Feng, Huilin He, Lingyu Li, Yiqiong Wen, Xiaofei Liu, Bifeng He, Shu Hua, Shibo Sun
    European Journal of Pharmacology.2025; 995: 177414.     CrossRef
  • Endoplasmic Reticulum Stress in Tuberculosis: Molecular Bases and Pathophysiological Implications in the Immunopathogenesis of the Disease
    Jorge Sousa, Lívia Caricio Martins, Julia Moura, Amanda Pereira, Bárbara Vasconcelos, Gustavo Ferro, Pedro Vasconcelos, Juarez Quaresma
    International Journal of Molecular Sciences.2025; 26(10): 4522.     CrossRef
  • The Critical Role of Autophagy in the Pathogenesis of Diabetic Osteoporosis: Mechanisms and Therapeutic Measures
    Kehao Hou, Weipeng Shi, Kuishuai Xu, Tianrui Wang, Yingze Zhang
    Drug Design, Development and Therapy.2025; Volume 19: 9913.     CrossRef
  • Glucolipotoxicity Suppressed Autophagy and Insulin Contents in Human Islets, and Attenuation of PERK Activity Enhanced Them in an ATG7-Dependent Manner
    Seoil Moon, Ji Yoon Lim, Mirang Lee, Youngmin Han, Hongbeom Kim, Wooil Kwon, Jin-Young Jang, Mi Na Kim, Kyong Soo Park, Hye Seung Jung
    Diabetes & Metabolism Journal.2024; 48(2): 231.     CrossRef
  • Endoplasmic reticulum stress: A possible connection between intestinal inflammation and neurodegenerative disorders
    Giorgio Vivacqua, Romina Mancinelli, Stefano Leone, Rosa Vaccaro, Ludovica Garro, Simone Carotti, Ludovica Ceci, Paolo Onori, Luigi Pannarale, Antonio Franchitto, Eugenio Gaudio, Arianna Casini
    Neurogastroenterology & Motility.2024;[Epub]     CrossRef
  • Docosahexanoic Acid Attenuates Palmitate-Induced Apoptosis by Autophagy Upregulation via GPR120/mTOR Axis in Insulin-Secreting Cells
    Seok-Woo Hong, Jinmi Lee, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
    Endocrinology and Metabolism.2024; 39(2): 353.     CrossRef
  • HIV-1 Tat-Mediated Human Müller Glial Cell Senescence Involves Endoplasmic Reticulum Stress and Dysregulated Autophagy
    Uma Maheswari Deshetty, Nivedita Chatterjee, Shilpa Buch, Palsamy Periyasamy
    Viruses.2024; 16(6): 903.     CrossRef
  • Gallic acid suppresses the progression of clear cell renal cell carcinoma through inducing autophagy via the PI3K/Akt/Atg16L1 signaling pathway
    Tianxiang Zhang, Xi Zhang, Yang Fei, Jinsen Lu, Dairan Zhou, Li Zhang, Song Fan, Jun Zhou, Chaozhao Liang, Yang Su
    International Journal of Oncology.2024;[Epub]     CrossRef
  • Dysregulation of pancreatic β-cell autophagy and the risk of type 2 diabetes
    Hayder M. Al-kuraishy, Majid S. Jabir, Ali I. Al-Gareeb, Daniel J. Klionsky, Ali K. Albuhadily
    Autophagy.2024; 20(11): 2361.     CrossRef
  • Endoplasmic reticulum stress mechanisms and exercise intervention in type 2 diabetes mellitus
    Qianyu Chen, Xiaoqin Zhao, Zujie Xu, Yiyao Liu
    Biomedicine & Pharmacotherapy.2024; 177: 117122.     CrossRef
  • Tangningtongluo Tablet ameliorates pancreatic damage in diabetic mice by inducing autophagy and inhibiting the PI3K/Akt/mTOR signaling pathway
    Ying Ren, Xiangka Hu, Mushuang Qi, Wanjun Zhu, Jin Li, Shuyu Yang, Chunmei Dai
    International Immunopharmacology.2024; 142: 113032.     CrossRef
  • Pancreatic islet remodeling in cotadutide-treated obese mice
    Renata Spezani, Thatiany Souza Marinho, Luiz E. Macedo Cardoso, Marcia Barbosa Aguila, Carlos Alberto Mandarim-de-Lacerda
    Life Sciences.2023; 327: 121858.     CrossRef
  • Modulation of Unfolded Protein Response Restores Survival and Function of β-Cells Exposed to the Endocrine Disruptor Bisphenol A
    Laura Maria Daian, Gabriela Tanko, Andrei Mircea Vacaru, Luiza Ghila, Simona Chera, Ana-Maria Vacaru
    International Journal of Molecular Sciences.2023; 24(3): 2023.     CrossRef
  • Interplay of skeletal muscle and adipose tissue: sarcopenic obesity
    Min Jeong Park, Kyung Mook Choi
    Metabolism.2023; 144: 155577.     CrossRef
  • Identification and analysis of type 2 diabetes-mellitus-associated autophagy-related genes
    Kun Cui, Zhizheng Li
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Sestrin2 in diabetes and diabetic complications
    Xiaodan Zhang, Zirui Luo, Jiahong Li, Yaxuan Lin, Yu Li, Wangen Li
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Crosstalk between autophagy and insulin resistance: evidence from different tissues
    Asie Sadeghi, Maryam Niknam, Mohammad Amin Momeni-Moghaddam, Maryam Shabani, Hamid Aria, Alireza Bastin, Maryam Teimouri, Reza Meshkani, Hamed Akbari
    European Journal of Medical Research.2023;[Epub]     CrossRef
  • Beta cell lipotoxicity in the development of type 2 diabetes: the need for species-specific understanding
    Patricia Thomas, Meurig T. Gallagher, Gabriela Da Silva Xavier
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
Pathophysiology
Glial and Vascular Cell Regulation of the Blood-Brain Barrier in Diabetes
Xiaolong Li, Yan Cai, Zuo Zhang, Jiyin Zhou
Diabetes Metab J. 2022;46(2):222-238.   Published online March 18, 2022
DOI: https://doi.org/10.4093/dmj.2021.0146
  • 16,604 View
  • 444 Download
  • 43 Web of Science
  • 44 Crossref
AbstractAbstract PDFPubReader   ePub   
As a structural barrier, the blood-brain barrier (BBB) is located at the interface between the brain parenchyma and blood, and modulates communication between the brain and blood microenvironment to maintain homeostasis. The BBB is composed of endothelial cells, basement membrane, pericytes, and astrocytic end feet. BBB impairment is a distinguishing and pathogenic factor in diabetic encephalopathy. Diabetes causes leakage of the BBB through downregulation of tight junction proteins, resulting in impaired functioning of endothelial cells, pericytes, astrocytes, microglia, nerve/glial antigen 2-glia, and oligodendrocytes. However, the temporal regulation, mechanisms of molecular and signaling pathways, and consequences of BBB impairment in diabetes are not well understood. Consequently, the efficacy of therapies diabetes targeting BBB leakage still lags behind the requirements. This review summarizes the recent research on the effects of diabetes on BBB composition and the potential roles of glial and vascular cells as therapeutic targets for BBB disruption in diabetic encephalopathy.

Citations

Citations to this article as recorded by  
  • Diabetic encephalopathy models: A systematic review from cells to animals
    Yongjie Xu, Changyudong Huang, Yiqiong Zhang, Haizhi Li, Huiru Yang, Mi Liu, Liying Zhu, Chengcheng Li, Yinxue Zhong, Lei Tang, Shuyun Zhao, Wei Pan
    Experimental Neurology.2026; 395: 115477.     CrossRef
  • NG2-Glia Cause Diabetic Blood-Brain Barrier Disruption by Secreting MMP-9
    Xiaolong Li, Yan Cai, Zhu Zhong, Maolin Li, Dong Huang, Zhifei Qiao, Hongli Zhou, Zuo Zhang, Jiyin Zhou
    Diabetes & Metabolism Journal.2026; 50(1): 47.     CrossRef
  • Smog, sugar, and synapses: Unraveling the PM2.5-insulin resistance-Alzheimer’s disease axis
    Hsuan-Yu Huang, Yu-Yin Huang, Chia-Lin Wu, Wei-Chien Huang, Chih-Ho Lai
    Redox Biology.2026; 90: 104031.     CrossRef
  • Time-dependent neurovascular unit dysfunction in ischemic stroke: mechanisms of neurovascular uncoupling and its clinical impact
    Rijhul Lahariya, Mainak Sinha, Bandana Kumari, Keyush Venket Subramanian, Gargee Anand
    International Journal of Neuroscience.2026; : 1.     CrossRef
  • Ischemic stroke and cardiovascular comorbidity
    S. A. Litvinova, T. A. Voronina, T. S. Ganshina, N. A. Gladysheva, B. B. Shoibonov, M. B. Vititnova, S. A. Kryzhanovskii, V. L. Dorofeev
    Pharmacokinetics and Pharmacodynamics.2026; (4): 46.     CrossRef
  • Hyperglycaemia perturbs blood-brain barrier integrity through its effects on endothelial cell characteristics and function
    Arshad Hashmat, Jingyuan Ya, Rais Kadir, Mansour Alwjwaj, Ulvi Bayraktutan
    Tissue Barriers.2025;[Epub]     CrossRef
  • Astrocyte involvement in metabolic regulation and disease
    Muhammad Naveed, Kathryn Smedlund, Qi-Gang Zhou, Weikang Cai, Jennifer W. Hill
    Trends in Endocrinology & Metabolism.2025; 36(3): 219.     CrossRef
  • Emerging role of adaptive immunity in diabetes-induced cognitive impairment: from the periphery to the brain
    Genhui Yang, Runtao Su, Jie Bu, Ying Li, Xueling Lin, Jiahui Jin, Yanjun Zhang, Pengwei Zhuang, Hong Guo, Qingsheng Yin
    Metabolic Brain Disease.2025;[Epub]     CrossRef
  • Type 2 Diabetes and Cognitive Decline: A Neurovascular Perspective
    Arbind K. Choudhary
    Chronicle of Diabetes Research and Practice.2025; 4(1): 31.     CrossRef
  • Diabetes Mellitus Impairs Blood‐Brain Barrier Integrality and Microglial Reactivity
    Shaojun Liu, Jie Hao, Tingting Yu, Valery V Tuchin, Junming Li, Dongyu Li, Dan Zhu
    Journal of Biophotonics.2025;[Epub]     CrossRef
  • Aging, vascular dysfunction, and the blood–brain barrier: unveiling the pathophysiology of stroke in older adults
    Saleh I. Alaqel, Mohd Imran, Abida Khan, Naira Nayeem
    Biogerontology.2025;[Epub]     CrossRef
  • Breaking the Barrier: The Role of Proinflammatory Cytokines in BBB Dysfunction
    Małgorzata Gryka-Marton, Anna D. Grabowska, Dariusz Szukiewicz
    International Journal of Molecular Sciences.2025; 26(8): 3532.     CrossRef
  • What do You Need to Know after Diabetes and before Diabetic Retinopathy?
    Shiyu Zhang, Jia Liu, Heng Zhao, Yuan Gao, Changhong Ren, Xuxiang Zhang
    Aging and disease.2025;[Epub]     CrossRef
  • Pericytes and Diabetic Microangiopathies: Tissue Resident Mesenchymal Stem Cells with High Plasticity and Regenerative Capacity
    Zeinab Shirbaghaee, Christine M. Sorenson, Nader Sheibani
    International Journal of Molecular Sciences.2025; 26(11): 5333.     CrossRef
  • Berberine Protects Cerebral Vessels and Alleviates Diabetic Encephalopathy by Inhibiting the Production of δ-Valerobetaine in the Gut Microbiota
    Zheng-Wei Zhang, Wei-Ping Wang, Jia-Chun Hu, Jin-Yue Lu, Ru Feng, Shao-Feng Xu, Ling Wang, Jie Fu, Hang Yu, Hui Xu, Hao-Jian Zhang, Xin-Yu Yang, Zhao Zhai, Jing-Yue Wang, Meng-Liang Ye, Heng-Tong Zuo, Jian-Ye Song, Yi Zhao, Xiang Hui, Xiao-Liang Wang, Jia
    Engineering.2025; 49: 290.     CrossRef
  • Hyperglycemia-induced blood-brain barrier dysfunction: Mechanisms and therapeutic interventions
    Changsheng Chen, Xi Xu, Jiahao Lu, Yuqing Xiang, Linsheng Shi, Dong Liu
    Microvascular Research.2025; 160: 104820.     CrossRef
  • Identification and Characterization of a Translational Mouse Model for Blood–Brain Barrier Leakage in Cerebral Small Vessel Disease
    Ruxue Jia, Gemma Solé-Guardia, Vivienne Verweij, Jessica M. Snabel, Bram Geenen, Anil Man Tuladhar, Robert Kleemann, Amanda J. Kiliaan, Maximilian Wiesmann
    International Journal of Molecular Sciences.2025; 26(14): 6706.     CrossRef
  • Epigenetic Regulation of DAPK1 and Netrin‐1 Drives Diabetic Encephalopathy
    Yang Zhou, Jia‐Xin Kou, Kai Zheng, Zi‐Xuan Guo, Hong‐Wei Fan, Wen‐Lian Li, Lu‐Lu Chu, Jing‐Wen Yin, Li‐Jie Liu, Nadezhda Brazhe, Zhi‐Gao Xiang, Feng Hu, Kai Shu, Ling‐Qiang Zhu, Dan Liu
    Advanced Science.2025;[Epub]     CrossRef
  • Do Long COVID and COVID Vaccine Side Effects Share Pathophysiological Picture and Biochemical Pathways?
    Jean-François Lesgards, Dominique Cerdan, Christian Perronne
    International Journal of Molecular Sciences.2025; 26(16): 7879.     CrossRef
  • Myelin basic protein and occludin may be the biomarkers to diagnose leukoaraiosis and cognitive dysfunction
    Yingping Chen, Hua Li, Junliang Lin, Huanjian Huang, Yingying Cao, Hong Zhou
    Scientific Reports.2025;[Epub]     CrossRef
  • From inflammation to intervention: exploring shared mechanisms and lifestyle strategies in diabetes mellitus and multiple sclerosis
    Karma Lama, Gyamcho Tshering Bhutia, Rajashree Deka, Narasimha M. Beeraka, Sukesh Kumar Gupta
    International Immunopharmacology.2025; 165: 115467.     CrossRef
  • Impact of type 2 diabetes mellitus on hematoma expansion and clinical outcomes in patients with spontaneous intracranial hematoma
    Junhua Yang, Sihui Wang, Xiangtian Ji, Yu Sun, Jingyu Feng, Bin Liu, Jun Yang
    Frontiers in Surgery.2025;[Epub]     CrossRef
  • Dynamic modulation of the blood–brain barrier in the healthy brain
    Alon Friedman, Ofer Prager, Yonatan Serlin, Daniela Kaufer
    Nature Reviews Neuroscience.2025; 26(12): 749.     CrossRef
  • Stroke: Epidemiology, Risk Factors, Signaling Pathways, and Clinical Management
    He Ren, Yuchun Liu, Mingyue Zhao, Hangyu Shen, Sheng Nie, Xiang Gao, Yi Huang
    MedComm.2025;[Epub]     CrossRef
  • Gut microbiota and type 2 diabetes mellitus: a focus on the gut-brain axis
    Yi Pan, Tong Bu, Xia Deng, Jue Jia, Guoyue Yuan
    Endocrine.2024; 84(1): 1.     CrossRef
  • Long-Term Exposure of Cultured Astrocytes to High Glucose Impact on Their LPS-Induced Activation
    Ayna Abdyeva, Ekaterina Kurtova, Irina Savinkova, Maksim Galkov, Liubov Gorbacheva
    International Journal of Molecular Sciences.2024; 25(2): 1122.     CrossRef
  • Role of autophagy in angiogenic potential of vascular pericytes
    Soheil Zamen Milani, Aysa Rezabakhsh, Mohammad Karimipour, Leila Salimi, Narges Mardi, Maryam Taghavi Narmi, Fatemeh Sadeghsoltani, Ferzane Valioglu, Reza Rahbarghazi
    Frontiers in Cell and Developmental Biology.2024;[Epub]     CrossRef
  • Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target?
    Megan Ritson, Caroline P.D. Wheeler-Jones, Helen B. Stolp
    Journal of Neuroimmunology.2024; 391: 578363.     CrossRef
  • Dynamic changes in key factors of the blood-brain barrier in early diabetic mice
    Zhi-yong Xu, Shu-xian Fu, Hui-chao Zhao, Yin-min Wang, Yan Liu, Jin-you Ma, Yan Yu, Jia-Le Zhang, Zhan-peng Han, Ming-xue Zheng
    Journal of Neuropathology & Experimental Neurology.2024; 83(9): 763.     CrossRef
  • Di(2-ethylhexyl) phthalate exposure aggravates hypoxia/reoxygenation injury in cerebral endothelial cells by downregulating epithelial cadherin expression
    Jin Hee Kim, Jae Hoon Lee, Zhengyu Nan, Ja Woo Choi, Jong Wook Song
    Toxicology Research.2024;[Epub]     CrossRef
  • Advancing the understanding of diabetic encephalopathy through unravelling pathogenesis and exploring future treatment perspectives
    Aarti Nagayach, Rakesh Bhaskar, Shampa Ghosh, Krishna Kumar Singh, Sung Soo Han, Jitendra Kumar Sinha
    Ageing Research Reviews.2024; 100: 102450.     CrossRef
  • Hyperglycemia in a NOD Mice Model of Type-I Diabetes Aggravates Collagenase-Induced Intracerebral Hemorrhagic Injury
    Qasim M. Alhadidi, Kevin M. Nash, Ghaith A. Bahader, Emily Zender, Marcia F. McInerney, Zahoor A. Shah
    Biomedicines.2024; 12(8): 1867.     CrossRef
  • Targeting ferroptosis in the neurovascular unit: A promising approach for treating diabetic cognitive impairment
    Wenlan Zhang, Yijing Yan, Chunmei Yi, Xijuan Jiang, Lin Guo, Shanshan Huang, Tong Xia, Fayin Huang, Yike Jiao, Huhu Li, Bin Yu, Yongna Dai
    International Immunopharmacology.2024; 142: 113146.     CrossRef
  • Neurometabolic substrate transport across brain barriers in diabetes mellitus: Implications for cognitive function and neurovascular health
    Ritwick Mondal, Shramana Deb, Dipanjan Chowdhury, Shramana Sarkar, Aakash Guha Roy, Gourav Shome, Vramanti Sarkar, Durjoy Lahiri, Julián Benito-León
    Neuroscience Letters.2024; 843: 138028.     CrossRef
  • Protective effects of berberine against diabetes-associated cognitive decline in mice
    Mrinal Gupta, Mohammad Rumman, Babita Singh, Shivani Pandey
    Acta Diabetologica.2024; 62(6): 943.     CrossRef
  • The NG2-glia is a potential target to maintain the integrity of neurovascular unit after acute ischemic stroke
    Xiaoyan Hu, Panpan Geng, Xiaoyun Zhao, Qian Wang, Changqing Liu, Chun Guo, Wen Dong, Xinchun Jin
    Neurobiology of Disease.2023; 180: 106076.     CrossRef
  • Tight junction disruption and the pathogenesis of the chronic complications of diabetes mellitus: A narrative review
    Ma Ludivina Robles-Osorio, Ernesto Sabath
    World Journal of Diabetes.2023; 14(7): 1013.     CrossRef
  • Function and therapeutic value of astrocytes in diabetic cognitive impairment
    Fanyu Meng, Jiafeng Fu, Lin Zhang, Mengqing Guo, Pengwei Zhuang, Qingsheng Yin, Yanjun Zhang
    Neurochemistry International.2023; 169: 105591.     CrossRef
  • Exploring the Molecular Targets for Type 2 Diabetes-Induced Alzheimer’s Disease Through Bioinformatics Analysis
    Lin Gao, Chengyu Huang, Hui Li, Shidi Wu, Xiaoyan Zhou, Changjiang Ying
    Epigenomics.2023; 15(11): 619.     CrossRef
  • In vivo retinal imaging is associated with cognitive decline, blood-brain barrier disruption and neuroinflammation in type 2 diabetic mice
    May Majimbi, Samuel McLenachan, Michael Nesbit, Fred K. Chen, Virginie Lam, John Mamo, Ryu Takechi
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves
    Dídac Mauricio, Mònica Gratacòs, Josep Franch-Nadal
    Cardiovascular Diabetology.2023;[Epub]     CrossRef
  • Transcranial photobiomodulation improves insulin therapy in diabetic microglial reactivity and the brain drainage system
    Shaojun Liu, Dongyu Li, Tingting Yu, Jingtan Zhu, Oxana Semyachkina-Glushkovskaya, Dan Zhu
    Communications Biology.2023;[Epub]     CrossRef
  • NG2‐glia crosstalk with microglia in health and disease
    Zuo Zhang, Xiaolong Li, Hongli Zhou, Jiyin Zhou
    CNS Neuroscience & Therapeutics.2022; 28(11): 1663.     CrossRef
  • Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes
    Maria Vargas-Soria, Juan Jose Ramos-Rodriguez, Angel del Marco, Carmen Hierro-Bujalance, Maria Jose Carranza-Naval, Maria Calvo-Rodriguez, Susanne J. van Veluw, Alan W. Stitt, Rafael Simó, Brian J. Bacskai, Carmen Infante-Garcia, Monica Garcia-Alloza
    Fluids and Barriers of the CNS.2022;[Epub]     CrossRef
Islet Studies and Transplantation
Article image
Regulation of Pancreatic β-Cell Mass by Gene-Environment Interaction
Shun-ichiro Asahara, Hiroyuki Inoue, Yoshiaki Kido
Diabetes Metab J. 2022;46(1):38-48.   Published online January 27, 2022
DOI: https://doi.org/10.4093/dmj.2021.0045
  • 11,694 View
  • 279 Download
  • 12 Web of Science
  • 11 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFPubReader   ePub   
The main pathogenic mechanism of diabetes consists of an increase in insulin resistance and a decrease in insulin secretion from pancreatic β-cells. The number of diabetic patients has been increasing dramatically worldwide, especially in Asian people whose capacity for insulin secretion is inherently lower than that of other ethnic populations. Causally, changes of environmental factors in addition to intrinsic genetic factors have been considered to have an influence on the increased prevalence of diabetes. Particular focus has been placed on “gene-environment interactions” in the development of a reduced pancreatic β-cell mass, as well as type 1 and type 2 diabetes mellitus. Changes in the intrauterine environment, such as intrauterine growth restriction, contribute to alterations of gene expression in pancreatic β-cells, ultimately resulting in the development of pancreatic β-cell failure and diabetes. As a molecular mechanism underlying the effect of the intrauterine environment, epigenetic modifications have been widely investigated. The association of diabetes susceptibility genes or dietary habits with gene-environment interactions has been reported. In this review, we provide an overview of the role of gene-environment interactions in pancreatic β-cell failure as revealed by previous reports and data from experiments.

Citations

Citations to this article as recorded by  
  • High-Fat Diet-Fed Kcnq1 Mutant Mice Have Reduced Pancreatic β-Cell Mass via Gene-Environment Interaction
    Shun-ichiro Asahara, Hiroyuki Inoue, Yuka Ihara, Kyoko Teruyama, Asuka Imai, Chisako Hara, Mizuki Hara, Masako Seike, Aisha Yokoi, Nozomi Kido, Hirotaka Suzuki, Ayumi Kanno, Yuka Inaba, Hitoshi Watanabe, Go Shioi, Maki Kimura-Koyanagi, Michihiro Matsumoto
    Diabetes & Metabolism Journal.2026; 50(1): 77.     CrossRef
  • The usefulness of HbA1c measurement in diabetic mouse models using various devices
    Koya Miyazaki, Aisha Yokoi, Hiroyuki Inoue, Hirotaka Suzuki, Nozomi Kido, Ayumi Kanno, Maki Kimura-Koyanagi, Yoshiaki Kido, Shun-ichiro Asahara
    Experimental Animals.2025; 74(3): 319.     CrossRef
  • Network pharmacology approach to the study of therapeutic role of selected phenolics on diabetic pancreatic islet cells based on multi-omics analysis
    Sai Anand, Kannakazhi Kantari, Piyush Kumar, Sai Sanwid Pradhan, Ashok Agraharam
    Network Modeling Analysis in Health Informatics and Bioinformatics.2025;[Epub]     CrossRef
  • Leptin Rs7799039 polymorphism is associated with type 2 diabetes mellitus Egyptian patients
    Amal Ahmed Mohamed, Dina M. Abo-Elmatty, Alaa S. Wahba, Omnia Ezzat Esmail, Hadeer Saied Mahmoud Salim, Wafaa Salah Mohammed Hegab, Mona Mostafa Farid Ghanem, Nadia Youssef Riad, Doaa Ghaith, Lamiaa I Daker, Shorouk Issa, Noha Hassan Radwan, Eman Sultan,
    Archives of Physiology and Biochemistry.2024; 130(6): 742.     CrossRef
  • Higher Genetic Risk for Type 2 Diabetes Is Associated With a Faster Decline of β-Cell Function in an East Asian Population
    Hyunsuk Lee, Jaewon Choi, Jong-Il Kim, Richard M. Watanabe, Nam H. Cho, Kyong Soo Park, Soo Heon Kwak
    Diabetes Care.2024; 47(8): 1386.     CrossRef
  • Protein Arginine Methyltransferases: Emerging Targets in Cardiovascular and Metabolic Disease
    Yan Zhang, Shibo Wei, Eun-Ju Jin, Yunju Jo, Chang-Myung Oh, Gyu-Un Bae, Jong-Sun Kang, Dongryeol Ryu
    Diabetes & Metabolism Journal.2024; 48(4): 487.     CrossRef
  • Recent Glycemia Is a Major Determinant of β-Cell Function in Type 2 Diabetes Mellitus
    Ji Yoon Kim, Jiyoon Lee, Sin Gon Kim, Nam Hoon Kim
    Diabetes & Metabolism Journal.2024; 48(6): 1135.     CrossRef
  • Increased risk of incident diabetes after therapy with immune checkpoint inhibitor compared with conventional chemotherapy: A longitudinal trajectory analysis using a tertiary care hospital database
    Minyoung Lee, Kyeongseob Jeong, Yu Rang Park, Yumie Rhee
    Metabolism.2023; 138: 155311.     CrossRef
  • The ameliorating effects of mesenchymal stem cells compared to α‐tocopherol on apoptosis and autophagy in streptozotocin‐induced diabetic rats: Implication of PI3K/Akt signaling pathway and entero‐insular axis
    Heba A. Mubarak, Manal M. Kamal, Yossra Mahmoud, Fatma S. Abd‐Elsamea, Eman Abdelbary, Marwa G. Gamea, Reham I. El‐Mahdy
    Journal of Cellular Biochemistry.2023; 124(11): 1705.     CrossRef
  • Association of Polygenic Variants with Type 2 Diabetes Risk and Their Interaction with Lifestyles in Asians
    Haeng Jeon Hur, Hye Jeong Yang, Min Jung Kim, Kyun-Hee Lee, Myung-Sunny Kim, Sunmin Park
    Nutrients.2022; 14(15): 3222.     CrossRef
  • Chemical Compounds and Ambient Factors Affecting Pancreatic Alpha-Cells Mass and Function: What Evidence?
    Gaia Chiara Mannino, Elettra Mancuso, Stefano Sbrignadello, Micaela Morettini, Francesco Andreozzi, Andrea Tura
    International Journal of Environmental Research and Public Health.2022; 19(24): 16489.     CrossRef
Short Communication
Basic Research
Article image
GPR40 Agonism Modulates Inflammatory Reactions in Vascular Endothelial Cells
Joo Won Kim, Eun Roh, Kyung Mook Choi, Hye Jin Yoo, Hwan-Jin Hwang, Sei Hyun Baik
Diabetes Metab J. 2022;46(3):506-511.   Published online January 24, 2022
DOI: https://doi.org/10.4093/dmj.2021.0092
  • 9,020 View
  • 272 Download
  • 18 Web of Science
  • 17 Crossref
AbstractAbstract PDFPubReader   ePub   
Endothelial dysfunction is strongly linked with inflammatory responses, which can impact cardiovascular disease. Recently, G protein-coupled receptor 40 (GPR40) has been investigated as a modulator of metabolic stress; however, the function of GPR40 in vascular endothelial cells has not been reported. We analyzed whether treatment of GPR40-specific agonists modulated the inflammatory responses in human umbilical vein endothelial cells (HUVECs). Treatment with LY2922470, a GPR40 agonist, significantly reduced lipopolysaccharide (LPS)-mediated nuclear factor-kappa B (NF-κB) phosphorylation and movement into the nucleus from the cytosol. However, treatment with another GPR40 agonist, TAK875, did not inhibit LPS-induced NF-κB activation. LPS treatment induced expression of adhesion molecules vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) and attachment of THP-1 cells to HUVECs, which were all decreased by LY2922470 but not TAK875. Our results showed that ligand-dependent agonism of GPR40 is a promising therapeutic target for overcoming inflammatory reactions in the endothelium.

Citations

Citations to this article as recorded by  
  • Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies
    Aditi Singh, Sucharita Shadangi, Pulkit Kr. Gupta, Soumendra Rana
    Comprehensive Physiology.2025;[Epub]     CrossRef
  • GPR40-full agonist AM1638 alleviates palmitate-induced oxidative damage in H9c2 cells via an AMPK-dependent pathway
    SukHwan Yun, Joo Won Kim, Min Jeong Park, Eyun Song, Soo Yeon Jang, Ahreum Jang, Kyung Mook Choi, Sei Hyun Baik, Hwan-Jin Hwang, Hye Jin Yoo
    BMB Reports.2025; 58(3): 133.     CrossRef
  • HD6277 Suppresses Muscle Atrophy by Promoting Myogenic Factors and Inhibiting Proteolysis in Aged Mice
    Joo Won Kim, SukHwan Yun, Min Jeong Park, Eyun Song, Sooyeon Jang, Ahreum Jang, Kyung Mook Choi, Sei Hyun Baik, Hwan‐Jin Hwang, Hye Jin Yoo
    Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub]     CrossRef
  • The Multitarget Compound ZLY032 Achieves Treatment of Chronic Wounds
    Manyu Gong, Zhiyuan Du, Tiantian Gong, Yu Wang, Chenchen Yin, Bosi Sun, Zijia Liu, Lianru Chen, Zibin Liao, Wenxin Wang, Tianjiao Zhao, Yifei Wang, Ying Dong, Kexin Wang, Mengru Ma, Weijun Li, Jiacheng Li, Haodong Li, Congcong Lin, Ying Zhang, Yu Liu, Xin
    Advanced Science.2025;[Epub]     CrossRef
  • Putative receptors and signaling pathways responsible for the biological actions of epoxyeicosatrienoic acids
    Matthew L. Edin, Joan P. Graves, Darryl C. Zeldin
    Journal of Biological Chemistry.2025; 301(11): 110737.     CrossRef
  • Synthetic GPR40/FFAR1 agonists: An exhaustive survey on the most recent chemical classes and their structure-activity relationships
    Abhik Paul, Sourin Nahar, Pankaj Nahata, Arnab Sarkar, Avik Maji, Ajeya Samanta, Sanmoy Karmakar, Tapan Kumar Maity
    European Journal of Medicinal Chemistry.2024; 264: 115990.     CrossRef
  • Metabolite-sensing GPCRs in rheumatoid arthritis
    Xuezhi Yang, Wankang Zhang, Luping Wang, Yingjie Zhao, Wei Wei
    Trends in Pharmacological Sciences.2024; 45(2): 118.     CrossRef
  • Aloe emodin promotes mucosal healing by modifying the differentiation fate of enteroendocrine cells via regulating cellular free fatty acid sensitivity
    Weilian Bao, Jiaren Lyu, Guize Feng, Linfeng Guo, Dian Zhao, Keyuan You, Yang Liu, Haidong Li, Peng Du, Daofeng Chen, Xiaoyan Shen
    Acta Pharmaceutica Sinica B.2024; 14(9): 3964.     CrossRef
  • IGF-1 inhibits inflammation and accelerates angiogenesis via Ras/PI3K/IKK/NF-κB signaling pathways to promote wound healing
    Xin Zhang, Fei Hu, Jie Li, Lin Chen, Yu-fei Mao, Qiu-bo Li, Chen-yao Nie, Cai Lin, Jian Xiao
    European Journal of Pharmaceutical Sciences.2024; 200: 106847.     CrossRef
  • Free Fatty Acids and Free Fatty Acid Receptors: Role in Regulating Arterial Function
    Fengzhi Yu, Boyi Zong, Lili Ji, Peng Sun, Dandan Jia, Ru Wang
    International Journal of Molecular Sciences.2024; 25(14): 7853.     CrossRef
  • Critical role of G protein-coupled receptor 40 in B cell response and the pathogenesis of rheumatoid arthritis in mice and patients
    Anqi Li, Xiaoyi Wang, Jingwen Li, Xiaoyu Li, Jue Wang, Yang Liu, Zhihong Wang, Xiaobing Yang, Jiapeng Gao, Juanjie Wu, Tao Sun, Lixia Huo, Yanfeng Yi, Jiantong Shen, Jiexun Cai, Yunliang Yao
    Cell Reports.2024; 43(10): 114858.     CrossRef
  • Recent Developments in Drug Design of Oral Synthetic Free Fatty Acid Receptor 1 Agonists
    Lei Liu, Qinghua Zhang, Yichuan Ma, Ling Lin, Wenli Liu, Aizhong Ding, Chunjian Wang, Shuiping Zhou, Jinyong Cai, Hai Tang
    Drug Design, Development and Therapy.2024; Volume 18: 5961.     CrossRef
  • GPR40 deficiency worsens metabolic syndrome‐associated periodontitis in mice
    Yanchun Li, Zhongyang Lu, Cameron L. Kirkwood, Keith L. Kirkwood, Stephen A. Wank, Ai‐Jun Li, Maria F. Lopes‐Virella, Yan Huang
    Journal of Periodontal Research.2023; 58(3): 575.     CrossRef
  • Signaling pathways and intervention for therapy of type 2 diabetes mellitus
    Rong Cao, Huimin Tian, Yu Zhang, Geng Liu, Haixia Xu, Guocheng Rao, Yan Tian, Xianghui Fu
    MedComm.2023;[Epub]     CrossRef
  • G Protein-Coupled Receptor 40 Agonist LY2922470 Alleviates Ischemic-Stroke-Induced Acute Brain Injury and Functional Alterations in Mice
    Yingyu Lu, Wanlu Zhou, Qinghua Cui, Chunmei Cui
    International Journal of Molecular Sciences.2023; 24(15): 12244.     CrossRef
  • AM1638, a GPR40-Full Agonist, Inhibited Palmitate- Induced ROS Production and Endoplasmic Reticulum Stress, Enhancing HUVEC Viability in an NRF2-Dependent Manner
    Hwan-Jin Hwang, Joo Won Kim, SukHwan Yun, Min Jeong Park, Eyun Song, Sooyeon Jang, Ahreum Jang, Kyung Mook Choi, Sei Hyun Baik, Hye Jin Yoo
    Endocrinology and Metabolism.2023; 38(6): 760.     CrossRef
  • Learn from failures and stay hopeful to GPR40, a GPCR target with robust efficacy, for therapy of metabolic disorders
    Hong-Ping Guan, Yusheng Xiong
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
Original Articles
Pathophysiology
Article image
Relationships between Islet-Specific Autoantibody Titers and the Clinical Characteristics of Patients with Diabetes Mellitus
Yiqian Zhang, Tong Yin, Xinlei Wang, Rongping Zhang, Jie Yuan, Yi Sun, Jing Zong, Shiwei Cui, Yunjuan Gu
Diabetes Metab J. 2021;45(3):404-416.   Published online July 21, 2020
DOI: https://doi.org/10.4093/dmj.2019.0239
  • 11,560 View
  • 201 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Dysimmunity plays a key role in diabetes, especially type 1 diabetes mellitus. Islet-specific autoantibodies (ISAs) have been used as diagnostic markers for different phenotypic classifications of diabetes. This study was aimed to explore the relationships between ISA titers and the clinical characteristics of diabetic patients.

Methods

A total of 509 diabetic patients admitted to Department of Endocrinology and Metabolism at the Affiliated Hospital of Nantong University were recruited. Anthropometric parameters, serum biochemical index, glycosylated hemoglobin, urinary microalbumin/creatinine ratio, ISAs, fat mass, and islet β-cell function were measured. Multiple linear regression analysis was performed to identify relationships between ISA titers and clinical characteristics.

Results

Compared with autoantibody negative group, blood pressure, weight, total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), visceral fat mass, fasting C-peptide (FCP), 120 minutes C-peptide (120minCP) and area under C-peptide curve (AUCCP) of patients in either autoantibody positive or glutamate decarboxylase antibody (GADA) positive group were lower. Body mass index (BMI), waist circumference, triglycerides (TGs), body fat mass of patients in either autoantibody positive group were lower than autoantibody negative group. GADA titer negatively correlated with TC, LDL-C, FCP, 120minCP, and AUCCP. The islet cell antibody and insulin autoantibody titers both negatively correlated with body weight, BMI, TC, TG, and LDL-C. After adjusting confounders, multiple linear regression analysis showed that LDL-C and FCP negatively correlated with GADA titer.

Conclusion

Diabetic patients with a high ISA titer, especially GADA titer, have worse islet β-cell function, but less abdominal obesity and fewer features of the metabolic syndrome.

Citations

Citations to this article as recorded by  
  • Positive Islet Cell Cytoplasmic Antibody and Long‐Term Use of Lipid‐Lowering Agents Are Positively Correlated With Peripheral Atherosclerosis in Patients With Autoimmune Diabetes: A Cross‐Sectional Study
    Xinyue Chen, Jie Yu, Yiwen Liu, Xuechen Wang, Fan Ping, Wei Li, Huabing Zhang, Lingling Xu, Yuxiu Li, Mallikarjuna Korivi
    Journal of Diabetes Research.2025;[Epub]     CrossRef
  • Relationship between β-Cell Autoantibodies and Their Combination with Anthropometric and Metabolic Components and Microvascular Complications in Latent Autoimmune Diabetes in Adults
    Tomislav Bulum, Marijana Vučić Lovrenčić, Jadranka Knežević Ćuća, Martina Tomić, Sandra Vučković-Rebrina, Lea Duvnjak
    Biomedicines.2023; 11(9): 2561.     CrossRef
  • RETRACTED ARTICLE: MiRNA-27a mediates insulin resistance in 3T3-L1 cells through the PPARγ
    Yangming Zhuang, Ming Li
    Molecular and Cellular Biochemistry.2022; 477(4): 1107.     CrossRef
  • Correlation between Insulin Resistance and Microalbuminuria Creatinine Ratio in Postmenopausal Women
    Han Na, Rong Wang, Hai-Long Zheng, Xiao-Pan Chen, Lin-Yang Zheng, Faustino R. Perez-Lopez
    International Journal of Endocrinology.2022; 2022: 1.     CrossRef
  • The longitudinal loss of islet autoantibody responses from diagnosis of type 1 diabetes occurs progressively over follow-up and is determined by low autoantibody titres, early-onset, and genetic variants
    C L Williams, R Fareed, G L M Mortimer, R J Aitken, I V Wilson, G George, K M Gillespie, A J K Williams, Chitrabhanu Ballav, Atanu Dutta, Michelle Russell-Taylor, Rachel Besser, James Bursell, Shanthi Chandran, Sejal Patel, Anne Smith, Manohara Kenchaiah,
    Clinical and Experimental Immunology.2022; 210(2): 151.     CrossRef
Basic Research
Article image
Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell
Kyung-Soo Kim, Yeon Kyung Choi, Mi Jin Kim, Jung Wook Hwang, Kyunghoon Min, Sang Youn Jung, Soo-Kyung Kim, Yong-Soo Choi, Yong-Wook Cho
Diabetes Metab J. 2021;45(2):260-269.   Published online July 10, 2020
DOI: https://doi.org/10.4093/dmj.2019.0191
  • 15,770 View
  • 254 Download
  • 13 Web of Science
  • 13 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Umbilical cord-mesenchymal stem cell-conditioned medium (UC-MSC-CM) has emerged as a promising cell-free therapy. The aim of this study was to explore the therapeutic effects of UC-MSC-CM on insulin resistance in C2C12 cell.

Methods

Insulin resistance was induced by palmitate. Effects of UC-MSC-CM on insulin resistance were evaluated using glucose uptake, glucose transporter type 4 (GLUT4) translocation, the insulin-signaling pathway, and mitochondrial contents and functions in C2C12 cell.

Results

Glucose uptake was improved by UC-MSC-CM. UC-MSC-CM treatment increased only in membranous GLUT4 expression, not in cytosolic GLUT4 expression. It restored the insulin-signaling pathway in insulin receptor substrate 1 and protein kinase B. Mitochondrial contents evaluated by mitochondrial transcription factor A, mitochondrial DNA copy number, and peroxisome proliferator-activated receptor gamma coactivator 1-alpha were increased by UC-MSC-CM. In addition, UC-MSC-CM significantly decreased mitochondrial reactive oxygen species and increased fatty acid oxidation and mitochondrial membrane potential. There was no improvement in adenosine triphosphate (ATP) contents, but ATP synthesis was improved by UC-MSC-CM. Cytokine and active factor analysis of UC-MSC-CM showed that it contained many regulators inhibiting insulin resistance.

Conclusion

UC-MSC-CM improves insulin resistance with multiple mechanisms in C2C12 cell.

Citations

Citations to this article as recorded by  
  • Ameliorative Effect of Combined Placenta-Derived Mesenchymal Stem Cells plus Platelet-rich Plasma on Polycystic Ovarian Model in Rats: A Biochemical and Histological Study
    Mojtaba Sarvestani, Alireza Rajabzadeh, Morteza Salimian, Tahereh Mazoochi, Gholamreza Ghavipanjeh
    Reproductive Sciences.2025; 32(3): 907.     CrossRef
  • Regenerative therapeutic effects of conditioned medium from human umbilical cord‑derived mesenchymal stem cells as an adjuvant to insulin therapy in a rat model of type 2 diabetes
    Siufui Hendrawan, Jennifer Lheman, Olivia Marcelina, Lydia Tantoso, Hans Baer, Shirly Gunawan
    World Academy of Sciences Journal.2025; 7(6): 1.     CrossRef
  • A Systematic Review of Palmitate-Mediated Insulin Resistance in C2C12 Myotubes
    John M. Zimmerman, Alexa J. Klein, Kipton B. Travis, Roger A. Vaughan
    Nutrients.2025; 17(22): 3619.     CrossRef
  • Wharton’s Jelly Mesenchymal Stem Cell Conditioned Medium Ameliorates Diabetes‐Induced Testicular Damage and Sperm Abnormalities by Mitigating Oxidative Stress, Apoptosis, and Inflammation
    Mojtaba Sargazi, Narges Karbalaei, Saied Karbalay-Doust, Sara Keshtgar, Zohre Aghaei, Pasquale Marrazzo
    Stem Cells International.2024;[Epub]     CrossRef
  • Secretome Derived from Mesenchymal Stem/Stromal Cells: A Promising Strategy for Diabetes and its Complications
    ling li, Siyu Hua, Lianghui You, Tianying Zhong
    Current Stem Cell Research & Therapy.2024; 19(10): 1328.     CrossRef
  • Neurotransmitters in Type 2 Diabetes and the Control of Systemic and Central Energy Balance
    Amnah Al-Sayyar, Maha M. Hammad, Michayla R. Williams, Mohammed Al-Onaizi, Jehad Abubaker, Fawaz Alzaid
    Metabolites.2023; 13(3): 384.     CrossRef
  • Neuroprotective Effect of Wharton’s Jelly-Derived Mesenchymal Stem Cell-Conditioned Medium (WJMSC-CM) on Diabetes-Associated Cognitive Impairment by Improving Oxidative Stress, Neuroinflammation, and Apoptosis
    Zohre Aghaei, Narges Karbalaei, Mohammad Reza Namavar, Masoud Haghani, Mahboobeh Razmkhah, Mahdi Khorsand Ghaffari, Marzieh Nemati, Andrea Ballini
    Stem Cells International.2023; 2023: 1.     CrossRef
  • Mesenchymal-Stem Cell-Derived Conditioned Media Versus Exosomes in the Treatment of Rat Model of Polycystic Ovary: An Attempt to Understand the Underlying Mechanisms (Biochemical and Histological Study)
    Soha Abd-elkawy Abd-elwahab, Noura Hassan Khamis, Rehab Ahmed Rifaai, Nashwa Fathy Gamal El-Tahawy, Randa Ahmed Ibrahim
    Microscopy and Microanalysis.2023; 29(3): 1244.     CrossRef
  • Therapeutic Potential of Mesenchymal Stem Cell‐Derived Conditioned Medium for Diabetes Mellitus and Related Complications
    Basak Isildar, Serbay Ozkan, Meral Koyuturk
    Advanced Therapeutics.2023;[Epub]     CrossRef
  • Treatment of type 2 diabetes mellitus with stem cells and antidiabetic drugs: a dualistic and future-focused approach
    Priyamvada Amol Arte, Kanchanlata Tungare, Mustansir Bhori, Renitta Jobby, Jyotirmoi Aich
    Human Cell.2023; 37(1): 54.     CrossRef
  • Perinatal Stem Cell Therapy to Treat Type 1 Diabetes Mellitus: A Never-Say-Die Story of Differentiation and Immunomodulation
    Francesca Paris, Valeria Pizzuti, Pasquale Marrazzo, Andrea Pession, Francesco Alviano, Laura Bonsi
    International Journal of Molecular Sciences.2022; 23(23): 14597.     CrossRef
  • Mesenchymal Stem Cell-Derived Apoptotic Bodies: Biological Functions and Therapeutic Potential
    Huixue Tang, Huikun Luo, Zihan Zhang, Di Yang
    Cells.2022; 11(23): 3879.     CrossRef
  • Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach
    Andreia Gomes, Pedro Coelho, Raquel Soares, Raquel Costa
    Cell and Tissue Research.2021; 385(3): 497.     CrossRef
Basic Research
Article image
Hypoxia Increases β-Cell Death by Activating Pancreatic Stellate Cells within the Islet
Jong Jin Kim, Esder Lee, Gyeong Ryul Ryu, Seung-Hyun Ko, Yu-Bae Ahn, Ki-Ho Song
Diabetes Metab J. 2020;44(6):919-927.   Published online May 11, 2020
DOI: https://doi.org/10.4093/dmj.2019.0181
  • 10,483 View
  • 195 Download
  • 20 Web of Science
  • 22 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Hypoxia can occur in pancreatic islets in type 2 diabetes mellitus. Pancreatic stellate cells (PSCs) are activated during hypoxia. Here we aimed to investigate whether PSCs within the islet are also activated in hypoxia, causing β-cell injury.

Methods

Islet and primary PSCs were isolated from Sprague Dawley rats, and cultured in normoxia (21% O2) or hypoxia (1% O2). The expression of α-smooth muscle actin (α-SMA), as measured by immunostaining and Western blotting, was used as a marker of PSC activation. Conditioned media (hypoxia-CM) were obtained from PSCs cultured in hypoxia.

Results

Islets and PSCs cultured in hypoxia exhibited higher expressions of α-SMA than did those cultured in normoxia. Hypoxia increased the production of reactive oxygen species. The addition of N-acetyl-L-cysteine, an antioxidant, attenuated the hypoxia-induced PSC activation in islets and PSCs. Islets cultured in hypoxia-CM showed a decrease in cell viability and an increase in apoptosis.

Conclusion

PSCs within the islet are activated in hypoxia through oxidative stress and promote islet cell death, suggesting that hypoxia-induced PSC activation may contribute to β-cell loss in type 2 diabetes mellitus.

Citations

Citations to this article as recorded by  
  • Engineering the pancreatic niche: Mechanobiological insights into stem cell-derived β-cell therapy for diabetes mellitus
    Swaminadhan Dandapani, Yongsung Hwang
    Mechanobiology.2026;[Epub]     CrossRef
  • Practical application of melatonin for pancreas disorders: protective roles against inflammation, malignancy, and dysfunctions
    Mohammad Sheibani, Azam Hosseinzadeh, Iman Fatemi, Ali Jamshidi Naeini, Saeed Mehrzadi
    Pharmacological Reports.2025; 77(2): 315.     CrossRef
  • Genome-Scale Metabolic Modeling of Human Pancreas with Focus on Type 2 Diabetes
    Mustafa Sertbas, Kutlu O. Ulgen
    OMICS: A Journal of Integrative Biology.2025; 29(4): 125.     CrossRef
  • Integration of Immune Cell Signatures and Diagnostic Gene Markers in Pancreatitis: A Comprehensive Study on Therapeutic Targets and Predictive Diagnosis
    Qianyu Xie, Birong Liu, Xiao Yu, Xiang Wei, Qiangsheng Xiao, Minghua Ren
    Human Mutation.2025;[Epub]     CrossRef
  • Effects of hypoxia in the diabetic corneal stroma microenvironment
    Purnima Sharma, Jian-Xing Ma, Dimitrios Karamichos
    Experimental Eye Research.2024; 240: 109790.     CrossRef
  • High‐resolution magic angle spinning nuclear magnetic resonance of donor pancreatic tissue may predict islet viability prior to isolation
    Carolyn M. Slupsky, Brian D. Sykes, Jonathan R. T. Lakey
    NMR in Biomedicine.2024;[Epub]     CrossRef
  • Nanomedicine regulating PSC-mediated intercellular crosstalk: Mechanisms and therapeutic strategies
    Hui Wang, Liang Qi, Han Han, Xuena Li, Mengmeng Han, Lei Xing, Ling Li, Hulin Jiang
    Acta Pharmaceutica Sinica B.2024; 14(11): 4756.     CrossRef
  • Visualizing hypoxic modulation of beta cell secretions via a sensor augmented oxygen gradient
    Kai Duan, Mengyang Zhou, Yong Wang, Jose Oberholzer, Joe F. Lo
    Microsystems & Nanoengineering.2023;[Epub]     CrossRef
  • Pancreatic stellate cells promote pancreatic β-cell death through exosomal microRNA transfer in hypoxia
    Esder Lee, Gyeong Ryul Ryu, Seung-Hyun Ko, Yu-Bae Ahn, Ki-Ho Song
    Molecular and Cellular Endocrinology.2023; 572: 111947.     CrossRef
  • Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy
    Zhengfeng Wang, Ru He, Shi Dong, Wence Zhou
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Recent advances in the development of bioartificial pancreas using 3D bioprinting for the treatment of type 1 diabetes: a review
    Anushikha Ghosh, Arka Sanyal, Abhik Mallick
    Exploration of Medicine.2023; : 886.     CrossRef
  • Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes
    Sarah S. Malik, Diksha Padmanabhan, Rebecca L. Hull-Meichle
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Diabetic mellitus, vascular calcification and hypoxia: A complex and neglected tripartite relationship
    Xue-Jiao Sun, Nai-Feng Liu
    Cellular Signalling.2022; 91: 110219.     CrossRef
  • HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer
    Shin Hamada, Ryotaro Matsumoto, Atsushi Masamune
    Cancers.2022; 14(2): 411.     CrossRef
  • Pancreatic Stellate Cells and Metabolic Alteration: Physiology and Pathophysiology
    Shin Hamada, Ryotaro Matsumoto, Atsushi Masamune
    Frontiers in Physiology.2022;[Epub]     CrossRef
  • Exosomal miR-140–3p and miR-143–3p from TGF-β1-treated pancreatic stellate cells target BCL2 mRNA to increase β-cell apoptosis
    Xiangyun Zhu, Dechen Liu, Guoqing Li, Mengmeng Zhi, Ji Sun, Liang Qi, Jingbo Li, Stephen J. Pandol, Ling Li
    Molecular and Cellular Endocrinology.2022; 551: 111653.     CrossRef
  • Mitochondria oxidative stress mediated nicotine-promoted activation of pancreatic stellate cells by regulating mitochondrial dynamics
    Yue Yuan, Zhiren Li, Miaomiao Li, Tong Jin, Xiaoyun Zhang, Xinjuan Liu, Jianyu Hao
    Toxicology in Vitro.2022; 84: 105436.     CrossRef
  • Antioxidant Mitoquinone Alleviates Chronic Pancreatitis via Anti-Fibrotic and Antioxidant Effects
    Miaomiao Li, Yue Yuan, Xue Han, Xinjuan Liu, Weizhen Zhang, Jianyu Hao
    Journal of Inflammation Research.2022; Volume 15: 4409.     CrossRef
  • Diabetic Ferroptosis and Pancreatic Cancer: Foe or Friend?
    Le Li, Xing-jia Yu, Lei Gao, Long Cheng, Bei Sun, Gang Wang
    Antioxidants & Redox Signaling.2022; 37(16-18): 1206.     CrossRef
  • Melatonin Induces Apoptosis and Modulates Cyclin Expression and MAPK Phosphorylation in Pancreatic Stellate Cells Subjected to Hypoxia
    Matias Estaras, Manuel R. Gonzalez-Portillo, Miguel Fernandez-Bermejo, Jose M. Mateos, Daniel Vara, Gerardo Blanco-Fernandez, Diego Lopez-Guerra, Vicente Roncero, Gines M. Salido, Antonio González
    International Journal of Molecular Sciences.2021; 22(11): 5555.     CrossRef
  • Integrated pancreatic microcirculatory profiles of streptozotocin‐induced and insulin‐administrated type 1 diabetes mellitus
    Yuan Li, Bingwei Li, Bing Wang, Mingming Liu, Xiaoyan Zhang, Ailing Li, Jian Zhang, Honggang Zhang, Ruijuan Xiu
    Microcirculation.2021;[Epub]     CrossRef
  • Pancreatic stellate cells - rising stars in pancreatic pathologies
    P Hrabák, M Kalousová, T Krechler, T Zima
    Physiological Research.2021; (S4): S597.     CrossRef
Review
Basic Research
The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond
Jun Sung Moon, Udayakumar Karunakaran, Elumalai Suma, Seung Min Chung, Kyu Chang Won
Diabetes Metab J. 2020;44(2):222-233.   Published online April 23, 2020
DOI: https://doi.org/10.4093/dmj.2020.0053
  • 14,632 View
  • 226 Download
  • 31 Web of Science
  • 31 Crossref
AbstractAbstract PDFPubReader   ePub   

Impaired β-cell function is the key pathophysiology of type 2 diabetes mellitus, and chronic exposure of nutrient excess could lead to this tragedy. For preserving β-cell function, it is essential to understand the cause and mechanisms about the progression of β-cells failure. Glucotoxicity, lipotoxicity, and glucolipotoxicity have been suggested to be a major cause of β-cell dysfunction for decades, but not yet fully understood. Fatty acid translocase cluster determinant 36 (CD36), which is part of the free fatty acid (FFA) transporter system, has been identified in several tissues such as muscle, liver, and insulin-producing cells. Several studies have reported that induction of CD36 increases uptake of FFA in several cells, suggesting the functional interplay between glucose and FFA in terms of insulin secretion and oxidative metabolism. However, we do not currently know the regulating mechanism and physiological role of CD36 on glucolipotoxicity in pancreatic β-cells. Also, the downstream and upstream targets of CD36 related signaling have not been defined. In the present review, we will focus on the expression and function of CD36 related signaling in the pancreatic β-cells in response to hyperglycemia and hyperlipidemia (ceramide) along with the clinical studies on the association between CD36 and metabolic disorders.

Citations

Citations to this article as recorded by  
  • Integrative gene target mapping, RNA sequencing, in silico molecular docking, ADMET profiling and molecular dynamics simulation study of marine derived molecules for type 1 diabetes mellitus
    Basavaraj Vastrad, Shivaling Pattanashetti, Veeresh Sadashivanavar, K. S. R. Pai, Chanabasayya Vastrad
    Molecular Diversity.2026;[Epub]     CrossRef
  • Bone Marrow Mesenchymal Stromal Cells and Their Derived Extracellular Vesicles Protect Pancreatic Beta‐TC‐6 Cells From Hypoxia‐Induced Injury via miR‐539‐3p‐Mediated Downregulation of CD36 Expression
    Na Lin, Yaoyao Liang, Minying Tang, Fei Liu, Liuyan Chen, Lvying Wu, Yunfeng Fu, Zhuoyu Li, Lingfeng Zhu, Jin Chen, Yuelin Zhang
    Stem Cells International.2026;[Epub]     CrossRef
  • Integrated biomarker analysis in type 2 diabetes: soluble CD36, glycine, homocysteine, miR-375, and miR-126
    Roza Talaat Yaseen, Sardar Nouri Ahmad
    Results in Chemistry.2026; 24: 103179.     CrossRef
  • CD36 inhibition corrects lipid-FetuinA mediated insulin secretory defects by preventing intracellular lipid accumulation and inflammation in the pancreatic beta cells
    Samanwita Mandal, Snehasish Nag, Oindrila Mukherjee, Nandita Das, Priyajit Banerjee, Tanmay Majumdar, Satinath Mukhopadhyay, Kathrin Maedler, Rakesh Kundu
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2025; 1871(2): 167580.     CrossRef
  • CD36 in liver diseases
    Yi Liu, Wenwei Yin
    Hepatology Communications.2025;[Epub]     CrossRef
  • Overcoming β-Cell Dysfunction in Type 2 Diabetes Mellitus: CD36 Inhibition and Antioxidant System
    Il Rae Park, Yong Geun Chung, Kyu Chang Won
    Diabetes & Metabolism Journal.2025; 49(1): 1.     CrossRef
  • Sulfo‐N‐Succinimidyl Oleate Sodium as CD36 Inhibitor: Dose Optimization and Its Effects on FFA Uptake, Inflammation, and ER Stress in HepG2 Cells
    Widya Wasityastuti, Shabrina Farras Tsany, Hanif Shidqi Pasaribu, Rahmalia Diani Saffana, Daniel Saputra Wahyudi, Dwi Aris Agung Nugrahaningsih
    Journal of Biochemical and Molecular Toxicology.2025;[Epub]     CrossRef
  • Structural insights and therapeutic potential of plant-based pectin as novel therapeutic for type 2 diabetes mellitus: A review
    Ting Ren, Xinrong Fan, Qifang Wu, Yu Wu, Xin Sun, Haibin Tong
    International Journal of Biological Macromolecules.2025; 307: 141876.     CrossRef
  • The potential biomarker value of soluble CD36 in the treatment of diabetic kidney disease: evidence from GLP-1 and insulin interventions
    Wenxuan Li, Yangang Wang
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • “Medicine food homology” plants in the treatment of diabetic nephropathy: pathogenic pathways and therapeutic approaches
    Zhong-Hong Yan, Dan-Mai Zhao, Xiao-Tian Wang, Rui Zhong, Bei-Chen Ding
    Food & Medicine Homology.2025;[Epub]     CrossRef
  • Palmitoylation-dependent modulation of CD36 trafficking and signaling integrates lipid uptake with metabolic disease pathogenesis
    Mingxun Li, Haoran Jia, Lei Zhang, Peng Chen, Shimeng Wang, Yongjiang Mao, Zhangping Yang
    Pharmacological Research.2025; 220: 107935.     CrossRef
  • Hyperglycemia Induced in Sprague–Dawley Rats Modulates the Expression of CD36 and CD69 During Wound Healing
    Vy Ho, Tommy Tran, Jaylan Patel, Betelhem Teshome, Vikrant Rai
    International Journal of Molecular Sciences.2025; 26(24): 12032.     CrossRef
  • Nrf2 inhibition regulates intracellular lipid accumulation in mouse insulinoma cells and improves insulin secretory function
    Alpana Mukhuty, Samanwita Mandal, Chandrani Fouzder, Snehasis Das, Dipanjan Chattopadhyay, Tanmay Majumdar, Rakesh Kundu
    Molecular and Cellular Endocrinology.2024; 581: 112112.     CrossRef
  • CD36 gene variant rs1761667(G/A) as a biomarker in obese type 2 diabetes mellitus cases
    Ashwin Kumar Shukla, Amreen Shamsad, Atar Singh Kushwah, Shalini Singh, Kauser Usman, Monisha Banerjee
    Egyptian Journal of Medical Human Genetics.2024;[Epub]     CrossRef
  • CD36 regulates macrophage and endothelial cell activation and multinucleate giant cell formation in anti neutrophil cytoplasm antibody vasculitis
    Xiang Zhang, Catherine King, Alexander Dowell, Paul Moss, Lorraine Harper, Dimitrios Chanouzas, Xiong-zhong Ruan, Alan David Salama
    Clinical Immunology.2024; 260: 109914.     CrossRef
  • Identification and validation of oxidative stress-related genes in sepsis-induced myopathy
    Ning Zhang, Dan Huang, Xiang Li, JinXia Yan, Qi Yan, WeiXing Ge, Jun Zhou
    Medicine.2024; 103(18): e37933.     CrossRef
  • Monocyte CD36 Expression Predicts Disease Activity in Patients With Crohn’s Disease
    Jiejie Zhu, Nannan Zhu, Jiren Wang, Qiuyuan Liu, Qiao Mei, Andrew S. Day
    Gastroenterology Research and Practice.2024;[Epub]     CrossRef
  • The identification of key genes and pathways in polycystic ovary syndrome by bioinformatics analysis of next-generation sequencing data
    Varun Alur, Basavaraj Vastrad, Varshita Raju, Chanabasayya Vastrad, Shivakumar Kotturshetti
    Middle East Fertility Society Journal.2024;[Epub]     CrossRef
  • The association of soluble cluster of differentiation 36 with metabolic diseases: A potential biomarker and therapeutic target
    Yun Li, Yaxi Chen, Xiong Z. Ruan
    Pediatric Discovery.2023;[Epub]     CrossRef
  • The role of candidate transport proteins in β‐cell long‐chain fatty acid uptake: Where are we now?
    Christina Clavelo‐Farrow, Patricia Thomas
    Diabetic Medicine.2023;[Epub]     CrossRef
  • SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients
    Ningfei Ji, Mingshun Zhang, Liang Ren, Yunyun Wang, Bicheng Hu, Jie Xiang, Yingyun Gong, Chaojie Wu, Guoqiang Qu, Wenqiu Ding, Zhiqiang Yin, Shan Li, Zhengxia Wang, Lianzheng Zhou, Xueqin Chen, Yuan Ma, Jinhai Tang, Yun Liu, Liang Liu, Mao Huang
    Emerging Microbes & Infections.2022; 11(1): 1115.     CrossRef
  • Is imaging-based muscle quantity associated with risk of diabetes? A meta-analysis of cohort studies
    Shanhu Qiu, Xue Cai, Yang Yuan, Bo Xie, Zilin Sun, Tongzhi Wu
    Diabetes Research and Clinical Practice.2022; 189: 109939.     CrossRef
  • Lipotoxicity in a Vicious Cycle of Pancreatic Beta Cell Exhaustion
    Vladimir Grubelnik, Jan Zmazek, Matej Završnik, Marko Marhl
    Biomedicines.2022; 10(7): 1627.     CrossRef
  • Association of cluster determinant 36, scavenger receptor class B type 1, and major facilitator superfamily domain containing the 2a genetic polymorphism with serum lipid profile in aging population with type 2 diabetes mellitus
    Xixiang Wang, Xiaojun Ma, Jingjing Xu, Yujie Guo, Shaobo Zhou, Huiyan Yu, Linhong Yuan
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • CD36-Fatty Acid-Mediated Metastasis via the Bidirectional Interactions of Cancer Cells and Macrophages
    Noorzaileen Eileena Zaidi, Nur Aima Hafiza Shazali, Thean-Chor Leow, Mohd Azuraidi Osman, Kamariah Ibrahim, Wan-Hee Cheng, Kok-Song Lai, Nik Mohd Afizan Nik Abd Rahman
    Cells.2022; 11(22): 3556.     CrossRef
  • The Past and Present Lives of the Intraocular Transmembrane Protein CD36
    Rucui Yang, Qingping Liu, Mingzhi Zhang
    Cells.2022; 12(1): 171.     CrossRef
  • Implicating the effect of ketogenic diet as a preventive measure to obesity and diabetes mellitus
    Sachin Kumar, Tapan Behl, Monika Sachdeva, Aayush Sehgal, Shilpa Kumari, Arun Kumar, Gagandeep Kaur, Harlokesh Narayan Yadav, Simona Bungau
    Life Sciences.2021; 264: 118661.     CrossRef
  • Contribution of rs3211938 polymorphism at CD36 to glucose levels, oxidized low-density lipoproteins, insulin resistance, and body mass index in Mexican mestizos with type-2 diabetes from western Mexico
    Beatriz Teresita Martín-Márquez, Flavio Sandoval-Garcia, Mónica Vazquez-Del Mercado, Erika-Aurora Martínez-García, Fernanda-Isadora Corona-Meraz, Ana-Lilia Fletes-Rayas, Soraya-Amalí Zavaleta-Muñiz
    Nutrición Hospitalaria.2021;[Epub]     CrossRef
  • Investigating the association of CD36 gene polymorphisms (rs1761667 and rs1527483) with T2DM and dyslipidemia: Statistical analysis, machine learning based prediction, and meta-analysis
    Ma’mon M. Hatmal, Walhan Alshaer, Ismail S. Mahmoud, Mohammad A. I. Al-Hatamleh, Hamzeh J. Al-Ameer, Omar Abuyaman, Malek Zihlif, Rohimah Mohamud, Mais Darras, Mohammad Al Shhab, Rand Abu-Raideh, Hilweh Ismail, Ali Al-Hamadi, Ali Abdelhay, Kanhaiya Singh
    PLOS ONE.2021; 16(10): e0257857.     CrossRef
  • Misregulation of Wnt Signaling Pathways at the Plasma Membrane in Brain and Metabolic Diseases
    Mustafa Karabicici, Yagmur Azbazdar, Evin Iscan, Gunes Ozhan
    Membranes.2021; 11(11): 844.     CrossRef
  • CD36 Signal Transduction in Metabolic Diseases: Novel Insights and Therapeutic Targeting
    Udayakumar Karunakaran, Suma Elumalai, Jun-Sung Moon, Kyu-Chang Won
    Cells.2021; 10(7): 1833.     CrossRef
Original Article
Basic Research
Article image
Notch1 Has an Important Role in β-Cell Mass Determination and Development of Diabetes
Young Sil Eom, A-Ryeong Gwon, Kyung Min Kwak, Jin-Young Youn, Heekyoung Park, Kwang-Won Kim, Byung-Joon Kim
Diabetes Metab J. 2021;45(1):86-96.   Published online February 26, 2020
DOI: https://doi.org/10.4093/dmj.2019.0160
  • 10,301 View
  • 220 Download
  • 18 Web of Science
  • 18 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Notch signaling pathway plays an important role in regulating pancreatic endocrine and exocrine cell fate during pancreas development. Notch signaling is also expressed in adult pancreas. There are few studies on the effect of Notch on adult pancreas. Here, we investigated the role of Notch in islet mass and glucose homeostasis in adult pancreas using Notch1 antisense transgenic (NAS).

Methods

Western blot analysis was performed for the liver of 8-week-old male NAS mice. We also conducted an intraperitoneal glucose tolerance test (IPGTT) and intraperitoneal insulin tolerance test in 8-week-old male NAS mice and male C57BL/6 mice (control). Morphologic observation of pancreatic islet and β-cell was conducted in two groups. Insulin secretion capacity in islets was measured by glucose-stimulated insulin secretion (GSIS) and perifusion.

Results

NAS mice showed higher glucose levels and lower insulin secretion in IPGTT than the control mice. There was no significant difference in insulin resistance. Total islet and β-cell masses were decreased in NAS mice. The number of large islets (≥250 µm) decreased while that of small islets (<250 µm) increased. Reduced insulin secretion was observed in GSIS and perifusion. Neurogenin3, neurogenic differentiation, and MAF bZIP transcription factor A levels increased in NAS mice.

Conclusion

Our study provides that Notch1 inhibition decreased insulin secretion and decreased islet and β-cell masses. It is thought that Notch1 inhibition suppresses islet proliferation and induces differentiation of small islets. In conclusion, Notch signaling pathway may play an important role in β-cell mass determination and diabetes.

Citations

Citations to this article as recorded by  
  • A genetics-guided integrative framework for drug repurposing: identifying antihypertensive drugs for type 2 diabetes
    Xue Zhong, Qiang Wei, Anshul Tiwari, Quan Wang, Yuting Tan, Rui Chen, Yan Yan, Nancy J. Cox, Bingshan Li
    npj Drug Discovery.2026;[Epub]     CrossRef
  • T‑cadherin and its impact on human diseases (Review)
    Yan Song, Xinyi Wang, Yunfei Bian
    Molecular Medicine Reports.2026; 33(4): 1.     CrossRef
  • Translational disease modeling of peripheral blood identifies type 2 diabetes biomarkers predictive of Alzheimer’s disease
    Brendan K. Ball, Jee Hyun Park, Alexander M. Bergendorf, Elizabeth A. Proctor, Douglas K. Brubaker
    npj Systems Biology and Applications.2025;[Epub]     CrossRef
  • Pancreatic β-cell remodeling in health and aging: Lessons from rodents and humans
    Radwan Darwish, Yasmine Alcibahy, Sangeeta Dhawan, Alexandra E. Butler, Abu Saleh Md Moin
    Ageing Research Reviews.2025; 110: 102815.     CrossRef
  • LATE-ONSET NEVUS COMEDONICUS IN AN ADULT PATIENT WITH DIABETES MELLITUS
    Metin Özaslan, Zeliha Çelik
    Kırıkkale Üniversitesi Tıp Fakültesi Dergisi.2025; 27(2): 246.     CrossRef
  • Rheb1 as a novel β-cell regulator connecting mTORC1, AMPK, and NOTCH1 pathways for efficient diabetes therapy
    Mostafa M Gouda
    World Journal of Diabetes.2025;[Epub]     CrossRef
  • Decidual/placental and first trimester plasma levels of hsa-miR-199a-3p|hsa-miR-199b-3p and hsa-miR-3150b-3p are associated with insulin secretion in pregnancy
    Amélie Taschereau, Frédérique White, Catherine Allard, Andrea G. Edlow, François Aguet, Kristin G. Ardlie, Jose C. Florez, Pierre-Étienne Jacques, S. Ananth Karumanchi, Camille E. Powe, Luigi Bouchard, Marie-France Hivert
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Notch signaling in metabolic diseases: A key regulator and potential target
    Zhaoqing Xi, Junxia Zhang, Mingwei Bao
    Biochemical and Biophysical Research Communications.2025; 781: 152492.     CrossRef
  • The stem cell within the vessel wall: multipotent pericytes modulating β-cell function and diabetic complications
    Huanjing Bi, Ruiyang Ma, Zuhan Chen, Ying Wang, Xiaoming Ding
    Stem Cell Research & Therapy.2025;[Epub]     CrossRef
  • Investigating the Potential Molecular Mechanisms of Mogroside V on Glucose Homeostasis by Transcriptome Profiling of Adult Mouse Hypothalamic Cells
    Tomasz Szmatoła, Artur Gurgul, Ewa Ocłoń, Igor Jasielczuk, Ewelina Semik-Gurgul
    Applied Sciences.2025; 15(23): 12391.     CrossRef
  • The rs2341471-G/G genotype of activating transcription factor 6 (ATF6) is the risk factor of type 2 diabetes in subjects with obesity or overweight
    Elena Klyosova, Iuliia Azarova, Irina Petrukhina, Ramis Khabibulin, Alexey Polonikov
    International Journal of Obesity.2024; 48(11): 1638.     CrossRef
  • Identification of Immune Gene Signature Associated with T Cells and Natural Killer Cells in Type 1 Diabetes
    Na Wang, Guofeng Wang, Xiuli Feng, Teng Yang
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 2983.     CrossRef
  • N6-methylation of RNA-bound adenosine regulator HNRNPC promotes vascular endothelial dysfunction in type 2 diabetes mellitus by activating the PSEN1-mediated Notch pathway
    Ying Cai, Tao Chen, Mingzhu Wang, Lihua Deng, Cui Li, Siqian Fu, Kangling Xie
    Diabetes Research and Clinical Practice.2023; 197: 110261.     CrossRef
  • Single‐cell RNA sequencing: Inhibited Notch2 signalling underlying the increased lens fibre cells differentiation in high myopia
    Yunqian Yao, Ling Wei, Zhenhua Chen, Hao Li, Jiao Qi, Qingfeng Wu, Xingtao Zhou, Yi Lu, Xiangjia Zhu
    Cell Proliferation.2023;[Epub]     CrossRef
  • Micro ribonucleic acid‐363 regulates the phosphatidylinositol 3‐kinase/threonine protein kinase axis by targeting NOTCH1 and forkhead box C2, leading to hepatic glucose and lipids metabolism disorder in type 2 diabetes mellitus
    Yu‐Huan Peng, Ping Wang, Xiao‐Qun He, Ming‐Zhao Hong, Feng Liu
    Journal of Diabetes Investigation.2022; 13(2): 236.     CrossRef
  • Soluble T-cadherin promotes pancreatic β-cell proliferation by upregulating Notch signaling
    Tomonori Okita, Shunbun Kita, Shiro Fukuda, Keita Fukuoka, Emi Kawada-Horitani, Masahito Iioka, Yuto Nakamura, Yuya Fujishima, Hitoshi Nishizawa, Dan Kawamori, Taka-aki Matsuoka, Maeda Norikazu, Iichiro Shimomura
    iScience.2022; 25(11): 105404.     CrossRef
  • Comparison of islet isolation result and clinical applicability according to GMP‐grade collagenase enzyme blend in adult porcine islet isolation and culture
    Kyungmin Kwak, Jae‐kyung Park, Joohyun Shim, Nayoung Ko, Hyoung‐Joo Kim, Yongjin Lee, Jun‐Hyeong Kim, Michael Alexander, Jonathan R. T. Lakey, Hyunil Kim, Kimyung Choi
    Xenotransplantation.2021;[Epub]     CrossRef
  • Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas
    Adem Y. Dawed, Sook Wah Yee, Kaixin Zhou, Nienke van Leeuwen, Yanfei Zhang, Moneeza K. Siddiqui, Amy Etheridge, Federico Innocenti, Fei Xu, Josephine H. Li, Joline W. Beulens, Amber A. van der Heijden, Roderick C. Slieker, Yu-Chuan Chang, Josep M. Mercade
    Diabetes Care.2021; 44(12): 2673.     CrossRef
Reviews
Obesity and Metabolic Syndrome
Adult Stem Cells: Beyond Regenerative Tool, More as a Bio-Marker in Obesity and Diabetes
Sabyasachi Sen
Diabetes Metab J. 2019;43(6):744-751.   Published online December 26, 2019
DOI: https://doi.org/10.4093/dmj.2019.0175
  • 8,949 View
  • 84 Download
  • 6 Web of Science
  • 7 Crossref
AbstractAbstract PDFPubReader   ePub   

Obesity, diabetes, and cardiovascular diseases are increasing rapidly worldwide and it is therefore important to know the effect of exercise and medications for diabetes and obesity on adult stem cells. Adult stem cells play a major role in remodeling and tissue regeneration. In this review we will focus mainly on two adult stem/progenitor cells such as endothelial progenitor cells and mesenchymal stromal cells in relation to aerobic exercise and diabetes medications, both of which can alter the course of regeneration and tissue remodelling. These two adult precursor and stem cells are easily obtained from peripheral blood or adipose tissue depots, as the case may be and are precursors to endothelium and mesenchymal tissue (fat, bone, muscle, and cartilage). They both are key players in maintenance of cardiovascular and metabolic homeostasis and can act also as useful biomarkers.

Citations

Citations to this article as recorded by  
  • Stem cells in regenerative medicine: Unlocking therapeutic potential through stem cell therapy, 3D bioprinting, gene editing, and drug discovery
    Idris Zubairu Sadiq, Fatima Sadiq Abubakar, Babangida Sanusi Katsayal, Bashiru Ibrahim, Auwal Adamu, Mohammed Aliyu Usman, Mukhtar Aliyu, Mukhtar Adeiza Suleiman, Aliyu Muhammad
    Biomedical Engineering Advances.2025; 9: 100172.     CrossRef
  • Adipose-derived stem cell exosomes: emerging roles and therapeutic application
    Yuhan Gong, Hui Ma, Zhongren Zheng, Xinjie Wang, Jiahua Zhang, Xiaowei Zhao
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Novel Therapeutics in Nonalcoholic Fatty Liver Disease: A Focus on Adult Stem Cells
    Seshagiri Rao Nandula, Eric S. Nylen, Sabyasachi Sen
    Metabolic Syndrome and Related Disorders.2023; 21(2): 71.     CrossRef
  • Obesity and Wound Healing: Focus on Mesenchymal Stem Cells
    Antonio Alma, Guya Diletta Marconi, Elena Rossi, Cristina Magnoni, Alessia Paganelli
    Life.2023; 13(3): 717.     CrossRef
  • Stem Cells in Tendon Regeneration and Factors governing Tenogenesis
    Lingli Ding, BingYu Zhou, Yonghui Hou, Liangliang Xu
    Current Stem Cell Research & Therapy.2022; 17(6): 503.     CrossRef
  • Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes
    Seshagiri Rao Nandula, Nabanita Kundu, Hassan B. Awal, Beda Brichacek, Mona Fakhri, Nikhila Aimalla, Adrian Elzarki, Richard L. Amdur, Sabyasachi Sen
    Cardiovascular Diabetology.2021;[Epub]     CrossRef
  • Tailored generation of insulin producing cells from canine mesenchymal stem cells derived from bone marrow and adipose tissue
    Watchareewan Rodprasert, Sirirat Nantavisai, Koranis Pathanachai, Prasit Pavasant, Thanaphum Osathanon, Chenphop Sawangmake
    Scientific Reports.2021;[Epub]     CrossRef
Obesity and Metabolic Syndrome
Two Faces of White Adipose Tissue with Heterogeneous Adipogenic Progenitors
Injae Hwang, Jae Bum Kim
Diabetes Metab J. 2019;43(6):752-762.   Published online December 26, 2019
DOI: https://doi.org/10.4093/dmj.2019.0174
  • 15,038 View
  • 256 Download
  • 55 Web of Science
  • 57 Crossref
AbstractAbstract PDFPubReader   ePub   

Chronic energy surplus increases body fat, leading to obesity. Since obesity is closely associated with most metabolic complications, pathophysiological roles of adipose tissue in obesity have been intensively studied. White adipose tissue is largely divided into subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT). These two white adipose tissues are similar in their appearance and lipid storage functions. Nonetheless, emerging evidence has suggested that SAT and VAT have different characteristics and functional roles in metabolic regulation. It is likely that there are intrinsic differences between VAT and SAT. In diet-induced obese animal models, it has been reported that adipogenic progenitors in VAT rapidly proliferate and differentiate into adipocytes. In obesity, VAT exhibits elevated inflammatory responses, which are less prevalent in SAT. On the other hand, SAT has metabolically beneficial effects. In this review, we introduce recent studies that focus on cellular and molecular components modulating adipogenesis and immune responses in SAT and VAT. Given that these two fat depots show different functions and characteristics depending on the nutritional status, it is feasible to postulate that SAT and VAT have different developmental origins with distinct adipogenic progenitors, which would be a key determining factor for the response and accommodation to metabolic input for energy homeostasis.

Citations

Citations to this article as recorded by  
  • Dietary vitamins A and K are inversely associated with visceral adiposity in US adults: NHANES 2011–2018
    Tatei Haramara Colmenares Villa, Guadalupe Ruiz-Vivanco, Leonardo M. Porchia, Enrique Torres-Rasgado, Esther López-Bayghen, M. Elba Gonzalez-Mejia
    Nutrition Research.2026; 146: 26.     CrossRef
  • Cinnamon powder intake enhances the effect of caloric restriction on white adipose tissue in male rats
    Lia Rafaella Ballard Kuhnert, Roberta da Fonseca Coutinho Pontes, Jessika Geisebel Oliveira Neto, Juliana Santos Romão, Carla Eponina de Carvalho Pinto, Karen Jesus Oliveira
    Journal of Molecular Histology.2025;[Epub]     CrossRef
  • Prognostic impact of visceral and subcutaneous fat area in stage I-III colon cancer patients with cachexia: a population-based multicenter study
    Xian-wen Liang, Jing Wen, Bing Liu, Sheng-zhong Wang, Jin-cai Wu, Tao Pan
    Frontiers in Nutrition.2025;[Epub]     CrossRef
  • Visceral adipocyte metabolic dysfunction in obesity related to altered chromatin accessibility to thyroid hormone receptor
    Hao Zhu, Ji-Ru Zhang, Zhen-Wu Ma, Wen-Na Zhang, Yun Yang, Xuan-Bei Lu, Chen-Yun Gan, Guo-Xian Ding, Jing Yu, Yu Duan, Xiao-Dong Wang
    Gene.2025; 962: 149554.     CrossRef
  • snRNA-seq reveals subcutaneous white adipose tissue remodeling upon return to thermoneutrality after cold stimulation
    Yusha Yang, Guanyu Zhang, Ting Yi, Shuran Yang, Shuai Wu, Yongqiang Zhang, Li Zhang, Xi Li, Xiuxuan Wu, Jun Li, Danfeng Yang
    Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
  • β-Hydroxybutyrate Reduces Body Weight by Modulating Fatty Acid Oxidation and Beiging in the Subcutaneous Adipose Tissue of DIO Mice
    Violeta Heras, Virginia Mela, Pallavi Kompella, Elena Rojano, Guillermo Paz-López, Lucia Hurtado-García, Almudena Ortega-Gomez, Maria José García-López, María Luisa García-Martín, Juan A. G. Ranea, Francisco J. Tinahones, Isabel Moreno-Indias
    International Journal of Molecular Sciences.2025; 26(11): 5064.     CrossRef
  • Association between computed tomography-based adipose tissue parameters and liver transplant outcomes in patients with hepatocellular carcinoma
    Zhihang Hu, Hao Chen, Zuyuan Lin, Chiyu He, Wei Shen, Huigang Li, Zhe Yang, Jinzhen Cai, Shusen Zheng, Di Lu, Xiao Xu
    Clinical Nutrition.2025; 52: 82.     CrossRef
  • The Dual Role of Perivascular Adipose Tissue in Vascular Homeostasis and Atherogenesis: From Physiology to Pathological Implications
    Raluca Niculescu, Adina Stoian, Emil Marian Arbănași, Eliza Russu, Dragoș-Florin Babă, Andrei Manea, Mircea Stoian, Florina Ioana Gliga, Iuliu Gabriel Cocuz, Adrian Horațiu Sabău, Dan-Alexandru Szabo, Ovidiu Simion Cotoi
    International Journal of Molecular Sciences.2025; 26(17): 8320.     CrossRef
  • Inhibition of lipolysis in visceral adipose tissue from obese mice and humans prevents impairment of endothelial Kir2.1 channels
    Emma C. Hudgins, Erica J. Johnson, Sabita Rokka, Bhaswati Kashyap, Arielle Mahugu, Thanh Nguyen, Anthony R. Tascone, Elizabeth McCarthy, Caitlin Halbert, Ibra S. Fancher
    Channels.2025;[Epub]     CrossRef
  • Female Adipose Tissue Sex Steroid Biosynthesis
    Natalia Hetemäki, Tomi S. Mikkola, Hanna Savolainen-Peltonen
    Seminars in Reproductive Medicine.2025; 43(02): 106.     CrossRef
  • Visceral Adipose Tissue Accumulation in Children With Obesity and Co-occurring ADHD: A Case-Control Analysis of Body Fat Distribution Patterns
    Muhan Li, Shijie Li, Yan Hu, Chenlu Yang, Aimin Liang
    Journal of Attention Disorders.2025;[Epub]     CrossRef
  • Prognostic value of body fat composition in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy
    Cheng-Hung Liao, Po-Ting Chen, Chin-Chen Chang, Kuo-How Huang, Shih-Chieh Jeff Chueh, Kao-Lang Liu
    Journal of the Formosan Medical Association.2025;[Epub]     CrossRef
  • Lipodystrophy as a target to delay premature aging
    Daniela G. Costa, Marisa Ferreira-Marques, Cláudia Cavadas
    Trends in Endocrinology & Metabolism.2024; 35(2): 97.     CrossRef
  • Subcutaneous fat predicts bone metastasis in breast cancer: A novel multimodality-based deep learning model
    Shidi Miao, Haobo Jia, Wenjuan Huang, Ke Cheng, Wenjin Zhou, Ruitao Wang
    Cancer Biomarkers.2024; 39(3): 171.     CrossRef
  • Association between abdominal adiposity and clinical outcomes in patients with acute ischemic stroke
    Kayo Wakisaka, Ryu Matsuo, Fumi Irie, Yoshinobu Wakisaka, Tetsuro Ago, Masahiro Kamouchi, Takanari Kitazono, Masaki Mogi
    PLOS ONE.2024; 19(1): e0296833.     CrossRef
  • NOTCH1 as a Negative Regulator of Avian Adipocyte Differentiation: Implications for Fat Deposition
    Zheng Wang, Yue Su, Mingyu Zhao, Zhenhua Ma, Jianhui Li, Zhuocheng Hou, Huifeng Li
    Animals.2024; 14(4): 585.     CrossRef
  • Visceral adipose of obese mice inhibits endothelial inwardly rectifying K+ channels in a CD36-dependent fashion
    Sabita Rokka, Masoumeh Sadeghinejad, Emma C. Hudgins, Erica J. Johnson, Thanh Nguyen, Ibra S. Fancher
    American Journal of Physiology-Cell Physiology.2024; 326(5): C1543.     CrossRef
  • Adipose-derived mesenchymal stromal cells in clinical trials: Insights from single-cell studies
    Anna Kostecka, Natalia Kalamon, Aneta Skoniecka, Magdalena Koczkowska, Piotr M. Skowron, Arkadiusz Piotrowski, Michał Pikuła
    Life Sciences.2024; 351: 122761.     CrossRef
  • Dynamics of single-nuclei transcriptomic profiling of adipose tissue from diverse anatomical locations during mouse aging process
    Yujie Wu, Ying Sun, Long Chen, Xingyan Tong, Can Liu, Lu Lu, Rui Zhang, Siyuan Wang, Ziyu Chen, Jiaman Zhang, Ziyin Han, Bo Zeng, Mingzhou Li, Long Jin
    Scientific Reports.2024;[Epub]     CrossRef
  • Glucose metabolism and radiodensity of abdominal adipose tissue: A 5‐year longitudinal study in a large PET cohort
    Kyoungjune Pak, Severi Santavirta, Seunghyeon Shin, Hyun‐Yeol Nam, Sven De Maeyer, Lauri Nummenmaa
    Clinical Endocrinology.2024; 101(6): 623.     CrossRef
  • The association of obesity and the risk of rheumatoid arthritis according to abdominal obesity status: a nationwide population-based study in Korea
    Jung Sun Lee, Ji Seon Oh, Sehee Kim, Ye-Jee Kim, Seokchan Hong, Yong-Gil Kim, Chang-Keun Lee, Bin Yoo
    Rheumatology International.2024; 44(12): 2863.     CrossRef
  • Anti-Obesity Effects of Pleurotus ferulae Water Extract on 3T3-L1 Adipocytes and High-Fat-Diet-Induced Obese Mice
    Seulmin Hong, Seonkyeong Park, Jangho Lee, Soohyun Park, Jaeho Park, Yugeon Lee
    Nutrients.2024; 16(23): 4139.     CrossRef
  • Association between cardiometabolic index and all-cause and cause-specific mortality among the general population: NHANES 1999–2018
    Mingjie Liu, Chendong Wang, Rundong Liu, Yan Wang, Bai Wei
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • Green tea beneficial effects involve changes in the profile of immune cells in the adipose tissue of obese mice
    Kaue Tognolli, Victoria Silva, Celso Pereira Batista Sousa-Filho, Claudia Andrea Lima Cardoso, Renata Gorjão, Rosemari Otton
    European Journal of Nutrition.2023; 62(1): 321.     CrossRef
  • Mechanic Insight into the Distinct and Common Roles of Ovariectomy Versus Adrenalectomy on Adipose Tissue Remodeling in Female Mice
    Weihao Chen, Fengyan Meng, Xianyin Zeng, Xiaohan Cao, Guixian Bu, Xiaogang Du, Guozhi Yu, Fanli Kong, Yunkun Li, Tian Gan, Xingfa Han
    International Journal of Molecular Sciences.2023; 24(3): 2308.     CrossRef
  • High-fat diet consumption by male rat offspring of obese mothers exacerbates adipose tissue hypertrophy and metabolic alterations in adult life
    Guadalupe L. Rodríguez-González, Sergio De Los Santos, Dayana Méndez-Sánchez, Luis A. Reyes-Castro, Carlos A. Ibáñez, Patricia Canto, Elena Zambrano
    British Journal of Nutrition.2023; 130(5): 783.     CrossRef
  • Obesity and the risk of cardiometabolic diseases
    Pedro L. Valenzuela, Pedro Carrera-Bastos, Adrián Castillo-García, Daniel E. Lieberman, Alejandro Santos-Lozano, Alejandro Lucia
    Nature Reviews Cardiology.2023; 20(7): 475.     CrossRef
  • Abdominal fat and muscle distributions in different stages of colorectal cancer
    Jun Han, Xinyang Liu, Min Tang, Fan Yang, Zuoyou Ding, Guohao Wu
    BMC Cancer.2023;[Epub]     CrossRef
  • Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index
    Sofía Elena Tesolato, Daniel González-Gamo, Ana Barabash, Paula Claver, Sofía Cristina de la Serna, Inmaculada Domínguez-Serrano, Jana Dziakova, Carmen de Juan, Antonio José Torres, Pilar Iniesta
    Cancers.2023; 15(13): 3324.     CrossRef
  • Lower subcutaneous fat index predicts bone metastasis in breast cancer
    Wen Wang, Wen-Juan Huang, Ping-Ping Liu, Shuang Fu, Meng-Lin Zhang, Xin Zhang, Rui-Tao Wang, Yuan-Xi Huang
    Cancer Biomarkers.2023; 38(1): 121.     CrossRef
  • RabGAP AS160/TBC1D4 deficiency increases long-chain fatty acid transport but has little additional effect on obesity and metabolic syndrome in ADMSCs-derived adipocytes of morbidly obese women
    Agnieszka Mikłosz, Bartłomiej Łukaszuk, Elżbieta Supruniuk, Kamil Grubczak, Magdalena Kusaczuk, Adrian Chabowski
    Frontiers in Molecular Biosciences.2023;[Epub]     CrossRef
  • White adipose tissue: Distribution, molecular insights of impaired expandability, and its implication in fatty liver disease
    Griselda Rabadán-Chávez, Rocío I. Díaz de la Garza, Daniel A. Jacobo-Velázquez
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2023; 1869(8): 166853.     CrossRef
  • Histological pattern and gene expression profiling of thyroid tissue in subjects with obesity
    A. Basolo, A. M. Poma, R. Giannini, G. Ceccarini, C. Pelosini, P. Fierabracci, M. U. Castany, S. Bechi Genzano, C. E. Ambrosini, G. Materazzi, L. Chiovato, F. Basolo, F. Santini, L. Torregrossa
    Journal of Endocrinological Investigation.2022; 45(2): 413.     CrossRef
  • Predictors of non-alcoholic fatty liver disease in children
    Menglong Li, Wen Shu, Jiawulan Zunong, Nubiya Amaerjiang, Huidi Xiao, Dan Li, Sten H. Vermund, Yifei Hu
    Pediatric Research.2022; 92(1): 322.     CrossRef
  • Distinct properties of adipose stem cell subpopulations determine fat depot-specific characteristics
    Hahn Nahmgoong, Yong Geun Jeon, Eun Seo Park, Yoon Ha Choi, Sang Mun Han, Jeu Park, Yul Ji, Jee Hyung Sohn, Ji Seul Han, Ye Young Kim, Injae Hwang, Yun Kyung Lee, Jin Young Huh, Sung Sik Choe, Tae Jung Oh, Sung Hee Choi, Jong Kyoung Kim, Jae Bum Kim
    Cell Metabolism.2022; 34(3): 458.     CrossRef
  • WT1 in Adipose Tissue: From Development to Adult Physiology
    Karin M. Kirschner, Holger Scholz
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • Shall We Begin the Voyage of Adipose Tissue Exploration?
    Yong Geun Jeon
    Molecules and Cells.2022; 45(6): 362.     CrossRef
  • Mammalian adipogenesis regulator (Areg) cells use retinoic acid signalling to be non‐ and anti‐adipogenic in age‐dependent manner
    Magda Zachara, Pernille Y Rainer, Horia Hashimi, Julie M Russeil, Daniel Alpern, Radiana Ferrero, Maria Litovchenko, Bart Deplancke
    The EMBO Journal.2022;[Epub]     CrossRef
  • The fates of different types of adipose tissue after transplantation in mice
    Shenglu Jiang, Jiayan Lin, Qian Zhang, Yunjun Liao, Feng Lu, Junrong Cai
    The FASEB Journal.2022;[Epub]     CrossRef
  • Analysis of different adipose depot gene expression in cachectic patients with gastric cancer
    Jun Han, Zuoyou Ding, Qiulin Zhuang, Lei Shen, Fan Yang, Szechun Sah, Guohao Wu
    Nutrition & Metabolism.2022;[Epub]     CrossRef
  • Adipose Stromal/Stem Cell-Derived Extracellular Vesicles: Potential Next-Generation Anti-Obesity Agents
    Mariachiara Zuccarini, Patricia Giuliani, Valentina Di Liberto, Monica Frinchi, Francesco Caciagli, Vanni Caruso, Renata Ciccarelli, Giuseppa Mudò, Patrizia Di Iorio
    International Journal of Molecular Sciences.2022; 23(3): 1543.     CrossRef
  • Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project
    Enric Sánchez, Marta Sánchez, Carolina López-Cano, Marcelino Bermúdez-López, José Manuel Valdivielso, Cristina Farràs-Sallés, Reinald Pamplona, Gerard Torres, Dídac Mauricio, Eva Castro, Elvira Fernández, Albert Lecube
    Nutrients.2022; 15(1): 203.     CrossRef
  • Insights behind the Relationship between Colorectal Cancer and Obesity: Is Visceral Adipose Tissue the Missing Link?
    Alice Chaplin, Ramon Maria Rodriguez, Juan José Segura-Sampedro, Aina Ochogavía-Seguí, Dora Romaguera, Gwendolyn Barceló-Coblijn
    International Journal of Molecular Sciences.2022; 23(21): 13128.     CrossRef
  • Potential effects of nutrition-based weight loss therapies in reversing obesity-related breast cancer epigenetic marks
    Paula M. Lorenzo, Ana B. Crujeiras
    Food & Function.2021; 12(4): 1402.     CrossRef
  • Metabolomic Profiles in Adipocytes Differentiated from Adipose-Derived Stem Cells Following Exercise Training or High-Fat Diet
    Seita Osawa, Hisashi Kato, Yuki Maeda, Hisashi Takakura, Junetsu Ogasawara, Tetsuya Izawa
    International Journal of Molecular Sciences.2021; 22(2): 966.     CrossRef
  • Adipocytes Are the Control Tower That Manages Adipose Tissue Immunity by Regulating Lipid Metabolism
    Jeu Park, Jee Hyung Sohn, Sang Mun Han, Yoon Jeong Park, Jin Young Huh, Sung Sik Choe, Jae Bum Kim
    Frontiers in Immunology.2021;[Epub]     CrossRef
  • Ceramides and Sphingosino-1-Phosphate in Obesity
    Ilona Juchnicka, Mariusz Kuźmicki, Jacek Szamatowicz
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Contribution of Adipose Tissue to the Chronic Immune Activation and Inflammation Associated With HIV Infection and Its Treatment
    Christine Bourgeois, Jennifer Gorwood, Anaelle Olivo, Laura Le Pelletier, Jacqueline Capeau, Olivier Lambotte, Véronique Béréziat, Claire Lagathu
    Frontiers in Immunology.2021;[Epub]     CrossRef
  • Subcutaneous, but not visceral, adipose tissue as a marker for prognosis in gastric cancer patients with cachexia
    Jun Han, Min Tang, Chaocheng Lu, Lei Shen, Jiaqi She, Guohao Wu
    Clinical Nutrition.2021; 40(9): 5156.     CrossRef
  • miR-410-3P inhibits adipocyte differentiation by targeting IRS-1 in cancer-associated cachexia patients
    Diya Sun, Zuoyou Ding, Lei Shen, Fan Yang, Jun Han, Guohao Wu
    Lipids in Health and Disease.2021;[Epub]     CrossRef
  • RETRACTED: Multipotent Stromal Cells from Subcutaneous Adipose Tissue of Normal Weight and Obese Subjects: Modulation of Their Adipogenic Differentiation by Adenosine A1 Receptor Ligands
    Mariachiara Zuccarini, Catia Lambertucci, Marzia Carluccio, Patricia Giuliani, Maurizio Ronci, Andrea Spinaci, Rosaria Volpini, Renata Ciccarelli, Patrizia Di Iorio
    Cells.2021; 10(12): 3560.     CrossRef
  • Obesity: The Crossroads of Opinion, Knowledge, and Opportunity
    L. A. Ruyatkina, D. S. Ruyatkin
    Meditsinskiy sovet = Medical Council.2020; (7): 108.     CrossRef
  • Sex Differences in Long-term Metabolic Effects of Maternal Resveratrol Intake in Adult Rat Offspring
    Purificación Ros, Francisca Díaz, Alejandra Freire-Regatillo, Pilar Argente-Arizón, Vicente Barrios, Jesús Argente, Julie A Chowen
    Endocrinology.2020;[Epub]     CrossRef
  • Adipose stem cells in obesity: challenges and opportunities
    Sunhye Shin, Asma S. El-Sabbagh, Brandon E. Lukas, Skylar J. Tanneberger, Yuwei Jiang
    Bioscience Reports.2020;[Epub]     CrossRef
  • Clinical and pathogenetic rationale for the prevention and treatment of obesity
    O.M. Korzh
    Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini.2020; 2020(2): 146.     CrossRef
  • OBESITY: CLINICAL AND PATHOGENETIC JUSTIFICATION OF PREVENTION AND TREATMENT
    O. M. Korzh
    International Medical Journal.2020; (2): 5.     CrossRef
  • The Effect and Mechanism of Subcutaneous and Visceral Adipose Tissue Loss on Gastric Cancer Patients With Cachexia
    Jun Han, Min Tang, Guyue Zhang, Chaocheng Lu, Jiaqi She, Guohao Wu
    SSRN Electronic Journal .2020;[Epub]     CrossRef
Original Articles
Pathophysiology
Metformin Ameliorates Lipotoxic β-Cell Dysfunction through a Concentration-Dependent Dual Mechanism of Action
Hong Il Kim, Ji Seon Lee, Byung Kook Kwak, Won Min Hwang, Min Joo Kim, Young-Bum Kim, Sung Soo Chung, Kyong Soo Park
Diabetes Metab J. 2019;43(6):854-866.   Published online June 27, 2019
DOI: https://doi.org/10.4093/dmj.2018.0179
  • 11,661 View
  • 140 Download
  • 18 Web of Science
  • 19 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Chronic exposure to elevated levels of free fatty acids contributes to pancreatic β-cell dysfunction. Although it is well known that metformin induces cellular energy depletion and a concomitant activation of AMP-activated protein kinase (AMPK) through inhibition of the respiratory chain, previous studies have shown inconsistent results with regard to the action of metformin on pancreatic β-cells. We therefore examined the effects of metformin on pancreatic β-cells under lipotoxic stress.

Methods

NIT-1 cells and mouse islets were exposed to palmitate and treated with 0.05 and 0.5 mM metformin. Cell viability, glucose-stimulated insulin secretion, cellular adenosine triphosphate, reactive oxygen species (ROS) levels and Rho kinase (ROCK) activities were measured. The phosphorylation of AMPK was evaluated by Western blot analysis and mRNA levels of endoplasmic reticulum (ER) stress markers and NADPH oxidase (NOX) were measured by real-time quantitative polymerase chain reaction analysis.

Results

We found that metformin has protective effects on palmitate-induced β-cell dysfunction. Metformin at a concentration of 0.05 mM inhibits NOX and suppresses the palmitate-induced elevation of ER stress markers and ROS levels in a AMPK-independent manner, whereas 0.5 mM metformin inhibits ROCK activity and activates AMPK.

Conclusion

This study suggests that the action of metformin on β-cell lipotoxicity was implemented by different molecular pathways depending on its concentration. Metformin at a usual therapeutic dose is supposed to alleviate lipotoxic β-cell dysfunction through inhibition of oxidative stress and ER stress.

Citations

Citations to this article as recorded by  
  • Metformin triggers apoptosis via endoplasmic reticulum stress in HER2‑positive breast cancer cell lines
    Eser Çakmak, Bi̇rşen Bi̇lgi̇ci̇
    Experimental and Therapeutic Medicine.2026; 31(4): 1.     CrossRef
  • Metformin promotes lipid droplet-mitochondria coupling and improves insulin secretion in pancreatic β-cells exposed to lipotoxicity
    Aneta M. Dobosz, Ewelina Krogulec, Nataniel Stefanowski, Maria Kendziorek, Magdalena Lebiedzinska-Arciszewska, Mariusz R. Wieckowski, Justyna Janikiewicz, Agnieszka Dobrzyn
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2025; 1870(7): 159664.     CrossRef
  • 5‐Aminoimidazole‐4‐carboxamide‐1‐β${bf {beta}}$‐d‐ribofuranoside ameliorates lipotoxicity through enhanced reticulophagy in HepG2 cells
    Ajay Krishnan U, Anuradha Carani Venkataraman, Vidhya Ramachandran
    Biotechnology and Applied Biochemistry.2025;[Epub]     CrossRef
  • Metformin enhances METTL14-Mediated m6A methylation to alleviate NIT-1 cells apoptosis induced by hydrogen peroxide
    Si-min Zhou, Xin-ming Yao, Yi Cheng, Yu-jie Xing, Yue Sun, Qiang Hua, Shu-jun Wan, Xiang-jian Meng
    Heliyon.2024; 10(2): e24432.     CrossRef
  • Roles of m6A modification in regulating PPER pathway in cadmium-induced pancreatic β cell death
    Yifei Sun, Rongxian Li, Wenhong Li, Nan Zhang, Guofen Liu, Bo Zhao, Zongqin Mei, Shiyan Gu, Zuoshun He
    Ecotoxicology and Environmental Safety.2024; 282: 116672.     CrossRef
  • Metformin’s effect on metabolic dysfunction-associated steatotic liver disease through the miR-200a-5p and AMPK/SERCA2b pathway
    Hang Chen, Minshan Huang, Dan Zhang, Hui Wang, Da Wang, Mengwei Li, Xianmei Wang, Rui Zhu, Jianjun Liu, Lanqing Ma
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Reduced Expression Level of Protein PhosphatasePPM1EServes to Maintain Insulin Secretion in Type 2 Diabetes
    Sevda Gheibi, Luis Rodrigo Cataldo, Alexander Hamilton, Mi Huang, Sebastian Kalamajski, Malin Fex, Hindrik Mulder
    Diabetes.2023; 72(4): 455.     CrossRef
  • Metformin restores prohormone processing enzymes and normalizes aberrations in secretion of proinsulin and insulin in palmitate‐exposed human islets
    Quan Wen, Azazul Islam Chowdhury, Banu Aydin, Mudhir Shekha, Rasmus Stenlid, Anders Forslund, Peter Bergsten
    Diabetes, Obesity and Metabolism.2023; 25(12): 3757.     CrossRef
  • Treatment of type 2 diabetes mellitus with stem cells and antidiabetic drugs: a dualistic and future-focused approach
    Priyamvada Amol Arte, Kanchanlata Tungare, Mustansir Bhori, Renitta Jobby, Jyotirmoi Aich
    Human Cell.2023; 37(1): 54.     CrossRef
  • Overexpression of miR-297b-5p in Mouse Insulin-Secreting Cells Promotes Metformin-Mediated Protection Against Stearic Acid-Induced Senescence by Targeting Igf1r
    Qingrui Zhao, Shenghan Su, Yuqing Lin, Xuebei Li, Lingfeng Dan, Chunxiao Yang, Chenchen Geng, Romano Regazzi, Xiaohan Li, Yimeng Dong, Changhao Sun, Xia Chu, Huimin Lu
    Frontiers in Bioscience-Landmark.2023;[Epub]     CrossRef
  • Metformin disrupts insulin secretion, causes proapoptotic and oxidative effects in rat pancreatic beta‐cells in vitro
    Maíra M.R. Valle, Eloisa Aparecida Vilas‐Boas, Camila F. Lucena, Simone A. Teixeira, Marcelo N. Muscara, Angelo R. Carpinelli
    Journal of Biochemical and Molecular Toxicology.2022;[Epub]     CrossRef
  • Protection by metformin against severe Covid-19: An in-depth mechanistic analysis
    Nicolas Wiernsperger, Abdallah Al-Salameh, Bertrand Cariou, Jean-Daniel Lalau
    Diabetes & Metabolism.2022; 48(4): 101359.     CrossRef
  • Insight Into Rho Kinase Isoforms in Obesity and Energy Homeostasis
    Lei Wei, Jianjian Shi
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Overexpression of miR-297b-5p Promotes Metformin-Mediated Protection Against Stearic Acid-Induced Senescence by Targeting Igf1r
    Qingrui Zhao, Shenghan Su, Yuqing Lin, Xuebei Li, Lingfeng Dan, Yunjin Zhang, Chunxiao Yang, Xiaohan Li, Yimeng Dong, Chenchen Geng, Changhao Sun, Xia Chu, Huimin Lu
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Metformin Dysregulates the Unfolded Protein Response and the WNT/β-Catenin Pathway in Endometrial Cancer Cells through an AMPK-Independent Mechanism
    Domenico Conza, Paola Mirra, Gaetano Calì, Luigi Insabato, Francesca Fiory, Francesco Beguinot, Luca Ulianich
    Cells.2021; 10(5): 1067.     CrossRef
  • NADPH Oxidase (NOX) Targeting in Diabetes: A Special Emphasis on Pancreatic β-Cell Dysfunction
    Suma Elumalai, Udayakumar Karunakaran, Jun-Sung Moon, Kyu-Chang Won
    Cells.2021; 10(7): 1573.     CrossRef
  • Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study
    Min Ho Kim, Hyung Jung Oh, Soon Hyo Kwon, Jin Seok Jeon, Hyunjin Noh, Dong Cheol Han, Hyoungnae Kim, Dong-Ryeol Ryu
    Kidney Research and Clinical Practice.2021; 40(4): 660.     CrossRef
  • Different Effects of Metformin and A769662 on Sodium Iodate-Induced Cytotoxicity in Retinal Pigment Epithelial Cells: Distinct Actions on Mitochondrial Fission and Respiration
    Chi-Ming Chan, Ponarulselvam Sekar, Duen-Yi Huang, Shu-Hao Hsu, Wan-Wan Lin
    Antioxidants.2020; 9(11): 1057.     CrossRef
  • Metformin Reduces Lipotoxicity-Induced Meta-Inflammation in β-Cells through the Activation of GPR40-PLC-IP3 Pathway
    Ximei Shen, Beibei Fan, Xin Hu, Liufen Luo, Yuanli Yan, Liyong Yang
    Journal of Diabetes Research.2019; 2019: 1.     CrossRef
Islet Studies and Transplantation
Myricetin Protects Against High Glucose-Induced β-Cell Apoptosis by Attenuating Endoplasmic Reticulum Stress via Inactivation of Cyclin-Dependent Kinase 5
Udayakumar Karunakaran, Suma Elumalai, Jun Sung Moon, Jae-Han Jeon, Nam Doo Kim, Keun-Gyu Park, Kyu Chang Won, Jaechan Leem, In-Kyu Lee
Diabetes Metab J. 2019;43(2):192-205.   Published online January 16, 2019
DOI: https://doi.org/10.4093/dmj.2018.0052
  • 9,213 View
  • 132 Download
  • 46 Web of Science
  • 46 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Chronic hyperglycemia has deleterious effects on pancreatic β-cell function and turnover. Recent studies support the view that cyclin-dependent kinase 5 (CDK5) plays a role in β-cell failure under hyperglycemic conditions. However, little is known about how CDK5 impair β-cell function. Myricetin, a natural flavonoid, has therapeutic potential for the treatment of type 2 diabetes mellitus. In this study, we examined the effect of myricetin on high glucose (HG)-induced β-cell apoptosis and explored the relationship between myricetin and CDK5.

Methods

To address this question, we subjected INS-1 cells and isolated rat islets to HG conditions (30 mM) in the presence or absence of myricetin. Docking studies were conducted to validate the interaction between myricetin and CDK5. Gene expression and protein levels of endoplasmic reticulum (ER) stress markers were measured by real-time reverse transcription polymerase chain reaction and Western blot analysis.

Results

Activation of CDK5 in response to HG coupled with the induction of ER stress via the down regulation of sarcoendoplasmic reticulum calcium ATPase 2b (SERCA2b) gene expression and reduced the nuclear accumulation of pancreatic duodenal homeobox 1 (PDX1) leads to β-cell apoptosis. Docking study predicts that myricetin inhibit CDK5 activation by direct binding in the ATP-binding pocket. Myricetin counteracted the decrease in the levels of PDX1 and SERCA2b by HG. Moreover, myricetin attenuated HG-induced apoptosis in INS-1 cells and rat islets and reduce the mitochondrial dysfunction by decreasing reactive oxygen species production and mitochondrial membrane potential (Δψm) loss.

Conclusion

Myricetin protects the β-cells against HG-induced apoptosis by inhibiting ER stress, possibly through inactivation of CDK5 and consequent upregulation of PDX1 and SERCA2b.

Citations

Citations to this article as recorded by  
  • Polyphenols in food and food wastes: Extraction, isolation, and health applications
    Malthe Fredsgaard, Andre Fussy, Gowri Købke Nybo, Jutta Papenbrock, Laura Sini Sofia Hulkko, Mina Dadjoo, Tanmay Chaturvedi, Mette Hedegaard Thomsen
    Food Chemistry: Molecular Sciences.2026; 12: 100351.     CrossRef
  • A Mechanism-based Perspective on the Use of Flavonoids in the Treatment of Diabetes and its Complications
    Sandesh Kumar Pattanaik, Manisha Prajapati Anil, Sudipta Jena, Diptirani Rath
    Current Diabetes Reviews.2026;[Epub]     CrossRef
  • Dietary daidzein supplementation alleviates myocardial inflammatory injury by modulating estrogen receptor beta-mediated ER stress pathway
    Zhongchao Gai, Sijia Yan, Chengyuan Min, Quanjian Zhao, Wen Luo, Guoli Gong, Jieqiong Zhao
    The Journal of Nutritional Biochemistry.2026; : 110336.     CrossRef
  • Myricetin Restores Autophagy to Attenuate Lumbar Intervertebral Disk Degeneration Via Negative Regulation of the JAK2/STAT3 Pathway
    Tian Mao, Junchi Fan
    Biochemical Genetics.2025; 63(3): 2743.     CrossRef
  • Myricetin alleviates learning and memory deficits in trimethyltin Alzheimer’s phenotype via attenuating hippocampal endoplasmic reticulum stress and regulating inflammation and oxidative stress
    Zahra Asgari, Saeid Iranzadeh, Mehrdad Roghani
    Brain Research Bulletin.2025; 227: 111382.     CrossRef
  • Myricetin Amplifies Glucose–Stimulated Insulin Secretion via the cAMP-PKA-Epac-2 Signaling Cascade
    Akhtar Ali, Zahida Memon, Abdul Hameed, Zaheer Ul-Haq, Muneeb Ali, Rahman M. Hafizur
    Biomedicines.2025; 13(6): 1447.     CrossRef
  • Impact of C-8 hydroxylation and C-7 methylglucosylation of dihydroquercetin on glucose metabolism in diabetic zebrafish larvae
    Yong Cheng, Beijun Ang, Dandan Ma, Zhiwei Li, Fengxian Guo, Zhaojun Wang, Qiuming Chen, Maomao Zeng, Jie Chen, Benu Adhikari, Liduan Yin, Tong Wang, Zongping Zheng, Zhiyong He
    Food Bioscience.2025; 71: 107319.     CrossRef
  • Mechanistic insight into the antidiabetic effects of Ficus hispida fruits: Inhibition of intestinal glucose absorption and pancreatic beta-cell apoptosis
    Nusaiba Jahan, Noimul Hasan Siddiquee, Rifayat Ara Khanom Riva, Nur Uddin Chowdhury, Marjanur Rahman Bhuiyan, Khondoker Shahin Ahmed, Hemayet Hossain, Sadikur Rahman Shuvo, AFM. Shahid Ud Daula, Jorddy Neves Cruz
    PLOS One.2025; 20(12): e0337465.     CrossRef
  • Profiling of secondary metabolite and evaluation of anti-diabetic potency of Crotalaria quinquefolia (L): In-vitro, in-vivo, and in-silico approaches
    Nazmun Nahar, Md. Nazmul Hasan Zilani, Partha Biswas, Md. Morsaline Billah, Shabana Bibi, Norah A. Albekairi, Abdulrahman Alshammari, Md. Nazmul Hasan
    Saudi Pharmaceutical Journal.2024; 32(1): 101887.     CrossRef
  • Mitochondrial aldehyde dehydrogenase-2 coordinates the hydrogen sulfide - AMPK axis to attenuate high glucose-induced pancreatic β-cell dysfunction by glutathione antioxidant system
    Udayakumar Karunakaran, Suma Elumalai, Seung Min Chung, Kathrin Maedler, Kyu Chang Won, Jun Sung Moon
    Redox Biology.2024; 69: 102994.     CrossRef
  • Network-based identification and mechanism exploration of active ingredients against Alzheimer’s disease via targeting endoplasmic reticulum stress from traditional chinese medicine
    Zhao Dai, Tian Hu, Junwen Wei, Xue Wang, Chuipu Cai, Yong Gu, Yunhui Hu, Wenjia Wang, Qihui Wu, Jiansong Fang
    Computational and Structural Biotechnology Journal.2024; 23: 506.     CrossRef
  • Myricetin as a Promising Flavonoid with Multitargeted Biological Activity
    A.S. Chiriapkin
    Juvenis Scientia.2024; 10(1): 5.     CrossRef
  • Naturally occurring small molecules with dual effect upon inflammatory signaling pathways and endoplasmic reticulum stress response
    Daniela Correia da Silva, Patrícia Valentão, David M. Pereira
    Journal of Physiology and Biochemistry.2024; 80(2): 421.     CrossRef
  • Immunopeptidome mining reveals a novel ERS-induced target in T1D
    Lina Wang, Shushu Yang, Gaohui Zhu, Jie Li, Gang Meng, Xiaoling Chen, Mengjun Zhang, Shufeng Wang, Xiangqian Li, Yu Pan, Yi Huang, Li Wang, Yuzhang Wu
    Cellular & Molecular Immunology.2024; 21(6): 604.     CrossRef
  • مقارنة تأثير المستخلص المائي لثمار نبات البامية Abelmoschus Esculentus مع عقار الميتفورمين على إناث الجرذان المصابة بالسكري
    عائشة أدريس, إبراهيم عزاقة, فاطمة عبدالله
    Journal of Pure & Applied Sciences.2024; 23(1): 96.     CrossRef
  • Endoplasmic reticulum stress in pancreatic β-cell dysfunction: The potential therapeutic role of dietary flavonoids
    Kingsley C. Mbara, Marthe C.D. Fotsing, Derek T. Ndinteh, Claudine N. Mbeb, Chinekwu S. Nwagwu, Rene Khan, Kopang C. Mokhetho, Himansu Baijnath, Manimbulu Nlooto, Shoeshoe Mokhele, Carmen M. Leonard, Vuyelwa J. Tembu, Clemence Tarirai
    Current Research in Pharmacology and Drug Discovery.2024; 6: 100184.     CrossRef
  • HDAC1 Promotes Mitochondrial Pathway Apoptosis and Inhibits the Endoplasmic Reticulum Stress Response in High Glucose-Treated Schwann Cells via Decreased U4 Spliceosomal RNA
    Tingting Jin, Ziming Wang, Fan Fan, Wandi Wei, Chenming Zhou, Ziyu Zhang, Yue Gao, Wenhui Li, Lin Zhu, Jun Hao
    Neurochemical Research.2024; 49(10): 2699.     CrossRef
  • Efficacy of Myricetin Supplementation on Glucose and Lipid Metabolism: A Systematic Review and Meta-Analysis of In Vivo Mice Studies
    Mihai Babotă, Oleg Frumuzachi, Corneliu Tanase, Andrei Mocan
    Nutrients.2024; 16(21): 3730.     CrossRef
  • Detection of polyphenols in carob pods ( Ceratonia siliqua ) from Southern Italy by a LC-HRMS method
    Calogero Alfano, Elisa Maria Domenica Messina, Gaetano Cammilleri, Francesco Giuseppe Galluzzo, Licia Pantano, Maria Drussilla Buscemi, Andrea Macaluso, Tiziana Bertuglia, Andrea Pulvirenti, Gianluigi Maria Lo Dico, Ursula M. Jacob, Tilman Fritsch, Vincen
    Natural Product Research.2024; : 1.     CrossRef
  • Omnifarious fruit polyphenols: an omnipotent strategy to prevent and intervene diabetes and related complication?
    Yao Chen, Xuejiao Qie, Wei Quan, Maomao Zeng, Fang Qin, Jie Chen, Benu Adhikari, Zhiyong He
    Critical Reviews in Food Science and Nutrition.2023; 63(20): 4288.     CrossRef
  • Regulation of reactive oxygen species by phytochemicals for the management of cancer and diabetes
    Heui Min Lim, See-Hyoung Park
    Critical Reviews in Food Science and Nutrition.2023; 63(22): 5911.     CrossRef
  • Bioactive compounds from Polygonatum genus as anti-diabetic agents with future perspectives
    Yan Shi, Dun Si, Donghong Chen, Xinfeng Zhang, Zhigang Han, Qiang Yu, Jingjing Liu, Jinping Si
    Food Chemistry.2023; 408: 135183.     CrossRef
  • Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes?
    Michele Lodato, Valérie Plaisance, Valérie Pawlowski, Maxime Kwapich, Alexandre Barras, Emeline Buissart, Stéphane Dalle, Sabine Szunerits, Jérôme Vicogne, Rabah Boukherroub, Amar Abderrahmani
    Cells.2023; 12(6): 940.     CrossRef
  • TFP5 attenuates cyclin‐dependent kinase 5‐mediated islet β‐cell damage in diabetes
    Shunyao Liu, Bo Li, Danna Ma, Yuejia Tao, Jiang Song, Li Bao, Guoqing Zhang, Hongyan Luo, Shilu Cao, Jing E, Yali Zheng
    Chemical Biology & Drug Design.2023; 102(1): 76.     CrossRef
  • Antiviral and Possible Prophylactic Significance of Myricetin for COVID-19
    Pawan K. Agrawal, Chandan Agrawal, Gerald Blunden
    Natural Product Communications.2023;[Epub]     CrossRef
  • In Vitro and In Silico Protocols for the Assessment of Anti-Tick Compounds from Pinus roxburghii against Rhipicephalus (Boophilus) microplus Ticks
    Sana Ayub, Nosheen Malak, Raquel Cossío-Bayúgar, Nasreen Nasreen, Afshan Khan, Sadaf Niaz, Adil Khan, Abdallah D. Alanazi, Mourad Ben Said
    Animals.2023; 13(8): 1388.     CrossRef
  • Protective Effect of Myricetin Against Experimentally Induced Torsion in Rats
    M. Tatar, Z. Polat, J. Öner, H. Öner
    Biology Bulletin.2023; 50(6): 1338.     CrossRef
  • The pharmacological mechanism of Abelmoschus manihot in the treatment of chronic kidney disease
    Cuiting Wei, Chao Wang, Run Li, Yunfeng Bai, Xue Wang, Qingyun Fang, Xiangmei Chen, Ping Li
    Heliyon.2023; 9(11): e22017.     CrossRef
  • Natural Polyphenols as SERCA Activators: Role in the Endoplasmic Reticulum Stress-Related Diseases
    Jana Viskupicova, Petronela Rezbarikova
    Molecules.2022; 27(16): 5095.     CrossRef
  • Research progress on the mechanism of beta-cell apoptosis in type 2 diabetes mellitus
    SuFang You, JingYi Zheng, YuPing Chen, HuiBin Huang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Myricetin inhibits pseudorabies virus infection through direct inactivation and activating host antiviral defense
    Huaiyue Hu, Zhiqiang Hu, Yingying Zhang, Hongping Wan, Zhongqiong Yin, Lixia Li, Xiaoxia Liang, Xinghong Zhao, Lizi Yin, Gang Ye, Yuan-Feng Zou, Huaqiao Tang, Renyong Jia, Yaqin Chen, Hao Zhou, Xu Song
    Frontiers in Microbiology.2022;[Epub]     CrossRef
  • Effects of myricetin against cadmium-induced neurotoxicity in PC12 cells
    Azadeh Aminzadeh, Ayda Salarinejad
    Toxicology Research.2021; 10(1): 84.     CrossRef
  • Pioglitazone-induced AMPK-Glutaminase-1 prevents high glucose-induced pancreatic β-cell dysfunction by glutathione antioxidant system
    Udayakumar Karunakaran, Suma Elumalai, Jun Sung Moon, Kyu Chang Won
    Redox Biology.2021; 45: 102029.     CrossRef
  • Chlorogenic acid and β-glucan from highland barley grain ameliorate β-cell dysfunction via inhibiting apoptosis and improving cell proliferation
    Ze-Hua Liu, Bo Li
    Food & Function.2021; 12(20): 10040.     CrossRef
  • The cyclin dependent kinase inhibitor Roscovitine prevents diet-induced metabolic disruption in obese mice
    Nabil Rabhi, Kathleen Desevin, Briana Noel Cortez, Ryan Hekman, Jean Z. Lin, Andrew Emili, Stephen R. Farmer
    Scientific Reports.2021;[Epub]     CrossRef
  • AdipoRon promotes diabetic fracture repair through endochondral ossification-based bone repair by enhancing survival and differentiation of chondrocytes
    Zhongyi Wang, Jinxin Tang, Ying Li, Yu Wang, Yanyang Guo, Qisheng Tu, Jake Chen, Chen Wang
    Experimental Cell Research.2020; 387(2): 111757.     CrossRef
  • A kinase of many talents: non-neuronal functions of CDK5 in development and disease
    Samanta Sharma, Piotr Sicinski
    Open Biology.2020;[Epub]     CrossRef
  • Mitochondrial dysfunction in the fetoplacental unit in gestational diabetes mellitus
    Luis Sobrevia, Paola Valero, Adriana Grismaldo, Roberto Villalobos-Labra, Fabián Pardo, Mario Subiabre, Gael Armstrong, Fernando Toledo, Sofía Vega, Marcelo Cornejo, Gonzalo Fuentes, Reinaldo Marín
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2020; 1866(12): 165948.     CrossRef
  • Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications
    Yasaman Taheri, Hafiz Ansar Rasul Suleria, Natália Martins, Oksana Sytar, Ahmet Beyatli, Balakyz Yeskaliyeva, Gulnaz Seitimova, Bahare Salehi, Prabhakar Semwal, Sakshi Painuli, Anuj Kumar, Elena Azzini, Miquel Martorell, William N. Setzer, Alfred Maroyi,
    BMC Complementary Medicine and Therapies.2020;[Epub]     CrossRef
  • Current Pharmacological Trends on Myricetin
    Gudiya Gupta, Mohd Aftab Siddiqui, Mohd Muazzam Khan, Mohd Ajmal, Rabiya Ahsan, Md Azizur Rahaman, Md Afroz Ahmad, Md Arshad, Mohammad Khushtar
    Drug Research.2020;[Epub]     CrossRef
  • Silencing cyclophilin A improves insulin secretion, reduces cell apoptosis, and alleviates inflammation as well as oxidant stress in high glucose-induced pancreatic β-cells via MAPK/NF-kb signaling pathway
    Tangying Li, Huibiao Quan, Huachuan Zhang, Leweihua Lin, Qianying Ou, Kaining Chen
    Bioengineered.2020; 11(1): 1047.     CrossRef
  • Endoplasmic reticulum stress contributes to NMDA-induced pancreatic β-cell dysfunction in a CHOP-dependent manner
    Xiao-Ting Huang, Wei Liu, Yong Zhou, Mei Sun, Chen-Chen Sun, Chen-Yu Zhang, Si-Yuan Tang
    Life Sciences.2019; 232: 116612.     CrossRef
  • Dapagliflozin rescues endoplasmic reticulum stress-mediated cell death
    Ryo Shibusawa, Eijiro Yamada, Shuichi Okada, Yasuyo Nakajima, Claire C. Bastie, Akito Maeshima, Kyoichi Kaira, Masanobu Yamada
    Scientific Reports.2019;[Epub]     CrossRef
  • Myricetin prevents thapsigargin-induced CDK5-P66Shc signalosome mediated pancreatic β-cell dysfunction
    Udayakumar Karunakaran, Ji Eun Lee, Suma Elumalai, Jun Sung Moon, Kyu Chang Won
    Free Radical Biology and Medicine.2019; 141: 59.     CrossRef
  • CDK5: Key Regulator of Apoptosis and Cell Survival
    Rabih Roufayel, Nimer Murshid
    Biomedicines.2019; 7(4): 88.     CrossRef
  • Oral DhHP-6 for the Treatment of Type 2 Diabetes Mellitus
    Kai Wang, Yu Su, Yuting Liang, Yanhui Song, Liping Wang
    International Journal of Molecular Sciences.2019; 20(6): 1517.     CrossRef
Reviews
Clinical Diabetes & Therapeutics
Latent Autoimmune Diabetes in Adults: A Review on Clinical Implications and Management
Silvia Pieralice, Paolo Pozzilli
Diabetes Metab J. 2018;42(6):451-464.   Published online December 17, 2018
DOI: https://doi.org/10.4093/dmj.2018.0190
  • 36,241 View
  • 969 Download
  • 63 Web of Science
  • 75 Crossref
AbstractAbstract PDFPubReader   ePub   

Latent autoimmune diabetes in adults (LADA) is a heterogeneous disease characterized by a less intensive autoimmune process and a broad clinical phenotype compared to classical type 1 diabetes mellitus (T1DM), sharing features with both type 2 diabetes mellitus (T2DM) and T1DM. Since patients affected by LADA are initially insulin independent and recognizable only by testing for islet-cell autoantibodies, it could be difficult to identify LADA in clinical setting and a high misdiagnosis rate still remains among patients with T2DM. Ideally, islet-cell autoantibodies screening should be performed in subjects with newly diagnosed T2DM, ensuring a closer monitoring of those resulted positive and avoiding treatment of hyperglycaemia which might increase the rate of β-cells loss. Thus, since the autoimmune process in LADA seems to be slower than in classical T1DM, there is a wider window for new therapeutic interventions that may slow down β-cell failure. This review summarizes the current understanding of LADA, by evaluating data from most recent studies, the actual gaps in diagnosis and management. Finally, we critically highlight and discuss novel findings and future perspectives on the therapeutic approach in LADA.

Citations

Citations to this article as recorded by  
  • GADA as a biomarker for type 1 diabetes
    A. Rekha, Muhammad Afzal, M. Arockia Babu, Surya Nath Pandey, Gaurav Gupta, Rakhi Mishra, Deepika Raina, Mohd Imran
    Clinica Chimica Acta.2026; 581: 120783.     CrossRef
  • Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study
    Rosa Giné-Balcells, Bogdan Vlacho, Olga Carmen Vidal-Pérez, Albert Lecube, Josep Franch-Nadal, Dídac Mauricio, Àngels Molló-Iniesta, Marta Hernández
    JMIR Research Protocols.2026; 15: e85375.     CrossRef
  • When Type 2 Diabetes Isn’t Type 2: Latent Autoimmune Diabetes in a Lean, Highly Physically Active Adult
    Saraswathi Saiprasad, Narayana Swamy
    Cureus.2026;[Epub]     CrossRef
  • Unmasking Latent Autoimmune Diabetes: A Case That Challenges Type 2 Diabetes
    Nicholas W Tyndall, Franchesca Farris-Cosme, Dylan D Walker, Trevor I Colwell
    Cureus.2026;[Epub]     CrossRef
  • An Adult Case of Diabetes With High Levels of GAD Antibodies Without Insulin Deficiency for More Than 10 Years
    Hideyuki Takeuchi, Naoyuki Iso-O, Atsuko Takai, Takashi Mikamo, Kozue Nagumo, Masumi Hara, Osamu Isozaki
    Case Reports in Endocrinology.2025;[Epub]     CrossRef
  • Prevalence of Diabetes-related Autoantibodies Among Individuals With Type 2 Diabetes From Primary Care and Endocrinology Community Practice Settings
    Laura D. Lomeli, Michelle D. Lundholm, Huijun Xiao, Keren Zhou, Kevin M. Pantalone
    Endocrine Practice.2025; 31(9): 1127.     CrossRef
  • Proper diagnosis of latent autoimmune diabetes in adults prompts appropriate pharmacotherapy; C-peptide is just one component
    Jenna C. Record, A. Cole Eichelberger, Brianna L. Johns, Gage T. Bouziden, Jeremy L. Johnson
    Journal of Diabetes & Metabolic Disorders.2025;[Epub]     CrossRef
  • LADA: The Evolving Landscape of Adult-Onset Autoimmune Diabetes
    Maneeth Mylavarapu, Lakshmi Sravya Popuri, Niharika Tanwar, Ankur Singla, Fabeha Zafar, Dharma Rayaprolu, Yaswanth Kancharla, Diptish Wankhade, Sara Cherkos Dawit
    SN Comprehensive Clinical Medicine.2025;[Epub]     CrossRef
  • A Case of Persistent Hyperglycemia: Autoimmune Link Between Hashimoto’s Thyroiditis and Latent Autoimmune Diabetes in Adults
    Ahmed Ibrahim, Mohmed Hussien Ahmed Mohmed, Haytham Darwish, Pierre Maximus, Manal Rezzek, Mahmoud HS Daoud, Ahmad Labad
    Cureus.2025;[Epub]     CrossRef
  • A Neural Ensemble Architecture with Pseudo-Random Input Sequence for Classifying LADA Diabetes
    Anthony Miller, John Panneerselvam, Lu Liu, V. Vijaya Baskar, Lauren Miller
    Applied Artificial Intelligence.2025;[Epub]     CrossRef
  • Latent autoimmune diabetes in youth
    Qingxia Sun, Min Yang, Yiheng Jing, Lingzhe Meng, Chang Zhang, Jie Ruan, Na Wu
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Stereotypical diagnostic bias for alcohol‐induced ketoacidosis could lead to death: Normal blood sugar levels in SGLT2 blocker‐induced severe diabetic ketoacidosis
    Shun Kudo, Sho Endo, Yurina Nanahara, Takao Katahira, Masayoshi Makio, Mikiko Yamauchi, Satoyuki Ogino, Akihiro Koreki, Takuto Ishida, Hiroyuki Uchida, Masaru Mimura, Michitaka Funayama, Yasushi Nemoto
    Psychiatry and Clinical Neurosciences Reports.2025;[Epub]     CrossRef
  • A Comprehensive Survey on Diabetes Type-2 (T2D) Forecast Using Machine Learning
    Satyanarayana Murthy nimmagadda, Gunnam Suryanarayana, Gangu Bharath Kumar, Ganta Anudeep, Gedela Vinay Sai
    Archives of Computational Methods in Engineering.2024; 31(5): 2905.     CrossRef
  • Ensemble machine learning reveals key features for diabetes duration from electronic health records
    Gabriel Cerono, Davide Chicco
    PeerJ Computer Science.2024; 10: e1896.     CrossRef
  • LADA 30th anniversary: A growing form of diabetes with persistent unresolved questions
    Ivy Lee Jia Jia, Raffaella Buzzetti, Richard David Leslie, Paolo Pozzilli
    Diabetes/Metabolism Research and Reviews.2024;[Epub]     CrossRef
  • Significance of Bacillus Calmette-Guerin (BCG) vaccine intervention for patients with Type 1 Diabetes (T1D): A systematic review and meta-analysis
    Sunil B. Korde, Smita R. Pillewan, Sanket R. Dumbre, Anjali R. Bandgar, Prajakta S. Shinde, Sunil Gairola, Vandana S. Nikam
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2024; : 103102.     CrossRef
  • Autoantibodies to Truncated GAD(96-585) Antigen Stratify Risk of Early Insulin Requirement in Adult-Onset Diabetes
    Sian L. Grace, Kathleen M. Gillespie, Claire L. Williams, Vito Lampasona, Peter Achenbach, Ewan R. Pearson, Alistair J.K. Williams, Anna E. Long, Timothy J. McDonald, Angus G. Jones
    Diabetes.2024; 73(10): 1583.     CrossRef
  • Prognosis and outcome of latent autoimmune diabetes in adults: T1DM or T2DM?
    Zhipeng Zhou, Mingyue Xu, Pingjie Xiong, Jing Yuan, Deqing Zheng, Shenghua Piao
    Diabetology & Metabolic Syndrome.2024;[Epub]     CrossRef
  • A Curious Case of New-Onset Diabetes
    Kristina Hernandez, Charity L. Tan
    The Journal for Nurse Practitioners.2023; 19(3): 104411.     CrossRef
  • Comprehensive review: Frailty in pancreas transplant candidates and recipients
    Ronald F. Parsons, Ekamol Tantisattamo, Wisit Cheungpasitporn, Arpita Basu, Yee Lu, Krista L. Lentine, Kenneth J. Woodside, Neeraj Singh, Joseph Scalea, Tarek Alhamad, Ty B. Dunn, Franco H. Cabeza Rivera, Sandesh Parajuli, Martha Pavlakis, Matthew Cooper
    Clinical Transplantation.2023;[Epub]     CrossRef
  • Managing latent autoimmune disease in adults
    David Morris
    Independent Nurse.2023; 2023(1): 18.     CrossRef
  • Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): The LADA primary care-protocol study
    Pilar Vich-Pérez, Juan Carlos Abánades-Herranz, Gustavo Mora-Navarro, Ángela María Carrasco-Sayalero, Miguel Ángel Salinero-Fort, Ignacio Sevilla-Machuca, Mar Sanz-Pascual, Cristina Álvarez Hernández-Cañizares, Carmen de Burgos-Lunar, Vijayaprakash Suppia
    PLOS ONE.2023; 18(2): e0281657.     CrossRef
  • Diagnostic Dilemmas and Current Treatment Approaches in Latent Onset Autoimmune Diabetes in Adults: A Concise Review
    Lakshmi Chandran, Ankul Singh S., Chitra Vellapandian
    Current Diabetes Reviews.2023;[Epub]     CrossRef
  • Anti-glutamic Acid Decarboxylase Antibody-Positive Gestational Diabetes Mellitus with Autoimmune Type 1 Diabetes Mellitus in the Early Postpartum Period: A Case Report and Literature Review
    Akiko Fujishima, Yohei Onodera, Hiroshi Miura, Yukihiro Terada
    The Tohoku Journal of Experimental Medicine.2023; 259(4): 327.     CrossRef
  • Een 54-jarige man met onverklaard gewichtsverlies
    N. Mutebi, A. Kharagjitsing
    Tijdschrift voor Geneeskunde.2023;[Epub]     CrossRef
  • Effects of Bacillus Calmette-Guérin on immunometabolism, microbiome and liver diseases
    Muhammad Umair Ijaz, Farzam Vaziri, Yu-Jui Yvonne Wan
    Liver Research.2023; 7(2): 116.     CrossRef
  • The Etiological Diagnosis of Diabetes: Still a Challenge for the Clinician
    Danièle Dubois-Laforgue, José Timsit
    Endocrines.2023; 4(2): 437.     CrossRef
  • Type 1 diabetes mellitus: features of differential diagnosis
    EV Gantsgorn, OV Denisenko, YaO Osipenko, DA Kalmykova, AV Ivanov, SS Gerasyuta, GA Bulguryan, MH Ivanova, DA Saakyan
    Bulletin of Russian State Medical University.2023;[Epub]     CrossRef
  • A 1‐year pilot study of intralymphatic injections of GAD‐alum in individuals with latent autoimmune diabetes in adults (LADA) with signs of high immunity: No safety concerns and resemblance to juvenile type 1 diabetes
    Ingrid K. Hals, Chandima Balasuriya, Rosaura Casas, Johnny Ludvigsson, Anneli Björklund, Valdemar Grill
    Diabetes, Obesity and Metabolism.2023; 25(11): 3400.     CrossRef
  • The relationship between red blood cell distribution width and islet β-cell function indexes in patients with latent autoimmune diabetes in adults
    Xiuli Fu, Qin Tan, Wei Wei, Sheng Ding, Zhongjing Wang
    BMC Endocrine Disorders.2023;[Epub]     CrossRef
  • A Review on Latent Autoimmune Diabetes in Adults
    Vijay Ravikumar, Ariba Ahmed, Ashish Anjankar
    Cureus.2023;[Epub]     CrossRef
  • Neutrophils and their role in the aetiopathogenesis of type 1 and type 2 diabetes
    Anna Giovenzana, Debora Carnovale, Brett Phillips, Alessandra Petrelli, Nick Giannoukakis
    Diabetes/Metabolism Research and Reviews.2022;[Epub]     CrossRef
  • Prevalence of Latent Autoimmune Diabetes in Adult Based on the Presence of GAD 65 Antibodies in North-Eastern Uttar Pradesh, India
    Himalina Sangma, Anshul Singh, Anubha Srivastava, Vatsala Misra
    Annals of the National Academy of Medical Sciences (India).2022; 58: 17.     CrossRef
  • Serum Bile Acid Profiles in Latent Autoimmune Diabetes in Adults and Type 2 Diabetes Patients
    Yu Zhou, Deli Ye, Xiaofen Yuan, Yonglie Zhou, Jun Xia, Giuseppe Pugliese
    Journal of Diabetes Research.2022; 2022: 1.     CrossRef
  • Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood
    Philippe Corsenac, Marie-Élise Parent, Hélène Mansaray, Andrea Benedetti, Hugues Richard, Simona Stäger, Marie-Claude Rousseau
    Diabetes & Metabolism.2022; 48(3): 101337.     CrossRef
  • Atypical Diabetes and Management Considerations
    Shivajirao Prakash Patil
    Primary Care: Clinics in Office Practice.2022; 49(2): 225.     CrossRef
  • Efficacy and safety of sitagliptin and insulin for latent autoimmune diabetes in adults: A systematic review and meta‐analysis
    Tong Lin, Yinhe Cai, Liting Tang, Youwei Lian, Min Liu, Chaonan Liu
    Journal of Diabetes Investigation.2022; 13(9): 1506.     CrossRef
  • Latent autoimmune diabetes in youth shows greater autoimmunity than latent autoimmune diabetes in adults: Evidence from a nationwide, multicenter, cross‐sectional study
    Jin Cheng, Xiaohan Tang, Xiang Yan, Gan Huang, Shuoming Luo, Zhiguang Zhou, Xia Li
    Pediatric Diabetes.2022; 23(5): 578.     CrossRef
  • Latent Autoimmune Diabetes in Adults and Metabolic Syndrome—A Mini Review
    Niansi Pan, Shimei Yang, Xiaohong Niu
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Lifestyle or Environmental Influences and Their Interaction With Genetic Susceptibility on the Risk of LADA
    Sofia Carlsson
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Antigen-specific immunotherapies in type 1 diabetes
    Xuejiao Zhang, Ying Dong, Dianyuan Liu, Liu Yang, Jiayi Xu, Qing Wang
    Journal of Trace Elements in Medicine and Biology.2022; 73: 127040.     CrossRef
  • Latent autoimmune diabetes in adults: a focus on β-cell protection and therapy
    Wenfeng Yin, Shuoming Luo, Zilin Xiao, Ziwei Zhang, Bingwen Liu, Zhiguang Zhou
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Diagnostic camouflage: A case report on Latent autoimmune diabetics of adulthood
    Sandhya kiran Neupane, Prakash Paudel Jaishi, Divyaa Koirala, Arjun Kandel, Prabhat Kiran Neupane
    Annals of Medicine & Surgery.2022;[Epub]     CrossRef
  • Clinical characteristics and cardiovascular risk profile in children and adolescents with latent autoimmune diabetes: Results from the German/Austrian prospective diabetes follow‐up registry
    Alena Welters, Sascha R. Tittel, Thomas Reinehr, Daniel Weghuber, Susanna Wiegand, Wolfram Karges, Clemens Freiberg, Thomas Meissner, Nanette C. Schloot, Reinhard W. Holl
    Pediatric Diabetes.2022; 23(8): 1602.     CrossRef
  • The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study
    Tuccinardi Dario, Giorgino Riccardo, Pieralice Silvia, Watanabe Mikiko, Maggi Daria, Palermo Andrea, Defeudis Giuseppe, Fioriti Elvira, Pozzilli Paolo, Manfrini Silvia
    Acta Diabetologica.2021; 58(4): 411.     CrossRef
  • Cross-reactive peptide epitopes of Enterovirus Coxsackie B4 and human glutamic acid decarboxylase detecting antibodies in latent autoimmune diabetes in adults versus type 1 diabetes
    Feliciana Real-Fernández, Alessandra Gallo, Francesca Nuti, Lorenzo Altamore, Gloria Giovanna Del Vescovo, Pietro Traldi, Eugenio Ragazzi, Paolo Rovero, Annunziata Lapolla, Anna Maria Papini
    Clinica Chimica Acta.2021; 515: 73.     CrossRef
  • Treating latent autoimmune diabetes in adults in the era of cardiovascular outcomes trials: Old dog should learn new tricks
    Theocharis Koufakis, Prashanth Vas, Kalliopi Kotsa
    Diabetic Medicine.2021;[Epub]     CrossRef
  • Defining and Classifying New Subgroups of Diabetes
    Ashok Balasubramanyam
    Annual Review of Medicine.2021; 72(1): 63.     CrossRef
  • Slowly evolving, immune-mediated diabetes in 14-year-old patient: a case report
    M. R. Ragimov, D. D. Omelchuk, L. I. Ibragimova, O. S. Derevyanko, T. V. Nikonova
    Diabetes mellitus.2021; 24(1): 70.     CrossRef
  • The role of autoimmunity in the pathophysiology of type 2 diabetes: Looking at the other side of the moon
    Theocharis Koufakis, George Dimitriadis, Symeon Metallidis, Pantelis Zebekakis, Kalliopi Kotsa
    Obesity Reviews.2021;[Epub]     CrossRef
  • Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination
    Johan H Jendle, Francisco J Ampudia-Blasco, Martin Füchtenbusch, Paolo Pozzilli
    European Endocrinology.2021; 1(1): 12.     CrossRef
  • Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination
    Johan H Jendle, Francisco J Ampudia-Blasco, Martin Füchtenbusch, Paolo Pozzilli
    touchREVIEWS in Endocrinology.2021; 17(1): 12.     CrossRef
  • Toward an Improved Classification of Type 2 Diabetes: Lessons From Research into the Heterogeneity of a Complex Disease
    Maria J Redondo, Ashok Balasubramanyam
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(12): e4822.     CrossRef
  • Bacillus Calmette-Guerin 's beneficial impact on glucose metabolism: Evidence for broad based applications
    Gabriella F. Shpilsky, Hiroyuki Takahashi, Anna Aristarkhova, Michele Weil, Nathan Ng, Kacie J. Nelson, Amanda Lee, Hui Zheng, Willem M. Kühtreiber, Denise L. Faustman
    iScience.2021; 24(10): 103150.     CrossRef
  • Masqueraders: how to identify atypical diabetes in primary care
    Sumera Ahmed, Sana Saeed, Jay H. Shubrook
    Journal of Osteopathic Medicine.2021; 121(12): 899.     CrossRef
  • Lada or Type 2 Diabetes Mellitus - A Challenging Diagnosis in Clinical Approach
    Lucia Mihaela Custură, Oana Deteşan, Raluca Maria Tilinca, Reka Annamaria Schmiedt, Brigitta Irén Bacso, Mariana Cornelia Tilinca
    Acta Medica Transilvanica.2021; 26(3): 55.     CrossRef
  • Antioxidant, Anti-Inflammatory, and Immunomodulatory Properties of Tea—The Positive Impact of Tea Consumption on Patients with Autoimmune Diabetes
    Anna Winiarska-Mieczan, Ewa Tomaszewska, Karolina Jachimowicz
    Nutrients.2021; 13(11): 3972.     CrossRef
  • A Review of Statistical and Machine Learning Techniques for Microvascular Complications in Type 2 Diabetes
    Nitigya Sambyal, Poonam Saini, Rupali Syal
    Current Diabetes Reviews.2021; 17(2): 143.     CrossRef
  • Bariatric Surgery Outcomes in Patients with Latent Autoimmune Diabetes of the Adult
    Marta Guimarães, Sofia S. Pereira, Mário Nora, Mariana P. Monteiro
    Obesity Facts.2021; 14(4): 425.     CrossRef
  • Особливості перебігу діабетичної хвороби нирок у хворих на латентний автоімунний діабет дорослих
    I.O. Tsaryk, N.V. Pashkovska
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(2): 116.     CrossRef
  • Latenter Autoimmundiabetes im Erwachsenen- und Kindesalter
    Alena Welters, Nanette C. Schloot
    Der Diabetologe.2020; 16(1): 27.     CrossRef
  • A treatment-based algorithm for identification of diabetes type in the National Health and Nutrition Examination Survey
    Mitra Mosslemi, Hannah L. Park, Christine E. McLaren, Nathan D. Wong
    Cardiovascular Endocrinology & Metabolism.2020; 9(1): 9.     CrossRef
  • Case 6-2020: A 34-Year-Old Woman with Hyperglycemia
    Richard C. Cabot, Eric S. Rosenberg, Virginia M. Pierce, David M. Dudzinski, Meridale V. Baggett, Dennis C. Sgroi, Jo-Anne O. Shepard, Kathy M. Tran, Emily K. McDonald, Tara Corpuz, Miriam S. Udler, Camille E. Powe, Christina A. Austin-Tse
    New England Journal of Medicine.2020; 382(8): 745.     CrossRef
  • Therapeutic approaches for latent autoimmune diabetes in adults: One size does not fit all
    Theocharis Koufakis, Niki Katsiki, Pantelis Zebekakis, George Dimitriadis, Kalliopi Kotsa
    Journal of Diabetes.2020; 12(2): 110.     CrossRef
  • Grenzformen zwischen Typ-1- und Typ-2-Diabetes
    Michael Hummel
    MMW - Fortschritte der Medizin.2020; 162(11): 60.     CrossRef
  • The Differential Expression of Long Noncoding RNAs in Type 2 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults
    Zhang Pengyu, Yan Yan, Fu Xiying, Yang Maoguang, Li Mo, Cheng Yan, Shen Hong, Wang Lijuan, Zhang Xiujuan, Cai Hanqing
    International Journal of Endocrinology.2020; 2020: 1.     CrossRef
  • A convenient diagnostic tool for discriminating adult-onset glutamic acid decarboxylase antibody-positive autoimmune diabetes from type 2 diabetes: a retrospective study
    Hon-Ke Sia, Shih-Te Tu, Pei-Yung Liao, Kuan-Han Lin, Chew-Teng Kor, Ling-Ling Yeh
    PeerJ.2020; 8: e8610.     CrossRef
  • Correct Diabetes Diagnosis and Treatment Allows Sailor to Remain on Active Duty
    Andrea R Frazier
    Military Medicine.2020; 185(9-10): e1843.     CrossRef
  • Hombre de 28 años con presentación de diabetes
    M. Ricci, J. Sanz Cánovas, V. Buonaluto, R. Gómez Huelgas
    Medicine - Programa de Formación Médica Continuada Acreditado.2020; 13(16): 942.e1.     CrossRef
  • Uncommon Presentations of Diabetes: Zebras in the Herd
    Karen L. Shidler, Lisa R. Letourneau, Lucia M. Novak
    Clinical Diabetes.2020; 38(1): 78.     CrossRef
  • Ketogenic Diet as a Trigger for Diabetic Ketoacidosis in a Misdiagnosis of Diabetes: A Case Report
    Alexander J. White-Cotsmire, Amber M. Healy
    Clinical Diabetes.2020; 38(3): 318.     CrossRef
  • Subphänotypen des Diabetes
    Oana Patricia Zaharia, Julia Szendrödi
    Der Diabetologe.2019; 15(4): 288.     CrossRef
  • Autoimmunity in latent autoimmune diabetes in adults
    Alessandro P. Delitala
    AIMS Medical Science.2019; 6(2): 132.     CrossRef
  • Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study
    Oana P Zaharia, Klaus Strassburger, Alexander Strom, Gidon J Bönhof, Yanislava Karusheva, Sofia Antoniou, Kálmán Bódis, Daniel F Markgraf, Volker Burkart, Karsten Müssig, Jong-Hee Hwang, Olof Asplund, Leif Groop, Emma Ahlqvist, Jochen Seissler, Peter Nawr
    The Lancet Diabetes & Endocrinology.2019; 7(9): 684.     CrossRef
  • The Influence of Type 2 Diabetes–Associated Factors on Type 1 Diabetes
    Maria J. Redondo, Carmella Evans-Molina, Andrea K. Steck, Mark A. Atkinson, Jay Sosenko
    Diabetes Care.2019; 42(8): 1357.     CrossRef
Complications
Pathophysiology of Diabetic Retinopathy: The Old and the New
Sentaro Kusuhara, Yoko Fukushima, Shuntaro Ogura, Naomi Inoue, Akiyoshi Uemura
Diabetes Metab J. 2018;42(5):364-376.   Published online October 22, 2018
DOI: https://doi.org/10.4093/dmj.2018.0182
  • 47,348 View
  • 1,471 Download
  • 175 Web of Science
  • 177 Crossref
AbstractAbstract PDFPubReader   ePub   

Vision loss in diabetic retinopathy (DR) is ascribed primarily to retinal vascular abnormalities—including hyperpermeability, hypoperfusion, and neoangiogenesis—that eventually lead to anatomical and functional alterations in retinal neurons and glial cells. Recent advances in retinal imaging systems using optical coherence tomography technologies and pharmacological treatments using anti-vascular endothelial growth factor drugs and corticosteroids have revolutionized the clinical management of DR. However, the cellular and molecular mechanisms underlying the pathophysiology of DR are not fully determined, largely because hyperglycemic animal models only reproduce limited aspects of subclinical and early DR. Conversely, non-diabetic mouse models that represent the hallmark vascular disorders in DR, such as pericyte deficiency and retinal ischemia, have provided clues toward an understanding of the sequential events that are responsible for vision-impairing conditions. In this review, we summarize the clinical manifestations and treatment modalities of DR, discuss current and emerging concepts with regard to the pathophysiology of DR, and introduce perspectives on the development of new drugs, emphasizing the breakdown of the blood-retina barrier and retinal neovascularization.

Citations

Citations to this article as recorded by  
  • Yellow lupine extract modulates diabetes-induced extracellular matrix changes in ocular tissue
    Maha Sayari, Kais Abderrahim, Abdelmajid Khabir, Houcine Dab
    Proceedings of the Indian National Science Academy.2026; 92(1): 340.     CrossRef
  • Choroidal vascularity index as a marker of health and disease: systematic review and meta-analyses
    Nicholas Chieh Loh, William Rojas-Carabali, Yuan Heng Lim, Jo Earn Bong, Valeria Villabona-Martinez, Carlos Cifuentes-González, Meenakshi Kumar, Srinivas Sadda, Leopold Schmetterer, Chui Ming Gemmy Cheung, Vishali Gupta, Dilraj S. Grewal, Sharon Fekrat, A
    Survey of Ophthalmology.2026; 71(1): 35.     CrossRef
  • Predicting intravitreal treatment response using ultrawide-field angiographic biomarkers in diabetic retinopathy
    Karthik Reddy, Callie Deng, Boonkit Purt, Yue Liang, Nikhil Bommakanti, Gina Yu, Julie Rosenthal, Yannis M. Paulus
    Advances in Ophthalmology Practice and Research.2026; 6(1): 20.     CrossRef
  • The role of blood pressure stability in diabetic retinopathy development
    Chin-Chih Shih, Ling-Na Shih, Hung-An Lin, Yi-Ting Hsieh
    Eye.2026; 40(2): 245.     CrossRef
  • Phase 1 dose-escalation study of IBI324, a VEGF-A/Ang-2 bispecific antibody, for the treatment of diabetic macular oedema
    Zilin Wang, Junran Sun, Kun Liu, Liming Tao, Qinghuai Liu, Miaoqin Wu, Shujie Lu, Junjie Deng, Li Li, Lei Qian, Xiaorong Li, Xiaodong Sun
    BMJ Open Ophthalmology.2026; 11(1): e002035.     CrossRef
  • Non-neuronal cell microenvironment control retinal vascular remodeling by CST3 in the oxygen-induced retinopathy in mice
    Ming-yan Du, Chao Qu, Tu-jing Zhao, Yan-hui Deng, Lin Ye, Hua-ping Tian, Run-ze Li, Zheng Li, Hao-jue Xu, Jie Li, Liang Zhou, Yi Shi, Lu-lin Huang
    Experimental Eye Research.2026; 264: 110860.     CrossRef
  • αA-Crystallin Attenuates Retinal Ischemia-Reperfusion Injury
    Huihang Wang, Yihua Zhu
    Current Eye Research.2026; : 1.     CrossRef
  • Erythrocyte deformability correlates with microvascular ischemia and disease severity in diabetic retinopathy
    Ye Eun Han, Joon Seo Lim, Yulim Kim, Inhye Kim, Jun Sung Moon, Junyeop Lee
    Journal of Diabetes Investigation.2026;[Epub]     CrossRef
  • Ocular Complications Associated with GLP1 Agonist Therapy
    Jimmy J. Thomas, Nidhi Mathews
    Open Journal of Internal Medicine.2026; 16(01): 21.     CrossRef
  • Towards trustworthy digital health: reliability of uncertainty-aware convolutional neural networks
    Luigi Di Biasi, Fabiola De Marco, Matteo Ruggiero, Alessia Auriemma Citarella, Genoveffa Tortora
    PeerJ Computer Science.2026; 12: e3414.     CrossRef
  • Evaluation of EB-203 as a potential treatment for non-proliferative diabetic retinopathy using a zebrafish model
    Yujin Lee, Jaewook Yang
    Biomedicine & Pharmacotherapy.2026; 196: 119035.     CrossRef
  • NOP14 promotes proliferative diabetic retinopathy through ribosome biogenesis and endothelial dysfunction via Wnt/β-catenin signaling activation
    Yanhui Lin, Wenjie Li, Zhigang Fei, Kun Xiong, Yanbing Wang, Yezhen Yang, Sha Ouyang, Yi-ni Yang, Yu Liu
    Experimental Cell Research.2026; 457(1): 114922.     CrossRef
  • Expanding the horizon of oculomics: A narrative review on the emerging roles of the anterior segment and mobile health
    Jaemyoung Sung, Akie Midorikawa-Inomata, Kenta Fujio, Takenori Inomata
    Survey of Ophthalmology.2026;[Epub]     CrossRef
  • The role of deep learning-based algorithms in retinal image processing: a review
    Canan Celik, İbrahim Yücedağ
    Multimedia Tools and Applications.2026;[Epub]     CrossRef
  • Stratified choroidal vascular structure in treatment-naïve diabetic retinopathy
    Hiroaki Endo, Satoru Kase, Mitsuo Takahashi, Yuki Ito, Shozo Sonoda, Tomonori Sakoguchi, Taiji Sakamoto, Satoshi Katsuta, Susumu Ishida, Manabu Kase
    Canadian Journal of Ophthalmology.2025; 60(1): e73.     CrossRef
  • Foveal avascular zone area measurement in diabetic patients: Superficial, deep or combined retinal vascular complex?
    Bruno Pereira, Ross Faria, Cátia Domingues, Ana Barros, Teresa Varandas, José Henriques, João Nascimento, Elisabete Carolino, Pedro Camacho
    Microvascular Research.2025; 157: 104743.     CrossRef
  • N 6-Methyladenosine Demethylase FTO Controls Macrophage Homeostasis in Diabetic Vasculopathy
    Siguo Feng, Qiuyang Zhang, Qing Liu, Chang Huang, Huiying Zhang, Fengsheng Wang, Yue Zhu, Qizhi Jian, Xue Chen, Qin Jiang, Biao Yan
    Diabetes.2025; 74(1): 82.     CrossRef
  • HDAC6 mediates NLRP3 inflammasome activation in the pathogenesis of diabetic retinopathy
    Jun-Sik Kim, Jae Hyun Jun, Jeongmi Lee, Sunyoung Park, Eunae Kim, Su Jung Hwang, Heesu Moon, Seung Hyun Baek, Hark Kyun Kim, Jinsu Park, Yoonsuk Cho, Jihoon Han, Chanhee Kim, Jongho Kim, Hyun-Mo Yang, Changsik Lee, Yeonseok Chung, Hyo-Jong Lee, Dong-Gyu J
    Metabolism.2025; 164: 156108.     CrossRef
  • Impact of duration of treatments with metformin and sulfonylureas, individually or in combination, on diabetic retinopathy among newly diagnosed type 2 diabetic patients: a pooled cohort’s analysis
    Mansour Bahardoust, Yadollah Mehrabi, Farzad Hadaegh, Davood Khalili, Ali Delpisheh
    International Journal of Retina and Vitreous.2025;[Epub]     CrossRef
  • Activated Growth Factor From Platelets as Treatment for Diabetic Retinopathy Through Antioxidant-Oxidative Stress Pathway
    Ramzi Amin, Rachmat Hidayat, Ziske Maritska, Trisa Putri
    Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 305.     CrossRef
  • NLRP3 inflammasomes pathway: a key target for Metformin
    Yasamin Hosseini, Amirhossein Niknejad, Ayeh Sabbagh Kashani, Mahsa Gholami, Mahtab Roustaie, Mohammad Mohammadi, Saeideh Momtaz, Stephen L. Atkin, Tannaz Jamialahmadi, Amir Hossein Abdolghaffari, Amirhossein Sahebkar
    Inflammopharmacology.2025; 33(4): 1729.     CrossRef
  • Cd248a regulates pericyte development and viability in zebrafish
    Chao Wang, Yinming Zhong, Yi Zhang, Yiyang Jiang, Chenshiyu Wang, Lele An, Chunhua Luo, Lan Yang, Zhicheng He, Ying Yang, Min Luo, Min Mao, Wenying Wang, Qing Liu, Yu Shi, Yi-Fang Ping
    Communications Biology.2025;[Epub]     CrossRef
  • Caveolae: Metabolic Platforms at the Crossroads of Health and Disease
    Dante Maria Stea, Alessio D’Alessio
    International Journal of Molecular Sciences.2025; 26(7): 2918.     CrossRef
  • Advancing ophthalmology with large language models: Applications, challenges, and future directions
    Qi Zhang, Shaopan Wang, Xu Wang, Changsheng Xu, Jiajun Liang, Zuguo Liu
    Survey of Ophthalmology.2025; 70(5): 1019.     CrossRef
  • Targeting therapy of PI3K/AKT signaling pathway via non-coding RNAs in diabetic retinopathy
    Shuai Lu, Jian Cai
    Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(9): 11493.     CrossRef
  • Novel Therapeutic Approaches for Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration
    Deokho Lee, Soo Jin Kim, Junyeop Lee
    Vision.2025; 9(2): 35.     CrossRef
  • Increased fatty acid-binding protein 4 levels are associated with the risk of developing retinopathy in type 2 diabetes mellitus patients
    Yan Liu, Kaihui Ma, Aiying Zhang, Yun Cui, Hui Zhao, Xinhua Li, Ke Zhao
    Diabetes & Metabolism.2025; 51(4): 101653.     CrossRef
  • Short-term real-world outcomes of diabetic macular edema treated with intravitreal faricimab
    Toshiaki Hirakata, Fumihiro Hara, Yuta Nochi, Daisuke Shinohara, Shutaro Yamamoto, Yoshimune Hiratsuka, Shintaro Nakao, Jiro Kogo
    PLOS One.2025; 20(5): e0323088.     CrossRef
  • Automated detection of hard exudates in retinal fundus images for diabetic retinopathy screening using textural-based radon transform and morphology reconstruction
    Esmat Ramezanzadeh, Naser Shoeibi, Akram Feizabadi, Touka Banaee, Mohammad Hossein Bahreyni Tussi, Meysam Tavakoli
    Biomedical Engineering Advances.2025; 9: 100180.     CrossRef
  • Emerging liposomal therapies for diabetic retinopathy: a review of novel targeting approaches and advances in retinal health outcomes
    Ravi Parashar, Preeti K. Suresh
    Drug Delivery.2025;[Epub]     CrossRef
  • Targeting neurotrophic dysregulation in diabetic retinopathy: a novel therapeutic avenue
    Divya Rana, Sanchit Dhankhar, Rupali Chauhan, Monika Saini, Randhir Singh, Parveen Kumar, Thakur Gurjeet Singh, Samrat Chauhan, Sushma Devi
    Molecular Biology Reports.2025;[Epub]     CrossRef
  • Integration of Immunometabolic Composite Indices and Machine Learning for Diabetic Retinopathy Risk Stratification: Insights from NHANES 2011 – 2020
    Cui Xuehao, Wen Dejia, Li Xiaorong
    Ophthalmology Science.2025; 5(6): 100854.     CrossRef
  • Switching to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular edema: a systematic review and meta-analysis
    Ali Tahmasebi, Nazanin Ebrahimiadib, Mohammadreza Niyousha, Narges Hassanpoor
    Graefe's Archive for Clinical and Experimental Ophthalmology.2025; 263(10): 2693.     CrossRef
  • Inhibition of retinal neovascularization by Dendrobium polysaccharides: a review
    Dan Liu, Xingwang Chen, Shanjun Cai
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Pathophysiological Mechanisms of Diabetes-Induced Macrovascular and Microvascular Complications: The Role of Oxidative Stress
    Bipradas Roy
    Medical Sciences.2025; 13(3): 87.     CrossRef
  • The role of gut microbiota dysbiosis in the inflammatory pathogenesis of diabetic retinopathy
    Liqing Xie, Wenjian Lin
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Risk of Systemic Health Events and Mortality After Vitrectomy for Diabetic Retinopathy in Patients with Type 2 Diabetes
    Dane A. Jester, Muhammad Z. Chauhan, Zain S. Hussain, Sam Karimaghaei, Jawad Muayad, Asad Loya, Ahmed F. Shakarchi, Ahmed B. Sallam
    Ophthalmology Science.2025; 5(6): 100880.     CrossRef
  • Inhibition of Endothelial HIF-1α by IDF-11774 Attenuates Retinal Neovascularization and Vascular Leakage
    Fengmei Yang, Jicheng Lin, Boyu Yang, Andina Hu, Kaixuan Cui, Peiqi Wu, Haolin Kong, Changxuan Liu, Kun Xu, Xi Lu, Shanshan Yu, Xiaoyu Tang, Yue Xu, Xiaoling Liang
    Investigative Ophthalmology & Visual Science.2025; 66(9): 47.     CrossRef
  • Recent advances in engineered exosome-based therapies for ocular vascular disease
    Jian Guan, Fanhe Meng, Chuanzhuo Wang, Binglun Zhang, Jun Chen, Jingnan Han
    Journal of Nanobiotechnology.2025;[Epub]     CrossRef
  • Emerging innovations in ophthalmic drug delivery for diabetic retinopathy: a translational perspective
    Souvik Adak, Vaishnavi Suresh Jadhav, Dharmendra Kumar Khatri
    Drug Delivery and Translational Research.2025;[Epub]     CrossRef
  • Revolutionizing Diabetic Macular Edema Treatment: FDA Approval of Susvimo
    Dinesh Kumar, Vrinda Gupta, Rajni Tanwar, Nicky Kumar Jaiswal
    SN Comprehensive Clinical Medicine.2025;[Epub]     CrossRef
  • Hyaluronic acid based light responsive long acting hydrogel for the intraocular delivery of spironolactone
    Sai Shreya Cheruvu, Shruthi Merugu, Manisha Malani, Onkar Kulkarni, Jayabalan Nirmal
    International Journal of Biological Macromolecules.2025; 321: 146451.     CrossRef
  • Fenofibrate and Diabetic Retinopathy
    A. Parra-Pineda, S. Lizarazo-Bocanegra, L. F. Villalba-Montero, C. C. Ayala-Quintero, F. Losada-Díaz, I. Correa-Osio, L. A. Lizarazo-Rojas, C. O. Mendivil
    Diabetes Therapy.2025; 16(9): 1763.     CrossRef
  • Sex- and age- differences in the expression of critical blood-brain barrier regulators: a physiological context
    Xue Mi, Zi-Ling Ye, Xu-Jun Zhang, Xiao-Chun Chen, Xiao-Man Dai
    Biology of Sex Differences.2025;[Epub]     CrossRef
  • Anthocyanin-Rich Berries and Their Bioactive Compounds in Ocular Health: Mechanisms and Therapeutic Potential
    Long Zuo, Mingjun Ye, Long Chen, Xiaohong Xu, Shengquan Huang, Xusheng Li, Weibin Bai
    Journal of Agricultural and Food Chemistry.2025; 73(38): 23724.     CrossRef
  • Core-shell nanotherapeutics for diabetic cataract and retinopathy: current state-of-the-art and translational challenges
    Gitika Kumari, Sourabh Kundu, Paras Famta, Krishna K. Kalahasti, Saurabh Srivastava, Geereddy Bhanuprakash Reddy, Dadi A. Srinivasarao
    Drug Delivery and Translational Research.2025;[Epub]     CrossRef
  • Transpupillary in vivo two-photon imaging reveals enhanced surveillance of retinal microglia in diabetic mice
    Noriyuki Sotani, Sentaro Kusuhara, Ryuto Nishisho, Hiroto Kuno, Hidenori Shima, Koichiro Haruwaka, Yuka Mori, Maya Kishi, Tomoyuki Furuyashiki, Kenta Kobayashi, Hiroaki Wake, Toru Takumi, Makoto Nakamura, Yoshihisa Tachibana
    Proceedings of the National Academy of Sciences.2025;[Epub]     CrossRef
  • PXN + monocytes accelerate diabetic retinopathy progression and inflammaging via SELPLG-SELL axis-mediated immune chemotaxis and RAS modulation
    Na Liang, Jing Li, Wenting Wang, Huifang Xu, Shaomin Peng
    Journal of the Renin-Angiotensin-Aldosterone System.2025;[Epub]     CrossRef
  • Evidence Supporting Autotaxin as a Potential New Drug Treatment Target in Patients With Advanced Diabetic Retinopathy
    Harumasa Yokota, Hiroki Hayashi, Hironori Nakagami, Akifumi Kushiyama, Junya Hanaguri, Megumi Honjo, Makoto Aihara, Makoto Kurano, Koji Igarashi, Sakura Kushiyam, Satoru Yamagami, Taiji Nagaoka
    Investigative Ophthalmology & Visual Science.2025; 66(15): 49.     CrossRef
  • Insights from RNA sequencing techniques revealing the molecular mechanisms associated with diabetic retinopathy
    Larwubah Kollie, Serina L. Gaye, Siyu Chen, Zongsuo Liang, Meilan Yu, Fei Gao
    Journal of Diabetes & Metabolic Disorders.2025;[Epub]     CrossRef
  • Recent Insights into the Etiopathogenesis of Diabetic Retinopathy and Its Management
    Arpon Biswas, Abhijit Deb Choudhury, Sristi Agrawal, Amol Chhatrapati Bisen, Sachin Nashik Sanap, Sarvesh Kumar Verma, Mukesh Kumar, Anjali Mishra, Shivansh Kumar, Mridula Chauhan, Rabi Sankar Bhatta
    Journal of Ocular Pharmacology and Therapeutics.2024; 40(1): 13.     CrossRef
  • GMFB/AKT/TGF‐β3 in Müller cells mediated early retinal degeneration in a streptozotocin‐induced rat diabetes model
    Tong Zhu, Yingao Li, Lilin Zhu, Jinyuan Xu, Zijun Feng, Hao Chen, Si Shi, Caiying Liu, Qingjian Ou, Furong Gao, Jieping Zhang, Caixia Jin, Jingying Xu, Jiao Li, Jingfa Zhang, Yanlong Bi, Guo‐tong Xu, Juan Wang, Haibin Tian, Lixia Lu
    Glia.2024; 72(3): 504.     CrossRef
  • The significance of glutaredoxins for diabetes mellitus and its complications
    Mengmeng Zhou, Eva-Maria Hanschmann, Axel Römer, Thomas Linn, Sebastian Friedrich Petry
    Redox Biology.2024; 71: 103043.     CrossRef
  • Proteomic analysis of diabetic retinopathy identifies potential plasma-protein biomarkers for diagnosis and prognosis
    Bent Honoré, Javad Nouri Hajari, Tobias Torp Pedersen, Tomas Ilginis, Hajer Ahmad Al-Abaiji, Claes Sepstrup Lønkvist, Jon Peiter Saunte, Dorte Aalund Olsen, Ivan Brandslund, Henrik Vorum, Carina Slidsborg
    Clinical Chemistry and Laboratory Medicine (CCLM).2024; 62(6): 1177.     CrossRef
  • Next generation therapeutics for retinal neurodegenerative diseases
    Matthew B. Appell, Jahnavi Pejavar, Ashwin Pasupathy, Sri Vishnu Kiran Rompicharla, Saed Abbasi, Kiersten Malmberg, Patricia Kolodziejski, Laura M. Ensign
    Journal of Controlled Release.2024; 367: 708.     CrossRef
  • Modeling early pathophysiological phenotypes of diabetic retinopathy in a human inner blood-retinal barrier-on-a-chip
    Thomas L. Maurissen, Alena J. Spielmann, Gabriella Schellenberg, Marc Bickle, Jose Ricardo Vieira, Si Ying Lai, Georgios Pavlou, Sascha Fauser, Peter D. Westenskow, Roger D. Kamm, Héloïse Ragelle
    Nature Communications.2024;[Epub]     CrossRef
  • Emerging role of ferroptosis in diabetic retinopathy: a review
    Ruohong Wang, Suyun Rao, Zheng Zhong, Ke Xiao, Xuhui Chen, Xufang Sun
    Journal of Drug Targeting.2024; 32(4): 393.     CrossRef
  • Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients
    Yong Zhuang, Zihao Zhuang, Qingyan Cai, Xin Hu, Huibin Huang
    Journal of Diabetes Investigation.2024; 15(7): 867.     CrossRef
  • Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study
    Maria Consiglia Trotta, Carlo Gesualdo, Caterina Claudia Lepre, Marina Russo, Franca Ferraraccio, Iacopo Panarese, Ernesto Marano, Paolo Grieco, Francesco Petrillo, Anca Hermenean, Francesca Simonelli, Michele D’Amico, Claudio Bucolo, Francesca Lazzara, F
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Berberine alleviates diabetic retinopathy by regulating the Th17/Treg ratio
    Yi Yang, Zexin Wen, Yanli Zhang, Pengfei Li, Junyao Zhao, Yujie Sun, Peng Wang, Wei Lin
    Immunology Letters.2024; 267: 106862.     CrossRef
  • Diabetic Retinopathy: Clinical Features, Risk Factors, and Treatment Options
    Sudhanshu Mishra, Pratik Kumar Vishwakarma, Mridani Tripathi, Smriti Ojha, Shivendra Mani Tripathi
    Current Diabetes Reviews.2024;[Epub]     CrossRef
  • RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models
    Uwe Grether, Richard H. Foxton, Sabine Gruener, Claudia Korn, Atsushi Kimbara, Anja Osterwald, Elisabeth Zirwes, Sabine Uhles, Janina Thoele, Nadine Colé, Mark Rogers-Evans, Stephan Röver, Matthias Nettekoven, Rainer E. Martin, Jean-Michel Adam, Jürgen Fi
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Diabetic retinopathy incidence, predictors and its association with longitudinal fasting blood sugar level changes among diabetes mellitus patients in Ethiopia: joint model
    Habtamu Wagnew Abuhay, Ayenew Molla Lakew, Haileab Fekadu Wolde, Berhanu Mengistu, Mandefro Tadesse Legesse, Melaku Kindie Yenit
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology
    Shintaro Nakao, Sentaro Kusuhara, Tomoaki Murakami
    Graefe's Archive for Clinical and Experimental Ophthalmology.2024; 262(12): 3749.     CrossRef
  • Relationship between VEGF expression and ganglion and photoreceptor cell densities in diabetic retinal layers
    Aswira ASLAM, Habibah S. MUHIDDIN, Andi M. ICHSAN
    Gazzetta Medica Italiana Archivio per le Scienze Mediche.2024;[Epub]     CrossRef
  • Health Utility Values Among Patients With Diabetic Retinopathy, Wet Age-Related Macular Degeneration, and Cataract in Thailand: A Multicenter Survey Using Time Trade-Off, EQ-5D-5L, and Health Utility Index 3
    Pear Ferreira Pongsachareonnont, Phantipa Sakthong, Voraporn Chaikitmongkol, Wantanee Dangboon Tsutsumi, Chavakij Bhoomibunchoo, Cameron P. Hurst, Yot Teerawattananon, Kittisak Kulvichit
    Value in Health Regional Issues.2024; 44: 101030.     CrossRef
  • Treatment of Acute and Long-COVID, Diabetes, Myocardial Infarction, and Alzheimer’s Disease: The Potential Role of a Novel Nano-Compound—The Transdermal Glutathione–Cyclodextrin Complex
    Ray Yutani, Vishwanath Venketaraman, Nisar Sheren
    Antioxidants.2024; 13(9): 1106.     CrossRef
  • Vitamin D levels and risk of ocular disorders: insights from bidirectional and multivariable Mendelian randomization analysis
    Shipei Fan, Xing-yu Shi, Xia Li, Jun Li, Song-ping Yu
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Methylglyoxal: A Key Factor for Diabetic Retinopathy and Its Effects on Retinal Damage
    Vladlen Klochkov, Chi-Ming Chan, Wan-Wan Lin
    Biomedicines.2024; 12(11): 2512.     CrossRef
  • Prevalence and its associated factors of diabetic retinopathy among type 1 and type 2 diabetic patients at public hospitals in Eastern Ethiopia, 2023: a hospital-based comparative cross-sectional study
    Feyisa Shasho Bayisa, Teshome Demis Nimani, Samuel Demissie Darcho
    Frontiers in Clinical Diabetes and Healthcare.2024;[Epub]     CrossRef
  • Prevalence of diabetic retinopathy and its associated risk factors among adults in Ethiopia: a systematic review and meta-analysis
    Temesgen Gebeyehu Wondmeneh, Jemal Abdu Mohammed
    Scientific Reports.2024;[Epub]     CrossRef
  • Advanced drug delivery strategies for diabetic retinopathy: current therapeutic advancement, and delivery methods overcoming barriers, and experimental modalities
    Mengistie Diress, Susbin Raj Wagle, Patrick Lim, Thomas Foster, Bozica Kovacevic, Corina Mihaela Ionescu, Armin Mooranian, Hani Al-Salami
    Expert Opinion on Drug Delivery.2024; 21(12): 1859.     CrossRef
  • Evaluating deep learning models for classifying OCT images with limited data and noisy labels
    Aleksandar Miladinović, Alessandro Biscontin, Miloš Ajčević, Simone Kresevic, Agostino Accardo, Dario Marangoni, Daniele Tognetto, Leandro Inferrera
    Scientific Reports.2024;[Epub]     CrossRef
  • Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema
    Kim Lien Huber, Heiko Stino, Irene Steiner, Philipp Fuchs, Felix Goldbach, Julia Mai, Bianca S. Gerendas, Katharina Kriechbaum, Ursula Schmidt-Erfurth, Andreas Pollreisz
    Investigative Ophthalmology & Visual Science.2024; 65(14): 46.     CrossRef
  • Comparison of retrobulbar circulation in type 2 diabetics and non-diabetics using color Doppler imaging
    Rachana Kotian, Thanuja G Pradeep, Raghav Venkatesh
    Indian Journal of Clinical and Experimental Ophthalmology.2024; 10(4): 655.     CrossRef
  • Diabetic Retinopathy Requiring Vitrectomy: Epidemiology and Pathology
    Ayman Ahmed Alkawas, Mahmoud Ali El Aswad, Mohamed Anas Hussein Awnallah, Khaled Salah El Din Abd El Kader
    Cuestiones de Fisioterapia.2024; 53(02): 695.     CrossRef
  • Pharmacological mechanism and clinical study of Qiming granules in treating diabetic retinopathy based on network pharmacology and literature review
    Yuxia Huang, Jia Wang, Yu Wang, Wei Kuang, Mengjun Xie, Mei Zhang
    Journal of Ethnopharmacology.2023; 302: 115861.     CrossRef
  • Vitreous humor proteome: unraveling the molecular mechanisms underlying proliferative and neovascular vitreoretinal diseases
    Fátima Milhano dos Santos, Sergio Ciordia, Joana Mesquita, João Paulo Castro de Sousa, Alberto Paradela, Cândida Teixeira Tomaz, Luís António Paulino Passarinha
    Cellular and Molecular Life Sciences.2023;[Epub]     CrossRef
  • Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy
    Gabriella Lupo, Aleksandra Agafonova, Alessia Cosentino, Giovanni Giurdanella, Giuliana Mannino, Debora Lo Furno, Ivana Roberta Romano, Rosario Giuffrida, Floriana D’Angeli, Carmelina Daniela Anfuso
    International Journal of Molecular Sciences.2023; 24(2): 913.     CrossRef
  • Predictive factors for microvascular recovery after treatments for diabetic retinopathy
    Junyeop Lee, Yoon-Jeon Kim, Joo-Yong Lee, Young Hee Yoon, June-Gone Kim
    BMC Ophthalmology.2023;[Epub]     CrossRef
  • Pathophysiology and diagnosis of diabetic retinopathy: a narrative review
    Mohadese Estaji, Bita Hosseini, Saeed Bozorg-Qomi, Babak Ebrahimi
    Journal of Investigative Medicine.2023; 71(3): 265.     CrossRef
  • Proteomics profiling of vitreous humor reveals complement and coagulation components, adhesion factors, and neurodegeneration markers as discriminatory biomarkers of vitreoretinal eye diseases
    Fátima M. Santos, Sergio Ciordia, Joana Mesquita, Carla Cruz, João Paulo Castro e Sousa, Luís A. Passarinha, Cândida T. Tomaz, Alberto Paradela
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Hypoxia-induced transcriptional differences in African and Asian versus European diabetic cybrids
    Andrew H. Dolinko, Marilyn Chwa, Kevin Schneider, Mithalesh K. Singh, Shari Atilano, Jie Wu, M. Cristina Kenney
    Scientific Reports.2023;[Epub]     CrossRef
  • Downregulation of plasma microRNA-29c-3p expression may be a new risk factor for diabetic retinopathy
    Bora TORUS, Hakan KORKMAZ, Kuyaş H. OZTURK, Fevziye B. ŞİRİN, Mehmet ARGUN, Sonmez ŞEVİK, Levent TÖK
    Minerva Endocrinology.2023;[Epub]     CrossRef
  • Short-Term Outcomes of Intravitreal Faricimab Injection for Diabetic Macular Edema
    Sentaro Kusuhara, Maya Kishimoto-Kishi, Wataru Matsumiya, Akiko Miki, Hisanori Imai, Makoto Nakamura
    Medicina.2023; 59(4): 665.     CrossRef
  • L-type calcium channel blocker increases VEGF concentrations in retinal cells and human serum
    Anmol Kumar, Stefan Mutter, Erika B. Parente, Valma Harjutsalo, Raija Lithovius, Sinnakaruppan Mathavan, Markku Lehto, Timo P. Hiltunen, Kimmo K. Kontula, Per-Henrik Groop, Satyajit Mohapatra
    PLOS ONE.2023; 18(4): e0284364.     CrossRef
  • Efficacy and safety of curcumin in diabetic retinopathy: A protocol for systematic review and meta-analysis
    Liyuan Wang, Jiayu Xu, Tianyang Yu, Hanli Wang, Xiaojun Cai, He Sun, Godwin Ovenseri-Ogbomo
    PLOS ONE.2023; 18(4): e0282866.     CrossRef
  • Highly water-soluble diacetyl chrysin ameliorates diabetes-associated renal fibrosis and retinal microvascular abnormality in db/db mice
    Young-Hee Kang, Sin-Hye Park, Young Eun Sim, Moon-Sik Oh, Hong Won Suh, Jae-Yong Lee, Soon Sung Lim
    Nutrition Research and Practice.2023; 17(3): 421.     CrossRef
  • Preventive and management approach of triptonide, a diterpenoid compound against streptozotocin-induced diabetic retinopathy in Wistar rat model
    Chandramohan Govindasamy, Khalid S. Al-Numair, Jun Li, Weibai Chen, Guoqiang Wu
    Arabian Journal of Chemistry.2023; 16(9): 105034.     CrossRef
  • New Insights on Dietary Polyphenols for the Management of Oxidative Stress and Neuroinflammation in Diabetic Retinopathy
    Gustavo Bernardes Fanaro, Marcelo Rodrigues Marques, Karin da Costa Calaza, Rafael Brito, André Moreira Pessoni, Henrique Rocha Mendonça, Deborah Emanuelle de Albuquerque Lemos, José Luiz de Brito Alves, Evandro Leite de Souza, Marinaldo Pacífico Cavalcan
    Antioxidants.2023; 12(6): 1237.     CrossRef
  • Evaluation of Social Platform-Based Continuity of Care in Improving Cognitive and Prognostic Effects of Young Patients with Diabetic Retinopathy
    Guo-lan Cao, Ke-jian Chen
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 1931.     CrossRef
  • Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value
    Yu-Qi Li, Lei Xin, Yu-Chi Zhao, Shang-Qi Li, Ya-Nuo Li
    World Journal of Hepatology.2023; 15(6): 786.     CrossRef
  • The rs1800469 T/T and rs1800470 C/C genotypes of the TGFB1 gene confer protection against diabetic retinopathy in a Southern Brazilian population
    Aline Rodrigues Costa, Cristine Dieter, Luís Henrique Canani, Taís Silveira Assmann, Daisy Crispim
    Genetics and Molecular Biology.2023;[Epub]     CrossRef
  • Evaluation of Self-Care in Patients with Diabetic Retinopathy
    Songül BİLTEKİN, Züleyha KILIÇ, Şefika Dilek GÜVEN
    Turkish Journal of Diabetes and Obesity.2023; 7(3): 214.     CrossRef
  • Diabetes mellitus and its influence on the incidence and process of diabetic retinopathy
    Janka Poráčová, Melinda Nagy, Marta Mydlárová Blaščáková, Mária Konečná, Vincent Sedlák, Mária Zahatňanská, Tatiana Kimáková, Hedviga Vašková, Viktória Rybárová, Mária Majherová, Ivan Uher
    Central European Journal of Public Health.2023; 31(Suppl 1): S4.     CrossRef
  • Dysregulation of the NLRP3 Inflammasome in Diabetic Retinopathy and Potential Therapeutic Targets
    Karanvir S. Raman, Joanne A. Matsubara
    Ocular Immunology and Inflammation.2022; 30(2): 470.     CrossRef
  • Adult-induced genetic ablation distinguishes PDGFB roles in blood-brain barrier maintenance and development
    Elisa Vazquez-Liebanas, Khayrun Nahar, Giacomo Bertuzzi, Annika Keller, Christer Betsholtz, Maarja Andaloussi Mäe
    Journal of Cerebral Blood Flow & Metabolism.2022; 42(2): 264.     CrossRef
  • Investigation on the Q-markers of Bushen Huoxue Prescriptions for DR treatment based on chemometric methods and spectrum-effect relationship
    Yueting Yu, Ziyu Zhu, Mengjun Xie, Liping Deng, Xuejun Xie, Mei Zhang
    Journal of Ethnopharmacology.2022; 285: 114800.     CrossRef
  • Corneal Confocal Microscopy in Type 1 Diabetes Mellitus: A Six-Year Longitudinal Study
    Stuti L. Misra, James A. Slater, Charles N. J. McGhee, Monika Pradhan, Geoffrey D. Braatvedt
    Translational Vision Science & Technology.2022; 11(1): 17.     CrossRef
  • Microphysiological Neurovascular Barriers to Model the Inner Retinal Microvasculature
    Thomas L. Maurissen, Georgios Pavlou, Colette Bichsel, Roberto Villaseñor, Roger D. Kamm, Héloïse Ragelle
    Journal of Personalized Medicine.2022; 12(2): 148.     CrossRef
  • Long-Term Oral Administration of Salidroside Alleviates Diabetic Retinopathy in db/db Mice
    Fei Yao, Xinyi Jiang, Ling Qiu, Zixuan Peng, Wei Zheng, Lexi Ding, Xiaobo Xia
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Classification of macular abnormalities using a lightweight CNN-SVM framework
    Xuqian Wang, Yu Gu
    Measurement Science and Technology.2022; 33(6): 065702.     CrossRef
  • Chorioretinal Hypoxia Detection Using Lipid-Polymer Hybrid Organic Room-Temperature Phosphorescent Nanoparticles
    Yingying Zeng, Van Phuc Nguyen, Yanxiu Li, Do Hyun Kang, Yannis M. Paulus, Jinsang Kim
    ACS Applied Materials & Interfaces.2022; 14(16): 18182.     CrossRef
  • LncRNA FLG-AS1 Mitigates Diabetic Retinopathy by Regulating Retinal Epithelial Cell Inflammation, Oxidative Stress, and Apoptosis via miR-380-3p/SOCS6 Axis
    Rong Luo, Lan Li, Fan Xiao, Jinsong Fu
    Inflammation.2022; 45(5): 1936.     CrossRef
  • Correlation between the progression of diabetic retinopathy and inflammasome biomarkers in vitreous and serum – a systematic review
    Charisse Y. J. Kuo, Rinki Murphy, Ilva D. Rupenthal, Odunayo O. Mugisho
    BMC Ophthalmology.2022;[Epub]     CrossRef
  • The relationship between the neutrophil-to-lymphocyte ratio and diabetic retinopathy in adults from the United States: results from the National Health and nutrition examination survey
    Xiaojie He, Shanshan Qi, Xi Zhang, Jiandong Pan
    BMC Ophthalmology.2022;[Epub]     CrossRef
  • Th22 cells induce Müller cell activation via the Act1/TRAF6 pathway in diabetic retinopathy
    Yufei Wang, Hongdan Yu, Jing Li, Wenqiang Liu, Shengxue Yu, Pan Lv, Lipan Zhao, Xiaobai Wang, Zhongfu Zuo, Xuezheng Liu
    Cell and Tissue Research.2022; 390(3): 367.     CrossRef
  • Prevalence and Factors Associated with Diabetic Retinopathy among Adult Diabetes Patients in Southeast Ethiopia: A Hospital-Based Cross-Sectional Study
    Biniyam Sahiledengle, Tesfaye Assefa, Wogene Negash, Anwar Tahir, Tadele Regasa, Yohannes Tekalegn, Ayele Mamo, Zinash Teferu, Damtew Solomon, Habtamu Gezahegn, Kebebe Bekele, Demisu Zenbaba, Alelign Tasew, Fikreab Desta, Zegeye Regassa, Zegeye Feleke, Ch
    Clinical Ophthalmology.2022; Volume 16: 3527.     CrossRef
  • Diabetic Retinopathy: Are lncRNAs New Molecular Players and Targets?
    Simona Cataldi, Mariagiovanna Tramontano, Valerio Costa, Marianna Aprile, Alfredo Ciccodicola
    Antioxidants.2022; 11(10): 2021.     CrossRef
  • Diosgenin protects retinal pigment epithelial cells from inflammatory damage and oxidative stress induced by high glucose by activating AMPK/Nrf2/HO‐1 pathway
    Yang Hao, Xuefeng Gao
    Immunity, Inflammation and Disease.2022;[Epub]     CrossRef
  • Selective Activation of the Wnt-Signaling Pathway as a Novel Therapy for the Treatment of Diabetic Retinopathy and Other Retinal Vascular Diseases
    Huy Nguyen, Sung-Jin Lee, Yang Li
    Pharmaceutics.2022; 14(11): 2476.     CrossRef
  • Development and validation of a predictive risk model based on retinal geometry for an early assessment of diabetic retinopathy
    Minglan Wang, Xiyuan Zhou, Dan Ning Liu, Jieru Chen, Zheng Zheng, Saiguang Ling
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy
    Charisse Y-J. Kuo, Jack J. Maran, Emma G. Jamieson, Ilva D. Rupenthal, Rinki Murphy, Odunayo O. Mugisho
    International Journal of Molecular Sciences.2022; 23(22): 14471.     CrossRef
  • VEGF Gene Polymorphism Among Diabetes Mellitus and Diabetic Retinopathy
    Samra Anees, Saima Shareef, Muhammad Roman, Shah Jahan
    Futuristic Biotechnology.2022; : 02.     CrossRef
  • Th22 Cells Induce Müller Cells Activation Via the Act1/Traf6 Pathway in Diabetic Retinopathy
    YuFei Wang, Hongdan Yu, Jing Li, Wenqiang Liu, Shengxue Yu, Pan Lv, Lipan Zhao, Xiaobai Wang, Zhongfu Zuo, Xuezheng Liu
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Pathogenesis of diabetic macular edema: the role of pro-inflammatory and vascular factors. Aliterature review
    M.L. Kyryliuk, S.A. Suk
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2022; 18(3): 180.     CrossRef
  • Potential of the Triad of Fatty Acids, Polyphenols, and Prebiotics from Cucurbita against COVID-19 in Diabetic Patients
    Qushmua E. Alzahrani, Richard B. Gillis, Stephen E. Harding, Luciano Henrique Pinto, Monica Gulati, Bhupinder Kapoor, Pooja Rani, Sachin Kumar Singh, Gary G. Adams
    Journal of Reports in Pharmaceutical Sciences.2022; 11(1): 28.     CrossRef
  • Effects of emixustat hydrochloride in patients with proliferative diabetic retinopathy: a randomized, placebo-controlled phase 2 study
    Ryo Kubota, Chirag Jhaveri, John M. Koester, Jeffrey K. Gregory
    Graefe's Archive for Clinical and Experimental Ophthalmology.2021; 259(2): 369.     CrossRef
  • Transient receptor potential vanilloid 4 channel deletion regulates pathological but not developmental retinal angiogenesis
    Holly C. Cappelli, Brianna D. Guarino, Anantha K. Kanugula, Ravi K. Adapala, Vidushani Perera, Matthew A. Smith, Sailaja Paruchuri, Charles K. Thodeti
    Journal of Cellular Physiology.2021; 236(5): 3770.     CrossRef
  • Involvement of miR‐126 rs4636297 and miR‐146a rs2910164 polymorphisms in the susceptibility for diabetic retinopathy: a case–control study in a type 1 diabetes population
    Eloísa Toscan Massignam, Cristine Dieter, Felipe Mateus Pellenz, Taís Silveira Assmann, Daisy Crispim
    Acta Ophthalmologica.2021;[Epub]     CrossRef
  • Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients
    Malgorzata Mrugacz, Anna Bryl, Katarzyna Zorena
    Journal of Clinical Medicine.2021; 10(3): 458.     CrossRef
  • Factors based on optical coherence tomography correlated with vision impairment in diabetic patients
    Hiroaki Endo, Satoru Kase, Hikari Tanaka, Mitsuo Takahashi, Satoshi Katsuta, Yasuo Suzuki, Minako Fujii, Susumu Ishida, Manabu Kase
    Scientific Reports.2021;[Epub]     CrossRef
  • Class-3 semaphorins: Potent multifunctional modulators for angiogenesis-associated diseases
    Bo Jiao, Shiyang Liu, Xi Tan, Pei Lu, Danning Wang, Hui Xu
    Biomedicine & Pharmacotherapy.2021; 137: 111329.     CrossRef
  • Single-Cell Analysis of Blood-Brain Barrier Response to Pericyte Loss
    Maarja A. Mäe, Liqun He, Sofia Nordling, Elisa Vazquez-Liebanas, Khayrun Nahar, Bongnam Jung, Xidan Li, Bryan C. Tan, Juat Chin Foo, Amaury Cazenave-Gassiot, Markus R. Wenk, Yvette Zarb, Barbara Lavina, Susan E. Quaggin, Marie Jeansson, Chengua Gu, David
    Circulation Research.2021;[Epub]     CrossRef
  • VEGFR1 signaling in retinal angiogenesis and microinflammation
    Akiyoshi Uemura, Marcus Fruttiger, Patricia A. D'Amore, Sandro De Falco, Antonia M. Joussen, Florian Sennlaub, Lynne R. Brunck, Kristian T. Johnson, George N. Lambrou, Kay D. Rittenhouse, Thomas Langmann
    Progress in Retinal and Eye Research.2021; 84: 100954.     CrossRef
  • Changes in Gene Expression Profiling and Phenotype in Aged Multidrug Resistance Protein 4-Deficient Mouse Retinas
    Kyung Woo Kim, Sentaro Kusuhara, Atsuko Katsuyama-Yoshikawa, Sho Nobuyoshi, Megumi Kitamura, Sotaro Mori, Noriyuki Sotani, Kaori Ueda, Wataru Matsumiya, Akiko Miki, Takuji Kurimoto, Hisanori Imai, Makoto Nakamura
    Antioxidants.2021; 10(3): 455.     CrossRef
  • Circular RNAs: Novel target of diabetic retinopathy
    Huan-ran Zhou, Hong-yu Kuang
    Reviews in Endocrine and Metabolic Disorders.2021; 22(2): 205.     CrossRef
  • MicroRNA-431-5p encapsulated in serum extracellular vesicles as a biomarker for proliferative diabetic retinopathy
    Bo Yu, Mengran Xiao, Fuhua Yang, Jing Xiao, Hui Zhang, Lin Su, Xiaomin Zhang, Xiaorong Li
    The International Journal of Biochemistry & Cell Biology.2021; 135: 105975.     CrossRef
  • EndMT Regulation by Small RNAs in Diabetes-Associated Fibrotic Conditions: Potential Link With Oxidative Stress
    Roberta Giordo, Yusra M. A. Ahmed, Hilda Allam, Salah Abusnana, Lucia Pappalardo, Gheyath K. Nasrallah, Arduino Aleksander Mangoni, Gianfranco Pintus
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Pharmacokinetics of genistein distribution in blood and retinas of diabetic and non-diabetic rats
    T. Hakami, M.I. Mahmoud, E. de Juan, M. Cooney
    Drug Metabolism and Pharmacokinetics.2021; 39: 100404.     CrossRef
  • Nimbolide ameliorates the streptozotocin-induced diabetic retinopathy in rats through the inhibition of TLR4/NF-κB signaling pathway
    Xiangwen Shu, Yali Hu, Chao Huang, Ning Wei
    Saudi Journal of Biological Sciences.2021; 28(8): 4255.     CrossRef
  • Basic regulatory effects and clinical value of metalloproteinase-14 and extracellular matrix metalloproteinase inducer in diabetic retinopathy
    Shuyan Li, Shiheng Lu, Lei Zhang, Shasha Liu, Lei Wang, Kai Lin, Jialun Du, Meixia Song
    Materials Express.2021; 11(6): 873.     CrossRef
  • Reduced Acrolein Detoxification in akr1a1a Zebrafish Mutants Causes Impaired Insulin Receptor Signaling and Microvascular Alterations
    Haozhe Qi, Felix Schmöhl, Xiaogang Li, Xin Qian, Christoph T. Tabler, Katrin Bennewitz, Carsten Sticht, Jakob Morgenstern, Thomas Fleming, Nadine Volk, Ingrid Hausser, Elena Heidenreich, Rüdiger Hell, Peter Paul Nawroth, Jens Kroll
    Advanced Science.2021;[Epub]     CrossRef
  • The Metaflammatory and Immunometabolic Role of Macrophages and Microglia in Diabetic Retinopathy
    Honglian Wu, Mengqi Wang, Xiaorong Li, Yan Shao
    Human Cell.2021; 34(6): 1617.     CrossRef
  • Inflammatory resolution and vascular barrier restoration after retinal ischemia reperfusion injury
    Steven F. Abcouwer, Sumathi Shanmugam, Arivalagan Muthusamy, Cheng-mao Lin, Dejuan Kong, Heather Hager, Xuwen Liu, David A. Antonetti
    Journal of Neuroinflammation.2021;[Epub]     CrossRef
  • Diferenças de mensuração de acuidade visual e velocidade de leitura para perto entre pacientes com retinopatia diabética. Repercussão entre conceitos de deficiência visual parcial e cegueira legal
    Roberta Freitas Momenté, Isabella Couto Amaral, Luiz Guilherme Coimbra de Brito, João Gabriel Volpato Ferraresi, Maria Luisa Gois da Fonsêca, Nadyr Antônia Damasceno, Luiz Claudio Santos de Souza Lima, Mauricio Bastos Pereira, Eduardo de França Damasceno
    Revista Brasileira de Oftalmologia.2021;[Epub]     CrossRef
  • Maintaining blood retinal barrier homeostasis to attenuate retinal ischemia-reperfusion injury by targeting the KEAP1/NRF2/ARE pathway with lycopene
    Hao Huang, Xielan Kuang, Xiaobo Zhu, Hao Cheng, Yuxiu Zou, Han Du, Han Tang, Linbin Zhou, Jingshu Zeng, Huijun Liu, Jianhua Yan, Chongde Long, Huangxuan Shen
    Cellular Signalling.2021; 88: 110153.     CrossRef
  • Luteolin, an aryl hydrocarbon receptor antagonist, alleviates diabetic retinopathy by regulating the NLRP/NOX4 signalling pathway: Experimental and molecular docking study
    Y. Yang, M. Zhou, H. Liu
    Physiology International.2021; 108(2): 172.     CrossRef
  • ALDH2/SIRT1 Contributes to Type 1 and Type 2 Diabetes‐Induced Retinopathy through Depressing Oxidative Stress
    Mengshan He, Pan Long, Tao Chen, Kaifeng Li, Dongyu Wei, Yufei Zhang, Wenjun Wang, Yonghe Hu, Yi Ding, Aidong Wen, Daniela Ribeiro
    Oxidative Medicine and Cellular Longevity.2021;[Epub]     CrossRef
  • Looking Ahead: Visual and Anatomical Endpoints in Future Trials of Diabetic Macular Ischemia
    Chui Ming Gemmy Cheung, Elizabeth Pearce, Beau Fenner, Piyali Sen, Victor Chong, Sobha Sivaprasad
    Ophthalmologica.2021; 244(5): 451.     CrossRef
  • The effect of psychotherapy on anxiety, depression, and quality of life in patients with diabetic retinopathy
    Suiping Li, Hong Liu, Xian Zhu
    Medicine.2021; 100(51): e28386.     CrossRef
  • Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy
    Lisa Toto, Federica Evangelista, Pasquale Viggiano, Emanuele Erroi, Giada D’Onofrio, Daniele Libertini, Annamaria Porreca, Rossella D’Aloisio, Parravano Mariacristina, Luca Di Antonio, Marta Di Nicola, Rodolfo Mastropasqua, Maurizio Battaglia Parodi
    BioMed Research International.2020;[Epub]     CrossRef
  • microRNA Expression Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients and Differences from Patients Treated with Anti-VEGF Therapy
    Julian Friedrich, David H. W. Steel, Reinier O. Schlingemann, Michael J. Koss, Hans-Peter Hammes, Guido Krenning, Ingeborg Klaassen
    Translational Vision Science & Technology.2020; 9(6): 16.     CrossRef
  • Update on the Effects of Antioxidants on Diabetic Retinopathy: In Vitro Experiments, Animal Studies and Clinical Trials
    Jose Javier Garcia-Medina, Elena Rubio-Velazquez, Elisa Foulquie-Moreno, Ricardo P Casaroli-Marano, Maria Dolores Pinazo-Duran, Vicente Zanon-Moreno, Monica del-Rio-Vellosillo
    Antioxidants.2020; 9(6): 561.     CrossRef
  • Methylglyoxal, a Highly Reactive Dicarbonyl Compound, in Diabetes, Its Vascular Complications, and Other Age-Related Diseases
    C. G. Schalkwijk, C. D. A. Stehouwer
    Physiological Reviews.2020; 100(1): 407.     CrossRef
  • Pericytes, inflammation, and diabetic retinopathy
    Benjamin G. Spencer, Jose J. Estevez, Ebony Liu, Jamie E. Craig, John W. Finnie
    Inflammopharmacology.2020; 28(3): 697.     CrossRef
  • Eye hemodynamic data and biochemical parameters of the lacrimal fluid of patients with non-proliferative diabetic retinopathy
    Guzal Kangilbaeva, Fazilat Bakhritdinova, Iroda Nabieva, Aziza Jurabekova
    Data in Brief.2020; 32: 106237.     CrossRef
  • Endocannabinoids in aqueous humour of patients with or without diabetes
    Patrick Richardson, Catherine Ortori, Dave Barrett, Saoirse O'Sullivan, Iskandar Idris
    BMJ Open Ophthalmology.2020; 5(1): e000425.     CrossRef
  • A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
    Kota Sato, Seiya Mochida, Daisuke Tomimoto, Takahiro Konuma, Naoki Kiyota, Satoru Tsuda, Yukihiro Shiga, Kazuko Omodaka, Toru Nakazawa
    Experimental Eye Research.2020; 193: 107997.     CrossRef
  • The Role of Bone Morphogenetic Proteins in Diabetic Complications
    Nimna Perera, Rebecca H. Ritchie, Mitchel Tate
    ACS Pharmacology & Translational Science.2020; 3(1): 11.     CrossRef
  • Increased Ephrin-B2 expression in pericytes contributes to retinal vascular death in rodents
    Maha Coucha, Amy C. Barrett, Joseph Bailey, Maryam Abdelghani, Mohammed Abdelsaid
    Vascular Pharmacology.2020; 131: 106761.     CrossRef
  • Mitochondrial Defects Drive Degenerative Retinal Diseases
    Deborah A. Ferrington, Cody R. Fisher, Renu A. Kowluru
    Trends in Molecular Medicine.2020; 26(1): 105.     CrossRef
  • Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis
    Takuya Miyagawa, Takashi Taniguchi, Ryosuke Saigusa, Maiko Fukayama, Takehiro Takahashi, Takashi Yamashita, Megumi Hirabayashi, Shunsuke Miura, Kouki Nakamura, Ayumi Yoshizaki, Shinichi Sato, Yoshihide Asano
    Rheumatology.2020; 59(8): 2005.     CrossRef
  • Natriuretic Peptides Attenuate Retinal Pathological Neovascularization Via Cyclic Guanosine Monophosphate Signaling in Pericytes and Astrocytes
    Katarina Špiranec Spes, Sabrina Hupp, Franziska Werner, Franziska Koch, Katharina Völker, Lisa Krebes, Ulrike Kämmerer, Katrin G. Heinze, Barbara M. Braunger, Michaela Kuhn
    Arteriosclerosis, Thrombosis, and Vascular Biology.2020; 40(1): 159.     CrossRef
  • Therapeutic investigation of quercetin nanomedicine in a zebrafish model of diabetic retinopathy
    Shuai Wang, Shanshan Du, Wenzhan Wang, Fengyan Zhang
    Biomedicine & Pharmacotherapy.2020; 130: 110573.     CrossRef
  • The role of CD44 in pathological angiogenesis
    Li Chen, Chenying Fu, Qing Zhang, Chengqi He, Feng Zhang, Quan Wei
    The FASEB Journal.2020; 34(10): 13125.     CrossRef
  • Associations between alcohol intake and diabetic retinopathy risk: a systematic review and meta-analysis
    Chen Chen, Zhaojun Sun, Weigang Xu, Jun Tan, Dan Li, Yiting Wu, Ting Zheng, Derong Peng
    BMC Endocrine Disorders.2020;[Epub]     CrossRef
  • Alpha-Smooth Muscle Actin-Positive Perivascular Cells in Diabetic Retina and Choroid
    Soo Jin Kim, Sang A. Kim, Yeong A. Choi, Do Young Park, Junyeop Lee
    International Journal of Molecular Sciences.2020; 21(6): 2158.     CrossRef
  • The G‐protein‐coupled chemoattractant receptor Fpr2 exacerbates neuroglial dysfunction and angiogenesis in diabetic retinopathy
    Ying Yu, Shengding Xue, Keqiang Chen, Yingying Le, Rongrong Zhu, Shiyi Wang, Shuang Liu, Xinliang Cheng, Huaijin Guan, Ji Ming Wang, Hui Chen
    FASEB BioAdvances.2020; 2(10): 613.     CrossRef
  • Dual-Acting Antiangiogenic Gene Therapy Reduces Inflammation and Regresses Neovascularization in Diabetic Mouse Retina
    Rute S. Araújo, Diogo B. Bitoque, Gabriela A. Silva
    Molecular Therapy Nucleic Acids.2020; 22: 329.     CrossRef
  • The cells involved in the pathological process of diabetic retinopathy
    Songtao Yang, Jiaoyue Zhang, Lulu Chen
    Biomedicine & Pharmacotherapy.2020; 132: 110818.     CrossRef
  • The Role of Transforming Growth Factor-Beta in Retinal Ganglion Cells with Hyperglycemia and Oxidative Stress
    Hsin-Yi Chen, Yi-Jung Ho, Hsiu-Chuan Chou, En-Chi Liao, Yi-Ting Tsai, Yu-Shan Wei, Li-Hsun Lin, Meng-Wei Lin, Yi-Shiuan Wang, Mei-Lan Ko, Hong-Lin Chan
    International Journal of Molecular Sciences.2020; 21(18): 6482.     CrossRef
  • Circadian rhythms in diabetic retinopathy: an overview of pathogenesis and investigational drugs
    Ashay D. Bhatwadekar, Varun Rameswara
    Expert Opinion on Investigational Drugs.2020; 29(12): 1431.     CrossRef
  • Blood-retinal barrier as a converging pivot in understanding the initiation and development of retinal diseases
    Xue Yang, Xiao-Wei Yu, Dan-Dan Zhang, Zhi-Gang Fan
    Chinese Medical Journal.2020; 133(21): 2586.     CrossRef
  • Immunosubunit β5i Knockout Suppresses Neovascularization and Restores Autophagy in Retinal Neovascularization by Targeting ATG5 for Degradation
    Liyang Ji, Li Li, Ying Zhao, Shengqiang Liu, Jingmin Li, Jinsong Zhang, Qi Zhao, Shuai Wang
    Investigative Opthalmology & Visual Science.2020; 61(14): 30.     CrossRef
  • En face slab optical coherence tomography imaging successfully monitors progressive degenerative changes in the innermost layer of the diabetic retina
    Atsuko Katsuyama, Sentaro Kusuhara, Shun-Ichiro Asahara, Shun-Ichiro Nakai, Sotaro Mori, Wataru Matsumiya, Akiko Miki, Takuji Kurimoto, Hisanori Imai, Yoshiaki Kido, Wataru Ogawa, Makoto Nakamura
    BMJ Open Diabetes Research & Care.2020; 8(1): e001120.     CrossRef
  • Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study
    Yoo-Ri Chung, Kyoung Hwa Ha, Hyeon Chang Kim, Sang Jun Park, Kihwang Lee, Dae Jung Kim
    Diabetes & Metabolism Journal.2019; 43(5): 640.     CrossRef
  • Age-related changes of the human retinal vessels: Possible involvement of lipid peroxidation
    Tapas Chandra Nag, Meenakshi Maurya, Tara Sankar Roy
    Annals of Anatomy - Anatomischer Anzeiger.2019; 226: 35.     CrossRef
  • Human iPSCs-Derived Endothelial Cells with Mutation in HNF1A as a Model of Maturity-Onset Diabetes of the Young
    Neli Kachamakova-Trojanowska, Jacek Stepniewski, Jozef Dulak
    Cells.2019; 8(11): 1440.     CrossRef
  • Diabetic Retinopathy–An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes
    Stephen H. Sinclair, Stanley S. Schwartz
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Identification of Diagnostic and Prognostic microRNAs for Recurrent Vitreous Hemorrhage in Patients with Proliferative Diabetic Retinopathy
    Parviz Mammadzada, Juliette Bayle, Johann Gudmundsson, Anders Kvanta, Helder André
    Journal of Clinical Medicine.2019; 8(12): 2217.     CrossRef
  • RANKL blockade suppresses pathological angiogenesis and vascular leakage in ischemic retinopathy
    Sangmi Ock, Soyoung Park, Junyeop Lee, Jaetaek Kim
    Biochemical and Biophysical Research Communications.2019; 516(2): 350.     CrossRef
  • EndogenousClostridium perfringensPanophthalmitis with Potential Entry Port from Diverticulitis Exacerbated by Proliferative Diabetic Retinopathy
    Vamsee Neerukonda, Anny M. S. Cheng, Swetha Dhanireddy, Samuel Alpert, Han Y. Yin
    Case Reports in Ophthalmological Medicine.2019; 2019: 1.     CrossRef
  • Attenuation of Retinal Endothelial Vasodilator Function in a Rat Model of Retinopathy of Prematurity
    Ayuki Nakano, Asami Mori, Shiho Arima, Daiki Asano, Akane Morita, Kenji Sakamoto, Tohru Nagamitsu, Tsutomu Nakahara
    Current Eye Research.2019; 44(12): 1360.     CrossRef
  • Efficacy of fenofibrate for diabetic retinopathy
    Xing-jie Su, Lin Han, Yan-Xiu Qi, Hong-wei Liu
    Medicine.2019; 98(14): e14999.     CrossRef
  • Nutraceuticals for the Treatment of Diabetic Retinopathy
    Maria Grazia Rossino, Giovanni Casini
    Nutrients.2019; 11(4): 771.     CrossRef
  • Efficacy of ranibizumab for the treatment of diabetic retinopathy
    Yong-bo Ren, Xing-jie Su, Yan-xiu Qi, He-qun Luan, Qi Sun
    Medicine.2019; 98(17): e15409.     CrossRef
Original Articles
Others
Generation of Insulin-Expressing Cells in Mouse Small Intestine by Pdx1, MafA, and BETA2/NeuroD
So-Hyun Lee, Marie Rhee, Ji-Won Kim, Kun-Ho Yoon
Diabetes Metab J. 2017;41(5):405-416.   Published online September 5, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.405
  • 8,953 View
  • 74 Download
  • 7 Web of Science
  • 7 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

To develop surrogate insulin-producing cells for diabetes therapy, adult stem cells have been identified in various tissues and studied for their conversion into β-cells. Pancreatic progenitor cells are derived from the endodermal epithelium and formed in a manner similar to gut progenitor cells. Here, we generated insulin-producing cells from the intestinal epithelial cells that induced many of the specific pancreatic transcription factors using adenoviral vectors carrying three genes: PMB (pancreatic and duodenal homeobox 1 [Pdx1], V-maf musculoaponeurotic fibrosarcoma oncogene homolog A [MafA], and BETA2/NeuroD).

Methods

By direct injection into the intestine through the cranial mesenteric artery, adenoviruses (Ad) were successfully delivered to the entire intestine. After virus injection, we could confirm that the small intestine of the mouse was appropriately infected with the Ad-Pdx1 and triple Ad-PMB.

Results

Four weeks after the injection, insulin mRNA was expressed in the small intestine, and the insulin gene expression was induced in Ad-Pdx1 and Ad-PMB compared to control Ad-green fluorescent protein. In addition, the conversion of intestinal cells into insulin-expressing cells was detected in parts of the crypts and villi located in the small intestine.

Conclusion

These data indicated that PMB facilitate the differentiation of mouse intestinal cells into insulin-expressing cells. In conclusion, the small intestine is an accessible and abundant source of surrogate insulin-producing cells.

Citations

Citations to this article as recorded by  
  • Stem Cells Reprogramming in Diabetes Mellitus and Diabetic Complications: Recent Advances
    Hafez R. Madkor, Mostafa K. Abd El-Aziz, Mostafa S. Abd El-Maksoud, Islam M. Ibrahim, Fares E.M. Ali
    Current Diabetes Reviews.2025;[Epub]     CrossRef
  • Insulin in Myenteric Neurons: Time-Dependent and Regional Changes in Type 1 Diabetic Rats
    Abigél Egyed-Kolumbán, Benita Onhausz, Bence Pál Barta, Zita Szalai, Ildikó Huliák, Mónika Kiricsi, Mária Bagyánszki, Nikolett Bódi
    Cells.2025; 14(11): 809.     CrossRef
  • Harnessing gut cells for functional insulin production: Strategies and challenges
    Kelvin Baafi, John C. March
    Biotechnology Notes.2023; 4: 7.     CrossRef
  • Differential Morphological Diagnosis of Various Forms of Congenital Hyperinsulinism in Children
    Lubov Borisovna Mitrofanova, Anastasia Arkadyevna Perminova, Daria Viktorovna Ryzhkova, Anna Andreyevna Sukhotskaya, Vladimir Gireyevich Bairov, Irina Leorovna Nikitina
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control
    Min Jung Kim, Eun Young Lee, Young-Hye You, Hae Kyung Yang, Kun-Ho Yoon, Ji-Won Kim
    Stem Cell Research.2020; 48: 101958.     CrossRef
  • ERK Regulates NeuroD1-mediated Neurite Outgrowth via Proteasomal Degradation
    Tae-young Lee, In-Su Cho, Narayan Bashyal, Francisco J Naya, Ming-Jer Tsai, Jeong Seon Yoon, Jung-Mi Choi, Chang-Hwan Park, Sung-Soo Kim, Haeyoung Suh-Kim
    Experimental Neurobiology.2020; 29(3): 189.     CrossRef
  • Generation of a PDX1–EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-3, using the CRISPR/Cas9 system
    Youngsun Lee, Hye Young Choi, Ara Kwon, Hyeyeon Park, Mi-Hyun Park, Ji-Won Kim, Min Jung Kim, Yong-Ou Kim, Sungwook Kwak, Soo Kyung Koo
    Stem Cell Research.2019; 41: 101632.     CrossRef
Obesity and Metabolic Syndrome
In Vitro Effect of Fatty Acids Identified in the Plasma of Obese Adolescents on the Function of Pancreatic β-Cells
Claudia Velasquez, Juan Sebastian Vasquez, Norman Balcazar
Diabetes Metab J. 2017;41(4):303-315.   Published online May 24, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.4.303
  • 7,539 View
  • 51 Download
  • 8 Web of Science
  • 6 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

The increase in circulating free fatty acid (FFA) levels is a major factor that induces malfunction in pancreatic β-cells. We evaluated the effect of FFAs reconstituted according to the profile of circulating fatty acids found in obese adolescents on the viability and function of the murine insulinoma cell line (mouse insulinoma [MIN6]).

Methods

From fatty acids obtained commercially, plasma-FFA profiles of three different youth populations were reconstituted: obese with metabolic syndrome; obese without metabolic syndrome; and normal weight without metabolic syndrome. MIN6 cells were treated for 24 or 48 hours with the three FFA profiles, and glucose-stimulated insulin secretion, cell viability, mitochondrial function and antioxidant activity were evaluated.

Results

The high FFA content and high polyunsaturated ω6/ω3 ratio, present in plasma of obese adolescents with metabolic syndrome had a toxic effect on MIN6 cell viability and function, increasing oxidative stress and decreasing glucose-dependent insulin secretion.

Conclusion

These results could help to guide nutritional management of obese young individuals, encouraging the increase of ω-3-rich food consumption in order to reduce the likelihood of deterioration of β-cells and the possible development of type 2 diabetes mellitus.

Citations

Citations to this article as recorded by  
  • The reversible effects of free fatty acids on sulfonylurea-stimulated insulin secretion are related to the expression and dynamin-mediated endocytosis of KATP channels in pancreatic β cells
    Chenmin Wei, Zichen Zhang, Qi Fu, Yunqiang He, Tao Yang, Min Sun
    Endocrine Connections.2023;[Epub]     CrossRef
  • Preparation of fatty acid solutions exerts significant impact on experimental outcomes in cell culture models of lipotoxicity
    Axel Römer, Divya Rawat, Thomas Linn, Sebastian F Petry
    Biology Methods and Protocols.2022;[Epub]     CrossRef
  • Lipotoxic Impairment of Mitochondrial Function in β-Cells: A Review
    Axel Römer, Thomas Linn, Sebastian F. Petry
    Antioxidants.2021; 10(2): 293.     CrossRef
  • Contribution of Oxidative Stress and Impaired Biogenesis of Pancreatic β-Cells to Type 2 Diabetes
    Petr Ježek, Martin Jabůrek, Lydie Plecitá-Hlavatá
    Antioxidants & Redox Signaling.2019; 31(10): 722.     CrossRef
  • The role of polyunsaturated fatty acids (n-3 PUFAs) on the pancreatic β-cells and insulin action
    Habtamu Wondifraw Baynes, Seifu Mideksa, Sintayehu Ambachew
    Adipocyte.2018; : 1.     CrossRef
  • Fatty Acid-Stimulated Insulin Secretion vs. Lipotoxicity
    Petr Ježek, Martin Jabůrek, Blanka Holendová, Lydie Plecitá-Hlavatá
    Molecules.2018; 23(6): 1483.     CrossRef
Review
Obesity and Metabolic Syndrome
Unusual Suspects in the Development of Obesity-Induced Inflammation and Insulin Resistance: NK cells, iNKT cells, and ILCs
Beatriz Dal Santo Francisco Bonamichi, Jongsoon Lee
Diabetes Metab J. 2017;41(4):229-250.   Published online May 22, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.4.229
  • 10,496 View
  • 90 Download
  • 44 Web of Science
  • 44 Crossref
AbstractAbstract PDFPubReader   ePub   

The notion that obesity-induced inflammation mediates the development of insulin resistance in animal models and humans has been gaining strong support. It has also been shown that immune cells in local tissues, in particular in visceral adipose tissue, play a major role in the regulation of obesity-induced inflammation. Specifically, obesity increases the numbers and activation of proinflammatory immune cells, including M1 macrophages, neutrophils, Th1 CD4 T cells, and CD8 T cells, while simultaneously suppressing anti-inflammatory cells such as M2 macrophages, CD4 regulatory T cells, regulatory B cells, and eosinophils. Recently, however, new cell types have been shown to participate in the development of obesity-induced inflammation and insulin resistance. Some of these cell types also appear to regulate obesity. These cells are natural killer (NK) cells and innate lymphoid cells (ILCs), which are closely related, and invariant natural killer T (iNKT) cells. It should be noted that, although iNKT cells resemble NK cells in name, they are actually a completely different cell type in terms of their development and functions in immunity and metabolism. In this review, we will focus on the roles that these relatively new players in the metabolism field play in obesity-induced insulin resistance and the regulation of obesity.

Citations

Citations to this article as recorded by  
  • Longitudinal assessment of maternal micronutrients (folate and vitamin B12) and homocysteine levels in women who develop gestational diabetes mellitus
    Shweta Madiwale, Nikita Joshi, Karuna Randhir, Hemlata Pisal, Vrushali Kadam, Ghattu Krishnaveni, Girija Wagh, Sanjay Gupte, Caroline Fall, Sadhana Joshi
    European Journal of Clinical Nutrition.2025; 79(6): 520.     CrossRef
  • Single-nucleotide polymorphisms in genes involved in folate metabolism or selected other metabolites and risk for gestational diabetes mellitus
    Ting-Ting Zheng, Jia-He Liu, Wan-Tong Huang, Bo Hong, Di Wang, Chun-Yi Liu, Jie Zhang, Si-Si Li, Shao-Wei Wu, Qi Wang, Lei Chen, Lei Jin
    World Journal of Diabetes.2025;[Epub]     CrossRef
  • Changes in circulating NK and innate-like T cells in type 1 and type 2 diabetes
    Marina Loguinova, Nikita Sergeev, Margarita Samsonova, Alyona Sorokina, Dmitry Grebennikov, Ivan Golodnikov, Anna Goncharenko, Gennady Bocharov, Dmitry Laptev, Rita Khusainova, Ildar Minniakhmetov, Marina Shestakova, Ivan Dedov, Natalia Mokrysheva
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • NK cell-activating receptor NKp46 does not participate in the development of obesity-induced inflammation and insulin resistance
    Gracia Nathalie, Beatriz Dal Santo Francisco Bonamichi, Jieun Kim, Jiwon Jeong, Haneul Kang, Emirrio Reinaldie Hartland, Eveline Eveline, Jongsoon Lee
    Molecules and Cells.2024; 47(3): 100007.     CrossRef
  • Adipose tissue macrophage heterogeneity in the single-cell genomics era
    Haneul Kang, Jongsoon Lee
    Molecules and Cells.2024; 47(2): 100031.     CrossRef
  • Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes
    Teresa Vilariño-García, María Polonio-González, Antonio Pérez-Pérez, Josep Ribalta, Francisco Arrieta, Manuel Aguilar, Juan Obaya, José Gimeno-Orna, Pedro Iglesias, Jorge Navarro, Santiago Durán, Juan Pedro-Botet, Víctor Sánchez-Margalet
    International Journal of Molecular Sciences.2024; 25(4): 2338.     CrossRef
  • TRP channels associated with macrophages as targets for the treatment of obese asthma
    Wenzhao Zhu, Dinxi Bai, Wenting Ji, Jing Gao
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • Brief Report: Relationship Between Adiposity and Biomarkers of Aging and Frailty Among Adults Aging With HIV
    Vitor H. F. Oliveira, Amanda L. Willig, Christine Horvat Davey, Thomas W. Buford, Prema Menezes, Edward Cachay, Heidi M. Crane, Greer A. Burkholder, Barbara M. Gripshover, Julia G. Fleming, John D. Cleveland, Allison R. Webel
    JAIDS Journal of Acquired Immune Deficiency Syndromes.2024; 95(4): 377.     CrossRef
  • Causal association of obesity with epigenetic aging and telomere length: a bidirectional mendelian randomization study
    Jixin Li, Wenru Wang, Zhenyu Yang, Linjie Qiu, Yan Ren, Dongling Wang, Meijie Li, Wenjie Li, Feng Gao, Jin Zhang
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • Insights into the Roles of Natural Killer Cells in Osteoarthritis
    Chang-Qing Zheng, Ling-Jun Zeng, Zhi-Hong Liu, Chen-Fang Miao, Ling-Yan Yao, Hong-Tao Song, Xiao-Mu Hu, Xin Zhou
    Immunological Investigations.2024; 53(5): 766.     CrossRef
  • OMIP‐104: A 30‐color spectral flow cytometry panel for comprehensive analysis of immune cell composition and macrophage subsets in mouse metabolic organs
    Joost M. Lambooij, Tamar Tak, Arnaud Zaldumbide, Bruno Guigas
    Cytometry Part A.2024; 105(7): 493.     CrossRef
  • Gestational diabetes mellitus is associated with distinct folate‐related metabolites in early and mid‐pregnancy: A prospective cohort study
    Wei Zheng, Yujie Zhang, Puyang Zhang, Tengda Chen, Xin Yan, Lin Li, Lijun Shao, Zhiru Song, Weiling Han, Jia Wang, Junhua Huang, Kaiwen Ma, Ruihua Yang, Yuru Ma, Lili Xu, Kexin Zhang, Xianxian Yuan, Guanghui Li
    Diabetes/Metabolism Research and Reviews.2024;[Epub]     CrossRef
  • Protective effects of Ganoderma lucidum spores on estradiol benzoate-induced TEC apoptosis and compromised double-positive thymocyte development
    Jihong Yang, Haitao Pan, Mengyao Wang, Anyao Li, Guoliang Zhang, Xiaohui Fan, Zhenhao Li
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Associations of Plasma Erythritol with Dietary Factors, Cardiometabolic, Inflammatory, and Gut Health Markers in People with and without HIV: A Cross-Sectional Study
    Aaron A. Fletcher, Jared C. Durieux, Ilya Bederman, John Feczko, Ornina Atieh, Jhony Baissary, Danielle Labbato, Kate Ailstock, Nicholas T. Funderburg, Grace A. McComsey
    Nutrients.2024; 16(20): 3449.     CrossRef
  • Associations of intermediate hyperglycemia with elevated abdominal obesity, high-sensitivity C-reactive protein, and leptin in Korean adults
    Heashoon Lee
    Journal of Korean Biological Nursing Science.2024; 26(3): 250.     CrossRef
  • Adipose tissue aging is regulated by an altered immune system
    Yi-Xiang Zhang, Min-Yi Ou, Zi-Han Yang, Yu Sun, Qing-Feng Li, Shuang-Bai Zhou
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • The Influence of Maternal Folate Status on Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Ruhan Xu, Shenhao Liu, Zhiqi Zhong, Yifei Guo, Tianqi Xia, Yanyan Chen, Lingling Ding
    Nutrients.2023; 15(12): 2766.     CrossRef
  • Gut microbiota, immunity, and bile acid metabolism: decoding metabolic disease interactions
    Qixiang Zhao, Jiayu Wu, Yong Ding, Yanli Pang, Changtao Jiang
    Life Metabolism.2023;[Epub]     CrossRef
  • Proteomic Analysis by 4D Label-free MS-PRM Provides Insight into the Role and Regulatory Mechanisms of IL-25 in NK Cells
    Juan Feng, Luoyao Huang, Shuaipeng Yang, Jiasheng Pan, Xiangxing Zhu, Dongsheng Tang
    Protein & Peptide Letters.2023; 30(10): 841.     CrossRef
  • No association of natural killer cell number and function in peripheral blood with overweight/obesity and metabolic syndrome in a cohort of young women
    Julia Keilen, Christina Gar, Marietta Rottenkolber, Louise U. Fueessl, Anna T. Joseph, Rika Draenert, Jochen Seissler, Andreas Lechner
    Physiological Reports.2022;[Epub]     CrossRef
  • Browning Epicardial Adipose Tissue: Friend or Foe?
    Elisa Doukbi, Astrid Soghomonian, Coralie Sengenès, Shaista Ahmed, Patricia Ancel, Anne Dutour, Bénédicte Gaborit
    Cells.2022; 11(6): 991.     CrossRef
  • Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells
    Meng-Wei Ko, Barbara Breznik, Emanuela Senjor, Anahid Jewett
    Advances in Cancer Biology - Metastasis.2022; 5: 100043.     CrossRef
  • Aldose reductase promotes diet‐induced obesity via induction of senescence in subcutaneous adipose tissue
    Devi Thiagarajan, Nosirudeen Quadri, Shabnam Jawahar, Hylde Zirpoli, Carmen Hurtado del Pozo, Raquel López‐Díez, Syed Nurul Hasan, Gautham Yepuri, Paul F. Gugger, Brian S. Finlin, Philip A. Kern, Kenneth Gabbay, Ann Marie Schmidt, Ravichandran Ramasamy
    Obesity.2022; 30(8): 1647.     CrossRef
  • Macrophages, Chronic Inflammation, and Insulin Resistance
    He Li, Ya Meng, Shuwang He, Xiaochuan Tan, Yujia Zhang, Xiuli Zhang, Lulu Wang, Wensheng Zheng
    Cells.2022; 11(19): 3001.     CrossRef
  • Ethnicity and the relationship between covid-19 and the herpes simplex viruses
    Peter Bond
    Medical Hypotheses.2021; 146: 110447.     CrossRef
  • Association between maternal folate status and gestational diabetes mellitus
    Yan Yang, Zixin Cai, Jingjing Zhang
    Food Science & Nutrition.2021; 9(4): 2042.     CrossRef
  • Natural Killer Cells: Friend or Foe in Metabolic Diseases?
    Yi Li, Fangjie Wang, Saber Imani, Ling Tao, Youcai Deng, Yue Cai
    Frontiers in Immunology.2021;[Epub]     CrossRef
  • Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis
    Anahid Jewett, Janko Kos, Kawaljit Kaur, Tahmineh Safaei, Christine Sutanto, Wuyang Chen, Paul Wong, Artin Keshishian Namagerdi, Changge Fang, Yuman Fong, Meng-Wei Ko
    Molecular Therapy - Oncolytics.2020; 16: 41.     CrossRef
  • NK cells induce hepatic ER stress to promote insulin resistance in obesity through osteopontin production
    Junhua Wu, Danyang Wu, Longyao Zhang, Chuxuan Lin, Jiahao Liao, Ruyin Xie, Zhulin Li, Siyang Wu, Aimin Liu, Weining Hu, Yang Xi, Shizhong Bu, Fuyan Wang
    Journal of Leukocyte Biology.2020; 107(4): 589.     CrossRef
  • Concentration of NK cells after β-glucan and vitamin D supplementation in patients with diabetic retinopathy
    Richter Josef, Pohorska Jitka, Závorková Martina, Král Vlastimil, Stiborova Ivana, Dobiasova Rajnohova Lucie, Vetvicka Vaclav
    Folia Microbiologica.2020; 65(4): 755.     CrossRef
  • Nutrition, the visceral immune system, and the evolutionary origins of pathogenic obesity
    Mary Jane West-Eberhard
    Proceedings of the National Academy of Sciences.2019; 116(3): 723.     CrossRef
  • Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders
    Mohammad Hosein Farzaei, Amit Kumar Singh, Ramesh Kumar, Courtney R. Croley, Abhay K. Pandey, Ericsson Coy-Barrera, Jayanta Kumar Patra, Gitishree Das, Rout George Kerry, Giuseppe Annunziata, Gian Carlo Tenore, Haroon Khan, Matteo Micucci, Roberta Budries
    International Journal of Molecular Sciences.2019; 20(19): 4957.     CrossRef
  • Correlations between Body Mass Index, Plasma High-Sensitivity C-Reactive Protein and Lipids in Patients with Schizophrenia
    Ted Boozalis, Sridevi Devaraj, Olaoluwa O. Okusaga
    Psychiatric Quarterly.2019; 90(1): 101.     CrossRef
  • Association of maternal folate status in the second trimester of pregnancy with the risk of gestational diabetes mellitus
    Kaipeng Xie, Pengfei Xu, Ziyi Fu, Xiaohong Gu, Hui Li, Xianwei Cui, Lianghui You, Lijun Zhu, Chenbo Ji, Xirong Guo
    Food Science & Nutrition.2019; 7(11): 3759.     CrossRef
  • An intracrine view of sex steroids, immunity, and metabolic regulation
    Katya B. Rubinow
    Molecular Metabolism.2018; 15: 92.     CrossRef
  • CD4+ T cells in obesity and obesity-associated diseases
    Yueshui Zhao, Ling Lin, Jing Li, Zhangang Xiao, Bo Chen, Lin Wan, Mingxing Li, Xu Wu, Chi Hin Cho, Jing Shen
    Cellular Immunology.2018; 332: 1.     CrossRef
  • Natural killer cells target and differentiate cancer stem-like cells/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy
    Kawaljit Kaur, Milica Perišić Nanut, Meng-Wei Ko, Tahmineh Safaie, Janko Kos, Anahid Jewett
    Current Opinion in Immunology.2018; 51: 170.     CrossRef
  • Parallels in Immunometabolic Adipose Tissue Dysfunction with Ageing and Obesity
    William Trim, James E. Turner, Dylan Thompson
    Frontiers in Immunology.2018;[Epub]     CrossRef
  • In response to Manuscript AJRI 01‐18‐016 entitled “Regulatory T cells, natural killer cells and obesity in patients with gestational diabetes mellitus”—Kawada T
    Thalita Frutuoso Lobo, Camila de Moraes Borges, Rosiane Mattar, Caio Perez Gomes, Ana Geisa Santos de Ângelo, Karen Piriscila Tezotto Pendeloski, Silvia Daher
    American Journal of Reproductive Immunology.2018;[Epub]     CrossRef
  • Endogenous lipid antigens for invariant natural killer T cells hold the reins in adipose tissue homeostasis
    Robert J. van Eijkeren, Olga Krabbe, Marianne Boes, Henk S. Schipper, Eric Kalkhoven
    Immunology.2018; 153(2): 179.     CrossRef
  • Regulatory T cells, natural killer cells, and obesity in patients with gestational diabetes mellitus
    Tomoyuki Kawada
    American Journal of Reproductive Immunology.2018;[Epub]     CrossRef
  • Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr−/− Mice
    Savitha Subramanian, Leela Goodspeed, Shari Wang, Yilei Ding, Kevin O’Brien, Godfrey Getz, Alan Chait, Catherine Reardon
    International Journal of Molecular Sciences.2018; 19(2): 510.     CrossRef
  • The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection
    Jordan E. Lake
    Current HIV/AIDS Reports.2017; 14(6): 211.     CrossRef
  • Cell Type-Specific Immunomodulation Induced by Helminthes: Effect on Metainflammation, Insulin Resistance and Type-2 Diabetes
    Vivekanandhan Aravindhan, Gowrishankar Anand
    The American Journal of Tropical Medicine and Hygiene.2017; 97(6): 1650.     CrossRef
Original Article
Others
Metformin Promotes Apoptosis but Suppresses Autophagy in Glucose-Deprived H4IIE Hepatocellular Carcinoma Cells
Deok-Bae Park
Diabetes Metab J. 2015;39(6):518-527.   Published online December 11, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.6.518
  • 8,939 View
  • 57 Download
  • 23 Web of Science
  • 24 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Metformin, a well-known anti-diabetic drug, has gained interest due to its association with the reduction of the prevalence of cancer in patients with type 2 diabetes and the anti-proliferative effect of metformin in several cancer cells. Here, we investigated the anti-proliferative effect of metformin with respect to apoptosis and autophagy in H4IIE hepatocellular carcinoma cells.

Methods

H4IIE rat cells were treated with metformin in glucose-free medium for 24 hours and were then subjected to experiments examining the onset of apoptosis and/or autophagy as well as the related signaling pathways.

Results

When H4IIE cells were incubated in glucose-free media for 24 hours, metformin and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) reduced the viability of cells. Inhibition of AMP-activated protein kinase (AMPK) by compound C significantly blocked cell death induced by metformin or AICAR. Pro-apoptotic events (nuclear condensation, hydrolysis of intact poly ADP ribose polymerase and caspase-3) were stimulated by metformin and then suppressed by compound C. Interestingly, the formation of acidic intracellular vesicles, a marker of autophagy, was stimulated by compound C. Although the deprivation of amino acids in culture media also induced apoptosis, neither metformin nor compound C affected cell viability. The expression levels of all of the autophagy-related proteins examined decreased with metformin, and two proteins (light chain 3 and beclin-1) were sensitive to compound C. Among the tested inhibitors against MAP kinases and phosphatidylinositol-3-kinase/mammalian target of rapamycin, SB202190 (against p38MAP kinase) significantly interrupted the effects of metformin.

Conclusion

Our data suggest that metformin induces apoptosis, but suppresses autophagy, in hepatocellular carcinoma cells via signaling pathways, including AMPK and p38 mitogen-activated protein kinase.

Citations

Citations to this article as recorded by  
  • Exploring the protective role of metformin and dehydrozingerone in sodium fluoride-induced neurotoxicity: evidence from prenatal rat models
    Tejas Ahuja, Farmiza Begum, Gautam Kumar, Smita Shenoy, Nitesh Kumar, Rekha R. Shenoy
    3 Biotech.2025;[Epub]     CrossRef
  • Mechanistic Insights into Autophagy-Dependent Cell Death (ADCD): A Novel Avenue for Cancer Therapy
    Md Ataur Rahman, Maroua Jalouli, Mohammed Al-Zharani, Ehsanul Hoque Apu, Abdel Halim Harrath
    Cells.2025; 14(14): 1072.     CrossRef
  • Multifaceted role of AMPK in autophagy: more than a simple trigger?
    Milos Mandic, Maja Misirkic Marjanovic, Kristina Janjetovic, Mihajlo Bosnjak, Ljubica Harhaji-Trajkovic, Vladimir Trajkovic, Ljubica Vucicevic
    American Journal of Physiology-Cell Physiology.2025; 329(5): C1380.     CrossRef
  • Metformin-induced and Mitochondrial Stress-mediated Apoptosis in Schizosaccharomyces pombe
    Hızlan Hıncal Ağuş, Cenk Kığ, Mustafa Kaçmaz
    Bilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi.2024; 11(1): 174.     CrossRef
  • Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways
    Mohammad Yasin Zamanian, Maryam Golmohammadi, Alexey Yumashev, Ahmed Hjazi, Mariam Alaa Toama, Mervat Ahmed AbdRabou, Anita Gehlot, Enas R. Alwaily, Niyousha Shirsalimi, Pankaj Kumar Yadav, Gervason Moriasi
    Cell Biochemistry and Function.2024;[Epub]     CrossRef
  • Metformin and its potential influence on cell fate decision between apoptosis and senescence in cancer, with a special emphasis on glioblastoma
    Melika Hajimohammadebrahim-Ketabforoush, Alireza Zali, Mohammadreza Shahmohammadi, Amir Ali Hamidieh
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Fatty Acid Synthase (FASN) Inhibitors Suppress Metformin-Induced Fat Accumulation and Apoptosis in H4IIE Hepatocellular Carcinoma Cells
    Deokbae Park, Hyejin Boo
    Development & Reproduction.2024; 28(4): 163.     CrossRef
  • Metformin Induces Lipogenesis and Apoptosis in H4IIE Hepatocellular Carcinoma Cells
    Deokbae Park, Sookyoung Lee, Hyejin Boo
    Development & Reproduction.2023; 27(2): 77.     CrossRef
  • Novel phloretin-based combinations targeting glucose metabolism in hepatocellular carcinoma through GLUT2/PEPCK axis of action: in silico molecular modelling and in vivo studies
    Alaa Elmetwalli, Neamat H. Kamosh, Rania El Safty, Amany I. Youssef, Mohammed M. Salama, Khaled M. Abd El-Razek, Tarek El-Sewedy
    Medical Oncology.2023;[Epub]     CrossRef
  • Targeted Pyroptosis Is a Potential Therapeutic Strategy for Cancer
    Hao Wu, Dianlun Qian, Xiangfeng Bai, Shibo Sun, Jayaprakash Narayana Kolla
    Journal of Oncology.2022; 2022: 1.     CrossRef
  • The effects of metformin on autophagy
    Guangli Lu, Zhen Wu, Jia Shang, Zhenxing Xie, Chaoran Chen, Chuning zhang
    Biomedicine & Pharmacotherapy.2021; 137: 111286.     CrossRef
  • Protective Effect of Metformin against Hydrogen Peroxide-Induced Oxidative Damage in Human Retinal Pigment Epithelial (RPE) Cells by Enhancing Autophagy through Activation of AMPK Pathway
    Xia Zhao, Linlin Liu, Yizhou Jiang, Marta Silva, Xuechu Zhen, Wenhua Zheng
    Oxidative Medicine and Cellular Longevity.2020; 2020: 1.     CrossRef
  • Metformin Induces Autophagy via the AMPK-mTOR Signaling Pathway in Human Hepatocellular Carcinoma Cells


    Chun Gao, Long Fang, Hui Zhang, Wei-Shuo Zhang, Xiao-Ou Li, Shi-Yu Du
    Cancer Management and Research.2020; Volume 12: 5803.     CrossRef
  • Metabolomics profiling of metformin-mediated metabolic reprogramming bypassing AMPKα
    Min Yan, Huan Qi, Tian Xia, Xinjie Zhao, Wen Wang, Zhichao Wang, Chang Lu, Zhen Ning, Huan Chen, Tongming Li, Dinesh Singh Tekcham, Xiumei Liu, Jing Liu, Di Chen, Xiaolong Liu, Guowang Xu, Hai-long Piao
    Metabolism.2019; 91: 18.     CrossRef
  • Metformin Induces Oxidative Stress-Mediated Apoptosis without the Blockade of Glycolysis in H4IIE Hepatocellular Carcinoma Cells
    Deokbae Park
    Biological and Pharmaceutical Bulletin.2019; 42(12): 2002.     CrossRef
  • Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation
    Cui Zhai, Wenhua Shi, Wei Feng, Yanting Zhu, Jian Wang, Shaojun Li, Xin Yan, Qingting Wang, Qianqian Zhang, Limin Chai, Cong Li, Pengtao Liu, Manxiang Li
    Life Sciences.2018; 208: 87.     CrossRef
  • Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells
    Aneta Rogalska, Barbara Bukowska, Agnieszka Marczak
    Toxicology in Vitro.2018; 47: 48.     CrossRef
  • Quantitative assessment of cell fate decision between autophagy and apoptosis
    Bing Liu, Zoltán N. Oltvai, Hülya Bayır, Gary A. Silverman, Stephen C. Pak, David H. Perlmutter, Ivet Bahar
    Scientific Reports.2017;[Epub]     CrossRef
  • Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients
    Shujuan Ma, Yixiang Zheng, Yanni Xiao, Pengcheng Zhou, Hongzhuan Tan
    Medicine.2017; 96(19): e6888.     CrossRef
  • ROS Production and ERK Activity Are Involved in the Effects of d-β-Hydroxybutyrate and Metformin in a Glucose Deficient Condition
    Santosh Lamichhane, Tonking Bastola, Ramesh Pariyar, Eun-Sol Lee, Ho-Sub Lee, Dae Lee, Jungwon Seo
    International Journal of Molecular Sciences.2017; 18(3): 674.     CrossRef
  • Metformin represses glucose starvation induced autophagic response in microvascular endothelial cells and promotes cell death
    Samson Mathews Samuel, Suparna Ghosh, Yasser Majeed, Gnanapragasam Arunachalam, Mohamed M. Emara, Hong Ding, Chris R. Triggle
    Biochemical Pharmacology.2017; 132: 118.     CrossRef
  • NHX-5, an Endosomal Na+/H+ Exchanger, Is Associated with Metformin Action
    Jeongho Kim, Hye-Yeon Lee, Jheesoo Ahn, Moonjung Hyun, Inhwan Lee, Kyung-Jin Min, Young-Jai You
    Journal of Biological Chemistry.2016; 291(35): 18591.     CrossRef
  • Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification
    Archana Bhaw-Luximon, Dhanjay Jhurry
    Journal of Cancer Research and Clinical Oncology.2016; 142(10): 2159.     CrossRef
  • Metformina: stary lek w nowej aplikacji
    Anna Dmoszyńska, Monika Podhorecka, Krzysztof Giannopoulos
    Acta Haematologica Polonica.2016; 47(2): 139.     CrossRef
Reviews
Pancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the Block
Jun Sung Moon, Kyu Chang Won
Diabetes Metab J. 2015;39(1):1-9.   Published online February 16, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.1.1
  • 11,522 View
  • 121 Download
  • 43 Web of Science
  • 43 Crossref
AbstractAbstract PDFPubReader   ePub   

Type 2 diabetes (T2D) has been known as 'bi-hormonal disorder' since decades ago, the role of glucagon from α-cell has languished whereas β-cell taking center stage. Recently, numerous findings indicate that the defects of glucagon secretion get involve with development and exacerbation of hyperglycemia in T2D. Aberrant α-cell responses exhibit both fasting and postprandial states: hyperglucagonemia contributes to fasting hyperglycemia caused by inappropriate hepatic glucose production, and to postprandial hyperglycemia owing to blunted α-cell suppression. During hypoglycemia, insufficient counter-regulation response is also observed in advanced T2D. Though many debates still remained for exact mechanisms behind the dysregulation of α-cell in T2D, it is clear that the blockade of glucagon receptor or suppression of glucagon secretion from α-cell would be novel therapeutic targets for control of hyperglycemia. Whereas there have not been remarkable advances in developing new class of drugs, currently available glucagon-like peptide-1 and dipeptidyl peptidase-IV inhibitors could be options for treatment of hyperglucagonemia. In this review, we focus on α-cell dysfunction and therapeutic potentials of targeting α-cell in T2D.

Citations

Citations to this article as recorded by  
  • The Natural History of Prediabetes and Cardiovascular Disease in the Pediatric Population
    Siham Accacha, Julia Barillas-Cerritos, Liana Gabriel, Ankita Srivastava, Shelly Gulkarov, Jennifer A. Apsan, Joshua De Leon, Allison B. Reiss
    Biomedicines.2026; 14(1): 198.     CrossRef
  • Transcriptomic heterogeneity of non-beta islet cells is associated with type 2 diabetes development in mouse models
    Pascal Gottmann, Thilo Speckmann, Mandy Stadion, Prateek Chawla, Judith Saurenbach, Nikolay Ninov, Heiko Lickert, Annette Schürmann
    Diabetologia.2025; 68(1): 166.     CrossRef
  • The Role of the Gut Microbiome in the Development and Progression of Type 2 Diabetes and Liver Disease
    Asha Guraka, Sreejesh Sreedharan, Ramesh Arasaradnam, Gyan Tripathi, Ali Kermanizadeh
    Nutrition Reviews.2025; 83(7): e2025.     CrossRef
  • Glucagon in glucose homeostasis and metabolic disease: from physiology to therapeutics
    Abdulbasit Amin, Toyin Mohammed Salman
    Journal of Basic and Clinical Physiology and Pharmacology.2025; 36(2-3): 139.     CrossRef
  • Prolonged glucagon exposure rewires lipid oxidation and drives diabetic kidney disease progression
    Xingfeng Liu, Jingwen Chen, Shengying Gu, Yibing Chen, Ruiping Zhang, Qingce Zang, Ting Li, Hanwen Li, Dejin Lu, Shaocong Hou, Lijuan Kong, Qian Jiang, Caiyi Xing, Wenjia Fan, Yanjun Wan, Jiaqi Zhang, Linyuan Zhu, Chunxiao Ma, Qijin Zhao, Hai Yan, Zeper A
    Nature Communications.2025;[Epub]     CrossRef
  • An extended minimal model of OGTT: estimation of α- and β-cell dysfunction, insulin resistance, and the incretin effect
    Vijaya Subramanian, Jonatan I. Bagger, Vinayak Harihar, Jens J. Holst, Filip K. Knop, Tina Villsbøll
    American Journal of Physiology-Endocrinology and Metabolism.2024; 326(2): E182.     CrossRef
  • Inhibition of Sodium-Glucose Cotransporter-2 during Serum Deprivation Increases Hepatic Gluconeogenesis via the AMPK/AKT/FOXO Signaling Pathway
    Jinmi Lee, Seok-Woo Hong, Min-Jeong Kim, Yu-Mi Lim, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
    Endocrinology and Metabolism.2024; 39(1): 98.     CrossRef
  • Effect of probiotic-fermented milk containing Lactiplantibacillus pentoses strain HBUAS 53657 on serum glutathione peroxidase activity and pancreatic histopathology in hyperglycemic rats
    Rita Yaswir, Eti Yerizel, Netti Suharti, Cimi Ilmiawati
    Acta Biochimica Indonesiana.2024; 7(2): 174.     CrossRef
  • Childhood Obesity, Diabetes, and Cardiovascular Disease Risk
    Mostafa Salama, Babu Balagopal, Ilene Fennoy, Seema Kumar
    The Journal of Clinical Endocrinology & Metabolism.2023; 108(12): 3051.     CrossRef
  • Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research’s Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health’s
    William T. Cefalu, Dana K. Andersen, Guillermo Arreaza-Rubín, Christopher L. Pin, Sheryl Sato, C. Bruce Verchere, Minna Woo, Norman D. Rosenblum
    Diabetes.2022; 71(1): 1.     CrossRef
  • Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research’s Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health’s
    William T. Cefalu, Dana K. Andersen, Guillermo Arreaza-Rubín, Christopher L. Pin, Sheryl Sato, C. Bruce Verchere, Minna Woo, Norman D. Rosenblum
    Diabetes Care.2022; 45(1): 3.     CrossRef
  • Daily Treatment of Mice with Type 2 Diabetes with Adropin for Four Weeks Improves Glucolipid Profile, Reduces Hepatic Lipid Content and Restores Elevated Hepatic Enzymes in Serum
    Marek Skrzypski, Paweł A. Kołodziejski, Ewa Pruszyńska-Oszmałek, Tatiana Wojciechowicz, Paulina Janicka, Małgorzata Krążek, Emilian Małek, Mathias Z. Strowski, Krzysztof W. Nowak
    International Journal of Molecular Sciences.2022; 23(17): 9807.     CrossRef
  • A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment
    Vijaya Subramanian, Jonatan I. Bagger, Jens J. Holst, Filip K. Knop, Tina Vilsbøll
    Frontiers in Physiology.2022;[Epub]     CrossRef
  • Increased serum cystatin C levels and responses of pancreatic α- and β-cells in type 2 diabetes
    Hui-qing Yuan, Jia-xi Miao, Jia-ping Xu, Su-xiang Zhu, Feng Xu, Xiao-hua Wang, Chun-hua Wang, Chao Yu, Xue-qin Wang, Jian-bin Su, Dong-mei Zhang
    Endocrine Connections.2022;[Epub]     CrossRef
  • Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis
    Shangyu Chai, Ruya Zhang, Ye Zhang, Richard David Carr, Yiman Zheng, Swapnil Rajpathak, Linong Ji
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes
    Soyeon Yoo, Dongkyu Kim, Gwanpyo Koh
    Journal of Clinical Medicine.2021; 10(11): 2487.     CrossRef
  • Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes
    Hong Wang, Jie Cao, Jian-bin Su, Xue-qin Wang, Xing Wang, Dong-mei Zhang, Xiao-hua Wang
    Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
  • Angiopoietins stimulate pancreatic islet development from stem cells
    Soujanya S. Karanth, Shuofei Sun, Huanjing Bi, Kaiming Ye, Sha Jin
    Scientific Reports.2021;[Epub]     CrossRef
  • A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives
    Josh Reed, Stephen Bain, Venkateswarlu Kanamarlapudi
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 3567.     CrossRef
  • The Role of the α Cell in the Pathogenesis of Diabetes: A World beyond the Mirror
    María Sofía Martínez, Alexander Manzano, Luis Carlos Olivar, Manuel Nava, Juan Salazar, Luis D’Marco, Rina Ortiz, Maricarmen Chacín, Marion Guerrero-Wyss, Mayela Cabrera de Bravo, Clímaco Cano, Valmore Bermúdez, Lisse Angarita
    International Journal of Molecular Sciences.2021; 22(17): 9504.     CrossRef
  • Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research’s Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health’s
    William T. Cefalu, Dana K. Andersen, Guillermo Arreaza-Rubín, Christopher L. Pin, Sheryl Sato, C. Bruce Verchere, Minna Woo, Norman D. Rosenblum, Norman Rosenblum, William Cefalu, Dana K. Andersen, Guillermo Arreaza-Rubín, Christine Dhara, Stephen P. Jame
    Canadian Journal of Diabetes.2021; 45(8): 697.     CrossRef
  • The role of GIP in α-cells and glucagon secretion
    Kimberley El, Jonathan E. Campbell
    Peptides.2020; 125: 170213.     CrossRef
  • Recommendations for improving clinical trial design to facilitate the study of youth-onset type 2 diabetes
    Muhammad Yazid Jalaludin, Margarita Barrientos-Pérez, Mona Hafez, Jane Lynch, Naim Shehadeh, Serap Turan, Daniel Weghuber
    Clinical Trials.2020; 17(1): 87.     CrossRef
  • Recent advances in understanding the role of glucagon-like peptide 1
    Josh Reed, Stephen Bain, Venkateswarlu Kanamarlapudi
    F1000Research.2020; 9: 239.     CrossRef
  • Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study
    Irene Roncero-Ramos, Juan F. Alcala-Diaz, Oriol A. Rangel-Zuñiga, Francisco Gomez-Delgado, Rosa Jimenez-Lucena, Antonio García-Rios, Cristina Vals-Delgado, Cristina Romero-Baldonado, Raul M. Luque, Jose M. Ordovas, Pablo Perez-Martinez, Antonio Camargo, J
    Clinical Nutrition.2020; 39(2): 492.     CrossRef
  • Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open‐label, active‐controlled, 12‐week study (STABLE II study)
    Soo Heon Kwak, You‐Cheol Hwang, Jong Chul Won, Ji Cheol Bae, Hyun Jin Kim, Sunghwan Suh, Eun Young Lee, Subin Lee, Sang‐Yong Kim, Jae Hyeon Kim
    Diabetes, Obesity and Metabolism.2020; 22(2): 173.     CrossRef
  • Pathophysiology of Type 2 Diabetes in Children and Adolescents
    Badhma Valaiyapathi, Barbara Gower , Ambika P. Ashraf
    Current Diabetes Reviews.2020; 16(3): 220.     CrossRef
  • Decellularized Tissue Matrix Enhances Self-Assembly of Islet Organoids from Pluripotent Stem Cell Differentiation
    Huanjing Bi, Soujanya S. Karanth, Kaiming Ye, Roland Stein, Sha Jin
    ACS Biomaterials Science & Engineering.2020; 6(7): 4155.     CrossRef
  • Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes
    Dipeeka K. Mandaliya, Sriram Seshadri
    Pancreatology.2019; 19(4): 617.     CrossRef
  • A contemporary biological pathway of islet amyloid polypeptide for the management of diabetic dementia
    Sushil Kumar Sah, Vijaya Paul Samuel, Sunita Dahiya, Yogendar Singh, Ritu M. Gilhotra, Gaurav Gupta, Anurag Mishra, Rakesh Kumar Sharma, Gubbiyappa Shiva Kumar, Nagaraja SreeHarsha, Dinesh Kumar Chellappan, Kamal Dua
    Chemico-Biological Interactions.2019; 306: 117.     CrossRef
  • Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes
    Dipeeka K. Mandaliya, Sriram Seshadri
    Pancreatology.2019; 19(2): 280.     CrossRef
  • Higher glucagon-to-insulin ratio is associated with elevated glycated hemoglobin levels in type 2 diabetes patients
    Minyoung Lee, Minkyung Kim, Jong Suk Park, Sangbae Lee, Jihong You, Chul Woo Ahn, Kyung Rae Kim, Shinae Kang
    The Korean Journal of Internal Medicine.2019; 34(5): 1068.     CrossRef
  • Insulin regulates glucagon-like peptide-1 secretion by pancreatic alpha cells
    Pan Liu, Jia Song, He Liu, Fei Yan, Tianyi He, Lingshu Wang, Huying Shen, Xinguo Hou, Li Chen
    Endocrine.2018; 62(2): 394.     CrossRef
  • Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential
    Ana Marta de Matos, Maria Paula de Macedo, Amélia Pilar Rauter
    Medicinal Research Reviews.2018; 38(1): 261.     CrossRef
  • Alpha cell function interacts with diet to modulate prediabetes and Type 2 diabetes
    Irene Roncero-Ramos, Rosa Jimenez-Lucena, Juan F. Alcala-Diaz, Cristina Vals-Delgado, Antonio P. Arenas-Larriva, Oriol A. Rangel-Zuñiga, Ana Leon-Acuña, María M. Malagon, Javier Delgado-Lista, Pablo Perez-Martinez, Jose M. Ordovas, Antonio Camargo, Jose L
    The Journal of Nutritional Biochemistry.2018; 62: 247.     CrossRef
  • Targetting PED/PEA-15 for diabetes treatment
    Francesca Fiory, Rosa Spinelli, Gregory Alexander Raciti, Luca Parrillo, Vittoria D’esposito, Pietro Formisano, Claudia Miele, Francesco Beguinot
    Expert Opinion on Therapeutic Targets.2017; 21(6): 571.     CrossRef
  • PANCREATIC ALPHA CELL DYSFUNCTION IN DIABETES MELLITUS AND ITS MANAGEMENT STRATEGIES
    Butungeshwar Pradhan, Chakradhar Majhi
    Journal of Evidence Based Medicine and Healthcare.2017; 4(45): 2775.     CrossRef
  • Glucagon and heart in type 2 diabetes: new perspectives
    Antonio Ceriello, Stefano Genovese, Edoardo Mannucci, Edoardo Gronda
    Cardiovascular Diabetology.2016;[Epub]     CrossRef
  • Potential Drug Combinations to Reduce Cardiovascular Disease Burden in Diabetes
    Sivaram Pillarisetti
    Trends in Pharmacological Sciences.2016; 37(3): 207.     CrossRef
  • The Biology of Glucagon and the Consequences of Hyperglucagonemia
    Nicolai J Wewer Albrechtsen, Rune E Kuhre, Jens Pedersen, Filip K Knop, Jens J Holst
    Biomarkers in Medicine.2016; 10(11): 1141.     CrossRef
  • Increasing GLP-1 Circulating Levels by Bariatric Surgery or by GLP-1 Receptor Agonists Therapy: Why Are the Clinical Consequences so Different?
    Chloé Amouyal, Fabrizio Andreelli
    Journal of Diabetes Research.2016; 2016: 1.     CrossRef
  • Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1
    Toya M Albury-Warren, Veethika Pandey, Lina P Spinel, Michal M Masternak, Deborah A Altomare
    Journal of Endocrinology.2016; 228(1): 49.     CrossRef
  • Blood Glucagon Levels Predict the Hemoglobin A1c Response to Saxagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin
    Hao Liu, Yun Hu, Feng-fei Li, Bing-li Liu, Xiao-fei Su, Jian-hua Ma
    Diabetes Therapy.2016; 7(4): 743.     CrossRef
Cell Therapy for Diabetic Neuropathy Using Adult Stem or Progenitor Cells
Ji Woong Han, Min Young Sin, Young-sup Yoon
Diabetes Metab J. 2013;37(2):91-105.   Published online April 16, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.2.91
  • 10,416 View
  • 78 Download
  • 30 Web of Science
  • 27 Crossref
AbstractAbstract PDFPubReader   ePub   

Diabetic neuropathy (DN) is the most common and disabling complication of diabetes that may lead to foot ulcers and limb amputations. Despite widespread awareness of DN, the only effective treatments are glucose control and pain management. A growing body of evidence suggests that DN is characterized by reduction of vascularity in peripheral nerves and deficiency in neurotrophic and angiogenic factors. Previous studies have tried to introduce neurotrophic or angiogenic factors in the form of protein or gene for therapy, but the effect was not significant. Recent studies have shown that bone marrow (BM)-derived stem or progenitor cells have favorable effects on the repair of cardiovascular diseases. Since these BM-derived stem or progenitor cells contain various angiogenic and neurotrophic factors, these cells have been attempted for treating experimental DN, and turned out to be effective for reversing various manifestations of experimental DN. These evidences suggest that cell therapy, affecting both vascular and neural components, can represent a novel therapeutic option for treatment of clinical DN.

Citations

Citations to this article as recorded by  
  • Extracellular Vesicles Derived From Mesenchymal Bone Marrow Cells Promote Antinociception in a Murine Model of Diabetic Neuropathy via the Endogenous Opioid System
    Gessica S. A. Silva, Afrânio F. Evangelista, Girlaine C. Santos, Thaís A. Santana, Luiza C. F. Opretzka, Pedro S. S. Lauria, Marco A. Stimamiglio, Milena B. P. Soares, Cristiane F. Villarreal
    Advanced Therapeutics.2026;[Epub]     CrossRef
  • Therapeutic Applications of Mesenchymal Stem Cell‐Derived Extracellular Vesicles in Diabetic Neuropathy; Challenges and Future Prospective
    Lei Shi, Hong xia Che, Huan Yang, Yang yang Li, Yuan yuan Jin
    Journal of Biochemical and Molecular Toxicology.2025;[Epub]     CrossRef
  • Mesenchymal stem cell therapy for type 2 diabetes: mechanisms, clinical evidence, and future directions
    Malek Zarei
    Molecular Biology Reports.2025;[Epub]     CrossRef
  • Efficacy of adipose‐derived mesenchymal stem cell therapy in the treatment of chronic micro‐ and macrovascular complications of diabetes
    Agnieszka Mikłosz, Adrian Chabowski
    Diabetes, Obesity and Metabolism.2024; 26(3): 793.     CrossRef
  • Interferon-gamma Treatment of Human Umbilical Cord Mesenchymal Stem Cells can Significantly Reduce Damage Associated with Diabetic Peripheral Neuropathy in Mice
    Li-Fen Yang, Jun-Dong He, Wei-Qi Jiang, Xiao-Dan Wang, Xiao-Chun Yang, Zhi Liang, Yi-Kun Zhou
    Current Stem Cell Research & Therapy.2024; 19(8): 1129.     CrossRef
  • Natural molecules as promising players against diabetic peripheral neuropathy: an emerging nutraceutical approach
    Rabia Akram, Haseeb Anwar, Muhammad Shahid Javed, Ali Imran, Azhar Rasul, Shoaib Ahmad Malik, Mobina Manzoor, Fakhar Islam, Ikram Ullah Khan, Faiqa Sajid, Tehreem Iman, Muhammad Ajmal Shah, Tao Sun, Ghulam Hussain, Mohd Asif Shah
    International Journal of Food Properties.2023; 26(1): 894.     CrossRef
  • A Receptor Story: Insulin Resistance Pathophysiology and Physiologic Insulin Resensitization’s Role as a Treatment Modality
    Stanley T. Lewis, Frank Greenway, Tori R. Tucker, Michael Alexander, Levonika K. Jackson, Scott A. Hepford, Brian Loveridge, Jonathan R. T. Lakey
    International Journal of Molecular Sciences.2023; 24(13): 10927.     CrossRef
  • Nanochannel‐Based Poration Drives Benign and Effective Nonviral Gene Delivery to Peripheral Nerve Tissue
    Jordan T. Moore, Christopher G. Wier, Luke R. Lemmerman, Lilibeth Ortega‐Pineda, Daniel J. Dodd, William R. Lawrence, Silvia Duarte‐Sanmiguel, Kavya Dathathreya, Ludmila Diaz‐Starokozheva, Hallie N. Harris, Chandan K. Sen, Ian L. Valerio, Natalia Higuita‐
    Advanced Biosystems.2020;[Epub]     CrossRef
  • Endothelial progenitor cells and peripheral neuropathy in subjects with type 2 diabetes mellitus
    Ioanna Eleftheriadou, Natalia Dimitrakopoulou, Nikolitsa Kafasi, Anastasios Tentolouris, Aglaia Dimitrakopoulou, Ioanna A. Anastasiou, Iordanis Mourouzis, Edward Jude, Nikolaos Tentolouris
    Journal of Diabetes and its Complications.2020; 34(4): 107517.     CrossRef
  • Autologous Bone Marrow Mononuclear Cell Transplantation Therapy Improved Symptoms in Patients with Refractory Diabetic Sensorimotor Polyneuropathy via the Mechanisms of Paracrine and Immunomodulation: A Controlled Study
    Wei Wei, Li Li, Lin Deng, Zhong-Jing Wang, Jing-Jian Dong, Xiao-Yu Lyu, Ting Jia, Li Wang, Hong-Xiang Wang, Hong Mao, Shi Zhao
    Cell Transplantation.2020; 29: 096368972094925.     CrossRef
  • Sodium nitrate preconditioning prevents progression of the neuropathic pain in streptozotocin-induced diabetes Wistar rats
    Hajar Oghbaei, Gisou Mohaddes, GholamReza Hamidian, Rana Keyhanmanesh
    Journal of Diabetes & Metabolic Disorders.2020; 19(1): 105.     CrossRef
  • The Influence of Diabetic Foot Exercise in Sensory Peripheral Neuropathy with Monofilament Test on Diabetes Mellitus Clients
    Tintin Sukartini, Candra Panji Asmoro, Nandani Alifah
    Jurnal Ners.2020; 14(3): 340.     CrossRef
  • Effects of mesenchymal stromal cells on motor function and collagen in the skeletal muscles of rats with type I diabetes
    Genoveva L. F. Luna, Thiago L. Russo, Maria A. Sabadine, Yisel C. Estrada‐Bonilla, Ana L. M. Andrade, Patricia Brassolatti, Fernanda F. Anibal, Ângela M. O. Leal
    International Journal of Experimental Pathology.2019; 100(5-6): 359.     CrossRef
  • Efficacy of autologous bone marrow mononuclear cell transplantation therapy in patients with refractory diabetic peripheral neuropathy
    Hong Mao, Wei Wei, Xiu-Li Fu, Jing-Jian Dong, Xiao-Yu Lyu, Ting Jia, Yang Tang, Shi Zhao
    Chinese Medical Journal.2019; 132(1): 11.     CrossRef
  • Effects of adipose derived stromal vascular fraction on diabetic neuropathy: an experimental study
    Berrak Karatan, Ersin Akşam, Esra Erden, Mustafa Erol Demirseren
    Journal of Plastic Surgery and Hand Surgery.2019; 53(6): 335.     CrossRef
  • Addressing Stem Cell Therapeutic Approaches in Pathobiology of Diabetes and Its Complications
    Bou-Yue Peng, Navneet Kumar Dubey, Viraj Krishna Mishra, Feng-Chou Tsai, Rajni Dubey, Win-Ping Deng, Hong-Jian Wei
    Journal of Diabetes Research.2018; 2018: 1.     CrossRef
  • Transplantation of human mobilized mononuclear cells improved diabetic neuropathy
    Se Hee Min, Jung Hee Kim, Yu Mi Kang, Seung Hak Lee, Byung-Mo Oh, Kyou-Sup Han, Meihua Zhang, Hoe Suk Kim, Woo Kyung Moon, Hakmo Lee, Kyong Soo Park, Hye Seung Jung
    Journal of Endocrinology.2018; 239(3): 277.     CrossRef
  • Fluoxetine pretreatment enhances neurogenic, angiogenic and immunomodulatory effects of MSCs on experimentally induced diabetic neuropathy
    Shaimaa A. Abdelrahman, Mai A. Samak, Sally M. Shalaby
    Cell and Tissue Research.2018; 374(1): 83.     CrossRef
  • Autologous Bone Marrow-Derived Stem Cells for Treating Diabetic Neuropathy in Metabolic Syndrome
    Wei Liu, Fengchun Yu, Zhenghong Zhou, Yi-Chen Li, Dongsheng Fan, Kai Zhu
    BioMed Research International.2017; 2017: 1.     CrossRef
  • Impaired olfactory function is related to the presence of neuropathy in adults with type 1 diabetes
    Anna Duda-Sobczak, Aleksandra Araszkiewicz, Magdalena Urbas, Lukasz Borucki, Katarzyna Kulas, Maciej Chudzinski, Aleksandra Suwalska, Dorota Zozulinska-Ziolkiewicz
    Diabetes and Vascular Disease Research.2017; 14(2): 139.     CrossRef
  • New insights into the ameliorative effects of ferulic acid in pathophysiological conditions
    Sumit Ghosh, Priyanka Basak, Sayanta Dutta, Sayantani Chowdhury, Parames C. Sil
    Food and Chemical Toxicology.2017; 103: 41.     CrossRef
  • Ferulic acid pretreatment could improve prognosis of autologous mesenchymal stromal cell transplantation for diabetic neuropathy
    Solmaz Mirzamohammadi, Mohammad Hadi Nematollahi, Mehrzad Mehrbani, Mehrnaz Mehrabani
    Cytotherapy.2016; 18(7): 925.     CrossRef
  • Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinic
    J Y Zhou, Z Zhang, G S Qian
    Cell Death Discovery.2016;[Epub]     CrossRef
  • Diabetes mellitus related bone metabolism and periodontal disease
    Ying-Ying Wu, E Xiao, Dana T Graves
    International Journal of Oral Science.2015; 7(2): 63.     CrossRef
  • Microvessel permeability correlates with diabetic peripheral neuropathy in early stage of streptozotocin-induced diabetes rats
    Liyuan Peng, Wei Liu, Fanglong Zhai, Li He, Hailan Wang
    Journal of Diabetes and its Complications.2015; 29(7): 865.     CrossRef
  • Mesenchymal Stem Cell-Based Treatment for Microvascular and Secondary Complications of Diabetes Mellitus
    Grace C. Davey, Swapnil B. Patil, Aonghus O’Loughlin, Timothy O’Brien
    Frontiers in Endocrinology.2014;[Epub]     CrossRef
  • Emerging roles of hematopoietic cells in the pathobiology of diabetic complications
    Hideto Kojima, Jongoh Kim, Lawrence Chan
    Trends in Endocrinology & Metabolism.2014; 25(4): 178.     CrossRef
Original Article
The Effects of Glyburide on Apoptosis and Endoplasmic Reticulum Stress in INS-1 Cells in a Glucolipotoxic Condition
Min Jeong Kwon, Hye Suk Chung, Chang Shin Yoon, Jung Hae Ko, Hae Jung Jun, Tae Kyun Kim, Soon Hee Lee, Kyung Soo Ko, Byoung Doo Rhee, Mi Kyung Kim, Jeong Hyun Park
Diabetes Metab J. 2011;35(5):480-488.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.480
  • 6,942 View
  • 66 Download
  • 8 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

β-cell death due to endoplasmic reticulum (ER) stress has been regarded as an important pathogenic component of type 2 diabetes. The possibility has been suggested that sulfonylurea, currently being used as one of the main oral hypoglycemic agents of type 2 diabetes, increases ER stress, which could lead to sulfonylurea failure. The authors of the present study examined ER stress of β-cells in a glucolipotoxic condition using glyburide (GB) in an environment mimicking type 2 diabetes.

Methods

Apoptosis was induced by adding various concentrations of GB (0.001 to 200 µM) to a glucolipotoxic condition using 33 mM glucose, and the effects of varied concentrations of palmitate were evaluated via annexin V staining. The markers of ER stress and pro-apoptotic markers were assessed by Western blotting and semi-quantitative reverse transcription-polymerase chain reaction. Additionally, the anti-apoptotic markers were evaluated.

Results

Addition of any concentration of GB in 150 µM palmitate and 33 mM glucose did not increase apoptosis. The expression of phosphorylated eukaryotic initiation factor (eIF-2α) was increased and cleaved caspase 3 was decreased by adding GB to a glucolipotoxic condition. However, other ER stress-associated markers such as Bip-1, X-box binding protein-1, ATF-4 and C/EBP-homologous protein transcription factor and anti-apoptotic markers phosphor-p85 phosphatidylinositol 3-kinase and phosphorylation of Akt did not change significantly.

Conclusion

GB did not show further deleterious effects on the degree of apoptosis or ER stress of INS-1 cells in a glucolipotoxic condition. Increased phosphorylation of eIF-2α may attenuate ER stress for adaptation to increased ER protein load.

Citations

Citations to this article as recorded by  
  • Loss of β‐cell identity in human islets treated with glibenclamide
    Claudia Fernández, Montserrat Nacher, Kevin Rivera, Sandra Marín‐Cañas, Maria Sorribas, Gabriel Moreno‐González, Elisabet Estil·les, Patricia San José, Noèlia Téllez, Eduard Montanya
    Diabetes, Obesity and Metabolism.2025; 27(10): 5782.     CrossRef
  • Enzyme-Instructed Self-Assembly of Endoplasmic Reticulum-Targeting Peptides for Selective Modulation of Cancer Cell Fate
    Jihun H. Roh, Priyanka Upadhyay, Chae-Young Lee, Beopbo Kang, Kyung-Bok Lee, Hyuk Nam Kwon, Beom Jin Kim
    Biomacromolecules.2025; 26(11): 8007.     CrossRef
  • The antagonistic atorvastatin-glibenclamide interactions suppressed the atorvastatin-induced Bax/cytochrome c/p53 mRNA expressions and increased Rho A mRNA expression in B16f10 melanoma cell culture
    Maryam Malek, Nasim Dana, Ahmad Ghasemi, Maedeh Ghasemi
    Gene Reports.2021; 23: 101156.     CrossRef
  • Expression profiles of stress-related genes in islets from donors with progressively impaired glucose metabolism
    Marcus Lundberg, Anton Stenwall, Angie Tegehall, Olle Korsgren, Oskar Skog
    Islets.2018; 10(2): 69.     CrossRef
  • Pharmacological Modulators of Endoplasmic Reticulum Stress in Metabolic Diseases
    Tae Jung, Kyung Choi
    International Journal of Molecular Sciences.2016; 17(2): 192.     CrossRef
  • The TRPA1 channel and oral hypoglycemic agents
    Carlos Manlio Diaz-Garcia
    Channels.2013; 7(6): 420.     CrossRef
  • Dimethyl sulfoxide reduces hepatocellular lipid accumulation through autophagy induction
    Young Mi Song, Sun-Ok Song, Yong-Keun Jung, Eun-Seok Kang, Bong Soo Cha, Hyun Chul Lee, Byung-Wan Lee
    Autophagy.2012; 8(7): 1085.     CrossRef
  • The Duration of Sulfonylurea Treatment Is Associated withβ-Cell Dysfunction in Patients with Type 2 Diabetes Mellitus
    Mi-Seon Shin, Jee Hee Yu, Chang Hee Jung, Jenie Yoonoo Hwang, Woo Je Lee, Min-Seon Kim, Joong-Yeol Park
    Diabetes Technology & Therapeutics.2012; 14(11): 1033.     CrossRef
Review
Fuel-Stimulated Insulin Secretion Depends upon Mitochondria Activation and the Integration of Mitochondrial and Cytosolic Substrate Cycles
Gary W. Cline
Diabetes Metab J. 2011;35(5):458-465.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.458
  • 65,535 View
  • 49 Download
  • 11 Crossref
AbstractAbstract PDFPubReader   ePub   

The pancreatic islet β-cell is uniquely specialized to couple its metabolism and rates of insulin secretion with the levels of circulating nutrient fuels, with the mitochondrial playing a central regulatory role in this process. In the β-cell, mitochondrial activation generates an integrated signal reflecting rates of oxidativephosphorylation, Kreb's cycle flux, and anaplerosis that ultimately determines the rate of insulin exocytosis. Mitochondrial activation can be regulated by proton leak and mediated by UCP2, and by alkalinization to utilize the pH gradient to drive substrate and ion transport. Converging lines of evidence support the hypothesis that substrate cycles driven by rates of Kreb's cycle flux and by anaplerosis play an integral role in coupling responsive changes in mitochondrial metabolism with insulin secretion. The components and mechanisms that account for the integrated signal of ATP production, substrate cycling, the regulation of cellular redox state, and the production of other secondary signaling intermediates are operative in both rodent and human islet β-cells.

Citations

Citations to this article as recorded by  
  • Metabolic reprogramming of pancreatic beta cells in type 2 diabetes and its therapeutic strategy
    Linxuan Miao, Runyu Miao, Yiqi Yao, Xinyi Fang, Huifang Guan, Jiaxing Tian, Xiaolin Tong
    Ageing Research Reviews.2026; 113: 102938.     CrossRef
  • Miro1- a key player in β-cell function and mitochondrial dynamics under diabetes mellitus
    Srikanth Kavyashree, Kannan Harithpriya, Kunka Mohanram Ramkumar
    Mitochondrion.2025; 84: 102039.     CrossRef
  • Nicotinamide Adenine Dinucleotide: The Redox Sensor in Aging-Related Disorders
    Giovanna Schiuma, Djidjell Lara, James Clement, Marco Narducci, Roberta Rizzo
    Antioxidants & Redox Signaling.2024;[Epub]     CrossRef
  • ROCK1 regulates insulin secretion from β-cells
    Byung-Jun Sung, Sung-Bin Lim, Won-Mo Yang, Jae Hyeon Kim, Rohit N. Kulkarni, Young-Bum Kim, Moon-Kyu Lee
    Molecular Metabolism.2022; 66: 101625.     CrossRef
  • Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity
    Xiaoting Luo, Jinzi Wu, Siqun Jing, Liang-Jun Yan
    Aging and disease.2016; 7(1): 90.     CrossRef
  • Characterization of Phospholipids in Insulin Secretory Granules and Mitochondria in Pancreatic Beta Cells and Their Changes with Glucose Stimulation
    Michael J. MacDonald, Lacmbouh Ade, James M. Ntambi, Israr-Ul H. Ansari, Scott W. Stoker
    Journal of Biological Chemistry.2015; 290(17): 11075.     CrossRef
  • Roles of Pyruvate, NADH, and Mitochondrial Complex I in Redox Balance and Imbalance inβCell Function and Dysfunction
    Xiaoting Luo, Rongrong Li, Liang-Jun Yan
    Journal of Diabetes Research.2015; 2015: 1.     CrossRef
  • Peroxisome Proliferator-activated Receptor γ (PPARγ) and Its Target Genes Are Downstream Effectors of FoxO1 Protein in Islet β-Cells
    Dhananjay Gupta, Averi A. Leahy, Navjot Monga, Mina Peshavaria, Thomas L. Jetton, Jack L. Leahy
    Journal of Biological Chemistry.2013; 288(35): 25440.     CrossRef
  • Desnutrin/ATGL Activates PPARδ to Promote Mitochondrial Function for Insulin Secretion in Islet β Cells
    Tianyi Tang, Marcia J. Abbott, Maryam Ahmadian, Andressa B. Lopes, Yuhui Wang, Hei Sook Sul
    Cell Metabolism.2013; 18(6): 883.     CrossRef
  • Potent humanin analog increases glucose‐stimulated insulin secretion through enhanced metabolism in the β cell
    Regina Kuliawat, Laura Klein, Zhenwei Gong, Marianna Nicoletta‐Gentile, Anjana Nemkal, Lingguang Cui, Claire Bastie, Kai Su, Derek Huffman, Manju Surana, Nir Barzilai, Norman Fleischer, Radhika Muzumdar
    The FASEB Journal.2013; 27(12): 4890.     CrossRef
  • Proliferation and differentiation of osteoblasts from the mandible of osteoporotic rats
    Shu-Juan Yu, Hong-Chen Liu, Ling-Ling E, Dong-Sheng Wang, Guo-Xiong Zhu
    Experimental Biology and Medicine.2012; 237(4): 395.     CrossRef
Original Article
Repeated Gene Transfection Impairs the Engraftment of Transplanted Porcine Neonatal Pancreatic Cells
Min Koo Seo, Cheng-Lin Sun, Ji-Won Kim, Kun-Ho Yoon, Suk Kyeong Lee
Diabetes Metab J. 2011;35(1):72-79.   Published online February 28, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.1.72
  • 30,986 View
  • 29 Download
  • 3 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Previously, we reported that neonatal porcine pancreatic cells transfected with hepatocyte growth factor (HGF) gene in an Epstein-Barr virus (EBV)-based plasmid (pEBVHGF) showed improved proliferation and differentiation compared to those of the control. In this study, we examined if pancreatic cells transfected repeatedly with pEBVHGF can be successfully grafted to control blood glucose in a diabetes mouse model.

Methods

Neonatal porcine pancreatic cells were cultured as a monolayer and were transfected with pEBVHGF every other day for a total of three transfections. The transfected pancreatic cells were re-aggregated and transplanted into kidney capsules of diabetic nude mice or normal nude mice. Blood glucose level and body weight were measured every other day after transplantation. The engraftment of the transplanted cells and differentiation into beta cells were assessed using immunohistochemistry.

Results

Re-aggregation of the pancreatic cells before transplantation improved engraftment of the cells and facilitated neovascularization of the graft. Right before transplantation, pancreatic cells that were transfected with pEBVHGF and then re-aggregated showed ductal cell marker expression. However, ductal cells disappeared and the cells underwent fibrosis in a diabetes mouse model two to five weeks after transplantation; these mice also did not show controlled blood glucose levels. Furthermore, pancreatic cells transplanted into nude mice with normal blood glucose showed poor graft survival regardless of the type of transfected plasmid (pCEP4, pHGF, or pEBVHGF).

Conclusion

For clinical application of transfected neonatal porcine pancreatic cells, further studies are required to develop methods of overcoming the damage for the cells caused by repeated transfection and to re-aggregate them into islet-like structures.

Citations

Citations to this article as recorded by  
  • Successful xenotransplantation with re‐aggregated and encapsulated neonatal pig liver cells for treatment of mice with acute liver failure
    Dong‐Sik Ham, Min‐Sang Song, Heon‐Seok Park, Marie Rhee, Hae Kyung Yang, Seung‐Hwan Lee, Ji‐Won Kim, Eun‐Sun Jung, Kun‐Ho Yoon
    Xenotransplantation.2015; 22(4): 249.     CrossRef
  • Glycated Albumin Causes Pancreatic β-Cells Dysfunction Through Autophagy Dysfunction
    Young Mi Song, Sun Ok Song, Young-Hye You, Kun-Ho Yoon, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee, Ji-Won Kim, Byung-Wan Lee
    Endocrinology.2013; 154(8): 2626.     CrossRef
  • Prevalence, Awareness, and Control of Hypertension among Diabetic Koreans
    Hyun Hee Chung, Kyu Chang Won
    Diabetes & Metabolism Journal.2011; 35(4): 337.     CrossRef
Review
Cell Replacement and Regeneration Therapy for Diabetes
Hee-Sook Jun
Korean Diabetes J. 2010;34(2):77-83.   Published online April 30, 2010
DOI: https://doi.org/10.4093/kdj.2010.34.2.77
  • 7,376 View
  • 47 Download
  • 6 Crossref
AbstractAbstract PDFPubReader   ePub   

Reduction of beta cell function and a beta cell mass is observed in both type 1 and type 2 diabetes. Therefore, restoration of this deficiency might be a therapeutic option for treatment of diabetes. Islet transplantation has benefits, such as reduced incidence of hypoglycemia and achievement of insulin independence. However, the major drawback is an insufficient supply of islet donors. Transplantation of cells differentiated in vitro or in vivo regeneration of insulin-producing cells are possible approaches for beta cell/islet regenerative therapy. Embryonic and adult stem cells, pancreatic ductal progenitor cells, acinar cells, and other endocrine cells have been shown to differentiate into pancreatic beta cells. Formation of fully functional beta cells and the safety of these cells are critical issues for successful clinical application.

Citations

Citations to this article as recorded by  
  • Regulation of insulin expression and release in gene and cell therapy of insulin-deficient diabetes
    Lifang Xie, Wanling Lu, Jiayang Yu, Yanhan Zhang, Hong Gao, Chunguang Xie, Yun Tian, Ming Liu, Gang Wang
    European Journal of Endocrinology.2025; 193(6): R57.     CrossRef
  • The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent advances and current challenges
    Yunfei Luo, Peng Yu, Jianping Liu
    Endocrine.2024; 86(1): 1.     CrossRef
  • Direct Reprogramming of Mice Skin Fibroblasts into Insulin-Producing CellsIn Vitro
    Israa S. Salman, Ahmed Majeed Al-Shammari, Mukhtar Khamis Haba
    Cellular Reprogramming.2022; 24(5): 271.     CrossRef
  • Effects of β-like cell autotransplantation through hepatic arterial intervention on diabetic dogs
    Yongxu Mu, Zhiming Hao, Junfeng He, Ruiqiang Yan, Haiyan Liu, Lei Zhang, Heming Liu, Xiaoyan Hu, Qiming Li
    Artificial Cells, Nanomedicine, and Biotechnology.2016; 44(5): 1333.     CrossRef
  • Meeting the Need for Regenerative Therapies I: Target-Based Incidence and Its Relationship to U.S. Spending, Productivity, and Innovation
    Nancy Parenteau, Janet Hardin-Young, William Shannon, Patrick Cantini, Alan Russell
    Tissue Engineering Part B: Reviews.2012; 18(2): 139.     CrossRef
  • Glucose-stimulated insulin secretion of various mesenchymal stem cells after insulin-producing cell differentiation
    Su-Jung Kim, Yong-Soo Choi, Eun-Sun Ko, Sang-Min Lim, Chang-Woo Lee, Dong-Il Kim
    Journal of Bioscience and Bioengineering.2012; 113(6): 771.     CrossRef
Original Articles
The Effect of Glucose Fluctuation on Apoptosis and Function of INS-1 Pancreatic Beta Cells
Mi Kyung Kim, Hye Sook Jung, Chang Shin Yoon, Jung Hae Ko, Hae Jung Jun, Tae Kyun Kim, Min Jeong Kwon, Soon Hee Lee, Kyung Soo Ko, Byoung Doo Rhee, Jeong Hyun Park
Korean Diabetes J. 2010;34(1):47-54.   Published online February 28, 2010
DOI: https://doi.org/10.4093/kdj.2010.34.1.47
  • 7,593 View
  • 44 Download
  • 22 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Blood glucose level continuously fluctuates within a certain range in the human body. In diabetes patients, the extent of such fluctuation is large, despite the strict control of blood glucose. Blood glucose fluctuation has been shown to mediate more adverse effects on vascular endothelial cells and diabetes complications than chronic hyperglycemia, which has been explained as due to oxidative stress. As few previous studies have reported the effects of chronic and intermittent hyperglycemia on the apoptosis and function of pancreatic beta cells, this study reported herein was performed to investigate such effects on these cells.

Methods

For chronic hyperglycemia, INS-1 cells were cultured for 5 days with changes of RPMI 1640 medium containing 33 mM glucose every 12 hours. For intermittent hyperglycemia, the medium containing 11 mM glucose was exchanged with the medium containing 33 mM glucose every 12 hours. Apoptosis was assessed by TUNEL assay Hoechst staining and cleaved caspase 3. Insulin secretory capacity was assessed, and the expression of Mn-SOD and Bcl-2 was measured by Western blotting.

Results

In comparison to the control group, INS-1 cells exposed to chronic hyperglycemia and intermittent hyperglycemia showed an increase in apoptosis. The apoptosis of INS-1 cells exposed to intermittent hyperglycemia increased significantly more than the apoptosis of INS-1 cells exposed to chronic hyperglycemia. In comparison to the control group, the insulin secretory capacity in the two hyperglycemic states was decreased, and more with intermittent hyperglycemia than with chronic hyperglycemia. The expression of Mn-SOD and Bcl-2 increased more with chronic hyperglycemia than with intermittent hyperglycemia.

Conclusion

Intermittent hyperglycemia induced a higher degree of apoptosis and decreased the insulin secretory capacity more in pancreatic beta cells than chronic hyperglycemia. This activity may be mediated by the anti-oxidative enzyme Mn-SOD and the anti-apoptotic signal Bcl-2.

Citations

Citations to this article as recorded by  
  • Association between the haemoglobin glycation index and 30-day and 365-day mortality in patients with heart failure admitted to the intensive care unit
    Ziyu Guo, Yike Li, Shuoyan An, Jingang Zheng
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Different Forms of Regulated Cell Death in Type-2-Diabetes-Mellitus-Related Osteoporosis: A Focus on Mechanisms and Therapeutic Strategies
    Chenchen Li, He Gong, Peipei Shi, Shuyu Liu, Qi Zhang
    International Journal of Molecular Sciences.2025; 26(9): 4417.     CrossRef
  • Intermittent fasting in the treatment of type 2 diabetes
    Damian Dyńka, Łukasz Rodzeń, Mateusz Rodzeń, Dorota Łojko, Adam Deptuła, Żaneta Grzywacz, Sebastian Kraszewski, Karolina Bartoń, Peter Martin, Anna Małgorzata Deptuła, Ken Berry, David Unwin
    Frontiers in Nutrition.2025;[Epub]     CrossRef
  • Hemoglobin glycation index can be used as a predictor of diabetes mellitus and prediabetes: a cohort study
    Jing-Xian Bai, De-Gang Mo, Min Liu, Tao Liu, Qian-Feng Han, Heng-Chen Yao
    BMC Endocrine Disorders.2025;[Epub]     CrossRef
  • Association between hemoglobin glycation index and diabetic kidney disease in type 2 diabetes mellitus in China: A cross- sectional inpatient study
    Sixu Xin, Xin Zhao, Jiaxiang Ding, Xiaomei Zhang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Plant polyphenols mechanisms of action on insulin resistance and against the loss of pancreatic beta cells
    Camelia Papuc, Gheorghe V. Goran, Corina N. Predescu, Liliana Tudoreanu, Georgeta Ștefan
    Critical Reviews in Food Science and Nutrition.2022; 62(2): 325.     CrossRef
  • Correlation between HbA1c and Triglyceride Level with Coronary Stenosis Degree in Type 2 Diabetes Mellitus with Coronary Heart Disease
    Laily Adninta, Indranila Samsuria, Edward Kurnia Setiawan Limijadi
    Open Access Macedonian Journal of Medical Sciences.2022; 10(B): 944.     CrossRef
  • Age‐specific associations of glycated haemoglobin variability with cardiovascular disease and mortality in patients with type 2 diabetes mellitus: A 10‐ year cohort study
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Florence Ting Yan Ng, Shu Ming Cheryl Chia, Ian Chi Kei Wong, Esther Wai Yin Chan, Cindy Lo Kuen Lam
    Diabetes, Obesity and Metabolism.2020; 22(8): 1316.     CrossRef
  • Molecular Mechanisms of Glucose Fluctuations on Diabetic Complications
    Zhen-Ye Zhang, Ling-Feng Miao, Ling-Ling Qian, Ning Wang, Miao-Miao Qi, Yu-Min Zhang, Shi-Peng Dang, Ying Wu, Ru-Xing Wang
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Resolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»
    Mikhail B. Antsiferov, Gagik R. Galstyan, Alexey V. Zilov, Alexander Y. Mayorov, Tatyana N. Markova, Nikolay A. Demidov, Olga M. Koteshkova, Dmitry N. Laptev, Alisa V. Vitebskaya
    Diabetes mellitus.2019; 22(3): 281.     CrossRef
  • Intermittent High Glucose Enhances the Proliferation of Rat Aortic Vascular Smooth Muscle Cells More Than Constant High Glucose via the Mitogen-Activated Protein Kinase Pathway
    Sung Hoon Yu, Hyung Joon Yoo, Dong Hyun Kang, Shin Je Moon, Jae Myung Yu
    Annals of Geriatric Medicine and Research.2017; 21(3): 131.     CrossRef
  • Association of variability in hemoglobin A1c with cardiovascular diseases and mortality in Chinese patients with type 2 diabetes mellitus — A retrospective population-based cohort study
    Eric Yuk Fai Wan, Colman Siu Cheung Fung, Daniel Yee Tak Fong, Cindy Lo Kuen Lam
    Journal of Diabetes and its Complications.2016; 30(7): 1240.     CrossRef
  • Ginsenoside Rg3 prevents INS-1 cell death from intermittent high glucose stress
    You Jeong Kim, Su Min Park, Hye Sook Jung, Eun Ju Lee, Tae Kyoon Kim, Tae-Nyun Kim, Min Jeong Kwon, Soon Hee Lee, Byoung Doo Rhee, Mi-kyung Kim, Jeong Hyun Park
    Islets.2016; 8(3): 57.     CrossRef
  • Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients
    Alina Babenko, Elena Ivanovna Krasilnikova, Nikolay Pavlovich Likhonosov, Anna Pavlovna Likhonosova, Elena Nikolaevna Grineva
    Diabetes mellitus.2014; 17(4): 72.     CrossRef
  • Exercising for Metabolic Control: Is Timing Important
    Jonida Haxhi, Alessandro Scotto di Palumbo, Massimo Sacchetti
    Annals of Nutrition and Metabolism.2013; 62(1): 14.     CrossRef
  • Combined contributions of over-secreted glucagon-like peptide 1 and suppressed insulin secretion to hyperglycemia induced by gatifloxacin in rats
    Yunli Yu, Xinting Wang, Can Liu, Dan Yao, Mengyue Hu, Jia Li, Nan Hu, Li Liu, Xiaodong Liu
    Toxicology and Applied Pharmacology.2013; 266(3): 375.     CrossRef
  • Blood glucose fluctuation affects skin collagen metabolism in the diabetic mouse by inhibiting the mitogen-activated protein kinase and Smad pathways
    X. Ye, X. Cheng, L. Liu, D. Zhao, Y. Dang
    Clinical and Experimental Dermatology.2013; 38(5): 530.     CrossRef
  • Glucose exposure pattern determines glucagon-like peptide 1 receptor expression and signaling through endoplasmic reticulum stress in rat insulinoma cells
    Ye-Hwang Cheong, Mi-Kyung Kim, Moon-Ho Son, Bong-Kiun Kaang
    Biochemical and Biophysical Research Communications.2011; 414(1): 220.     CrossRef
  • Overexpression of Insig-1 protects β cell against glucolipotoxicity via SREBP-1c
    Ke Chen, ping jin, Hong-hui He, Yan-hong Xie, Xiao-yun Xie, Zhao-hui Mo
    Journal of Biomedical Science.2011;[Epub]     CrossRef
  • Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes
    Gong Su, Shuhua Mi, Hong Tao, Zhao Li, Hongxia Yang, Hong Zheng, Yun Zhou, Changsheng Ma
    Cardiovascular Diabetology.2011;[Epub]     CrossRef
  • Lithospermic acid B protects beta-cells from cytokine-induced apoptosis by alleviating apoptotic pathways and activating anti-apoptotic pathways of Nrf2–HO-1 and Sirt1
    Byung-Wan Lee, Sung Wan Chun, Soo Hyun Kim, Yongho Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee
    Toxicology and Applied Pharmacology.2011; 252(1): 47.     CrossRef
  • WITHDRAWN: Effect of blood glucose fluctuation on the function of rat pancreatic islets in vivo
    Wang Yanjun, Xiao Yue, Li Shixing
    Regulatory Peptides.2011;[Epub]     CrossRef
Transdifferentiation of Enteroendocrine K-cells into Insulin-expressing Cells.
Esder Lee, Jun Mo Yu, Min Kyung Lee, Gyeong Ryul Ryu, Seung Hyun Ko, Yu Bae Ahn, Sung Dae Moon, Ki Ho Song
Korean Diabetes J. 2009;33(6):475-484.   Published online December 1, 2009
DOI: https://doi.org/10.4093/kdj.2009.33.6.475
  • 3,663 View
  • 40 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
Despite a recent breakthough in human islet transplantation for treating type 1 diabetes mellitus, the limited availability of donor pancreases remains a major obstacle. Endocrine cells within the gut epithelium (enteroendocrine cells) and pancreatic beta cells share similar pathways of differentiation during embryonic development. In particular, K-cells that secrete glucose-dependent insulinotropic polypeptide (GIP) have been shown to express many of the key proteins found in beta cells. Therefore, we hypothesize that K-cells can be transdifferentiated into beta cells because both cells have remarkable similarities in their embryonic development and cellular phenotypes. METHODS: K-cells were purified from heterogeneous STC-1 cells originating from an endocrine tumor of a mouse intestine. In addition, a K-cell subclone expressing stable Nkx6.1, called "Kn4-cells," was successfully obtained. In vitro differentiation of K-cells or Kn4-cells into beta cells was completed after exendin-4 treatment and serum deprivation. The expressions of insulin mRNA and protein were examined by RT-PCR and immunocytochemistry. The interacellular insulin content was also measured. RESULTS: K-cells were found to express glucokinase and GIP as assessed by RT-PCR and Western blot analysis. RT-PCR showed that K-cells also expressed Pdx-1, NeuroD1/Beta2, and MafA, but not Nkx6.1. After exendin-4 treatment and serum deprivation, insulin mRNA and insulin or C-peptide were clearly detected in Kn4-cells. The intracellular insulin content was also increased significantly in these cells. CONCLUSION: K-cells are an attractive potential source of insulin-producing cells for treatment of type 1 diabetes mellitus. However, more experiments are necessary to optimize a strategy for converting K-cells into beta cells.

Citations

Citations to this article as recorded by  
  • Reprogramming of enteroendocrine K cells to pancreatic β-cells through the combined expression of Nkx6.1 and Neurogenin3, and reaggregation in suspension culture
    Esder Lee, Gyeong Ryul Ryu, Sung-Dae Moon, Seung-Hyun Ko, Yu-Bae Ahn, Ki-Ho Song
    Biochemical and Biophysical Research Communications.2014; 443(3): 1021.     CrossRef
Reviews
Stimulation of Glucagon Like Peptide-1 Secretion in Enteroendocrine L cells.
Byung Joon Kim
Korean Diabetes J. 2009;33(6):458-463.   Published online December 1, 2009
DOI: https://doi.org/10.4093/kdj.2009.33.6.458
  • 3,367 View
  • 32 Download
  • 2 Crossref
AbstractAbstract PDF
GLP-1 (glucagon like peptide-1) is new anti-diabetic drug with a number of beneficial effects. It stimulates glucose dependant insulin secretion and restoration of beta cell mass through enhancement of islet mass. However, it is easily inactivated after being secreted from enteroendocrine L cells. Recent trial to increased GLP-1 is to directly stimulate L cells through its receptor located in the surface of L cell. Taste receptor in the apical surface of L cell is activated by various tastants contained in the food. Tongue perceives taste sense through the heterotrimeric G-protein (alpha-gustducin) and its downstream signaling cascades. Same taste receptors are also expressed in enteroendocrine cells. In duodenal L cell, alpha-gustducin was detected by immunofluorescence stainig at the luminal projections of enteroendocrine cells. And several other taste signaling elements were also found in L cells. Ingestion of sweet or bitter compounds revealed stimulation of GLP-1 secretion and the regulation of plasma insulin and glucose. In this review, I will briefly introduce the possibilities to stimulate GLP-1 secretion though the membrane receptor in enteroendocrine cell. And it will be the good candidate to develop the treatment modality for obesity, diabetes and abnormal gut motility.

Citations

Citations to this article as recorded by  
  • Repression of sterol regulatory element-binding protein 1-c is involved in the protective effects of exendin-4 in pancreatic β-cell line
    Seok-Woo Hong, Jinmi Lee, Se Eun Park, Eun-Jung Rhee, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee
    Molecular and Cellular Endocrinology.2012; 362(1-2): 242.     CrossRef
  • Exendin-4 Protects Oxidative Stress-Induced β-Cell Apoptosis through Reduced JNK and GSK3β Activity
    Ju-Young Kim, Dong-Mee Lim, Chan Il Moon, Kyung-Jin Jo, Seong-Kyu Lee, Haing-Woon Baik, Ki-Ho Lee, Kang-Woo Lee, Keun-Young Park, Byung-Joon Kim
    Journal of Korean Medical Science.2010; 25(11): 1626.     CrossRef
Autophagy in Diabetes.
Hye Seung Jung, Myung Shik Lee
Korean Diabetes J. 2009;33(6):453-457.   Published online December 1, 2009
DOI: https://doi.org/10.4093/kdj.2009.33.6.453
  • 2,831 View
  • 39 Download
AbstractAbstract PDF
Diabetes mellitus is characterized by decreased insulin secretion and action. Decreased insulin secretion results from a reduction in mass and/or function of pancreatic beta-cells. Apoptosis, oxidative stress, mitochondrial dysfunction, and endoplasmic reticulum (ER) stress responses have been suggested as mechanisms for the changes in beta-cells in type 2 diabetes; however, the underlying causes have not been clearly elucidated. Autophagy is an intracellular process that maintains cellular homeostasis through degradation and recycling of organelles. Recently, we reported reduction of beta-cell mass in autophagy-deficient mice. Pancreatic insulin content was also decreased due to the decreased beta-cell mass and the reduced number of insulin granules. Morphological analysis of these beta-cells revealed an accumulation of ubiquitinated proteins, swollen mitochondria, and distended ER. Insulin secretory function ex vivo was also impaired. As a result, autophagy-deficient mice showed hypoinsulinemia and hyperglycemia. These results suggested that autophagy is necessary to maintain the structure, mass and function of beta-cells. In addition, as autophagy may play a protective role against ER stress and rejuvenate organelle function, impaired autophagy may lead to mitochondrial dysfunction and ER stress, which have been implicated as causes of insulin resistance. Therefore, in addition to beta-cell homeostasis, dysregulated autophagy may possibly be involved in insulin resistance.
Original Articles
High Glucose and/or Free Fatty Acid Damage Vascular Endothelial Cells via Stimulating of NAD(P)H Oxidase-induced Superoxide Production from Neutrophils.
Sang Soo Kim, Sun Young Kim, Soo Hyung Lee, Yang Ho Kang, In Ju Kim, Yong Ki Kim, Seok Man Son
Korean Diabetes J. 2009;33(2):94-104.   Published online April 1, 2009
DOI: https://doi.org/10.4093/kdj.2009.33.2.94
  • 3,185 View
  • 26 Download
AbstractAbstract PDF
BACKGROUND
Oxidative stress and inflammation are important factors in the pathogenesis of diabetes and contribute to the development of diabetic complications. To understand the mechanisms that cause vascular complications in diabetes, we examined the effects of high glucose and/or free fatty acids on the production of superoxide from neutrophils and their role in endothelial cell damage. METHODS: Human neutrophils were incubated in the media containing 5.5 mM D-glucose, 30 mM D-glucose, 3 nM oleic acid, or 30 microM oleic acid for 1 hour to evaluate superoxide production through NAD(P)H oxidase activation. Human aortic endothelial cells were co-cultured with neutrophils exposed to high glucose and oleic acid. We then measured neutrophil adhesion to endothelial cells, neutrophil activation and superoxide production, neutrophil-mediated endothelial cell cytotoxicity and subunits of neutrophil NAD(P)H oxidase. RESULTS: After 1 hour of incubation with various concentrations of glucose and oleic acid, neutrophil adherence to high glucose and oleic acid-treated endothelial cells was significantly increased compared with adhesion to low glucose and oleic acid-treated endothelial cells. Incubation of neutrophils with glucose and free fatty acids increased superoxide production in a dose-dependent manner. High glucose and oleic acid treatment significantly increased expression of the membrane components of NAD(P)H oxidase of neutrophil (gp91(phox)). Endothelial cells co-cultured with neutrophils exposed to high glucose and oleic acid showed increased cytolysis, which could be prevented by an antioxidant, N-acetylcysteine. CONCLUSION: These results suggest that high glucose and/orfree fatty acidsincrease injury of endothelial cells via stimulating NAD(P)H oxidase-induced superoxide production from neutrophils.
Protective Effects of Glucagon Like Peptide-1 on HIT-T15 beta Cell Apoptosis via ER Stress Induced by 2-deoxy-D-glucose.
Ju Young Kim, Seong Kyu Lee, Haing Woon Baik, Ki Ho Lee, Hyun Jin Kim, Kang Seo Park, Byung Joon Kim
Korean Diabetes J. 2008;32(6):477-487.   Published online December 1, 2008
DOI: https://doi.org/10.4093/kdj.2008.32.6.477
  • 3,628 View
  • 33 Download
  • 3 Crossref
AbstractAbstract PDF
BACKGROUND
The characteristic feature of pancreatic beta cells is highly developed endoplasmic reticulum (ER) due to a heavy engagement in insulin secretion. The ER serves several important function, including post-translational modification, folding, and assembly of newly synthesized secretory proteins, and its proper function is essential to cell survival. Various stress conditions can interfere with ER function. Pancreatic beta cells may be particularly vulnerable to ER stress that causes to impair insulin biosynthesis and beta cell survival through apoptosis. Glucagon like peptide-1 (GLP-1) is a new drug for treatment of type 2 diabetes and has effects on stimulation of insulin secretion and beta cell preservation. Also, it may have an antiapoptotic effect on beta cells, but detailed mechanisms are not proven. Therefore, we investigated the protective mechanism of GLP-1 in beta cells through ER stress response induced by 2-deoxy-D-glucose (2DG). METHODS: For induction of the ER stress, HIT-T15 cells (hamster beta cell line) were treated with 2DG (10 mM). Apoptosis was evaluated with MTT assay, hoechst 33342 staining and Annexin/PI flow cytometry. Expression of ER stress-related molecules was determined by real-time PCR or western blot. For blocking ER stress, we pretreated HIT-T15 cells with exendin-4 (Ex-4; GLP-1 receptor agonist) for 1 hour before stress induction. RESULTS: After induction with ER stress (2DG), beta cells were lost by apoptosis. We found that Ex-4 had a protective effect through ER stress related molecules (GRP78, GRP94, XBP-1, eIF2alpha, CHOP) modulation. Also, Ex-4 recovered the expression of insulin2 mRNA in beta cells. CONCLUSION: These results suggest that GLP-1 may protect beta cells apoptosis through ER stress modulation.

Citations

Citations to this article as recorded by  
  • Exendin-4 Protects Against Sulfonylurea-Induced β-Cell Apoptosis
    Ju-Young Kim, Dong-Mee Lim, Hyung-Seo Park, Chan-Il Moon, Kyung-Jin Choi, Seong-Kyu Lee, Haing-Woon Baik, Keun-Young Park, Byung-Joon Kim
    Journal of Pharmacological Sciences.2012; 118(1): 65.     CrossRef
  • GLP-1 Can Protect Proinflammatory Cytokines Induced Beta Cell Apoptosis through the Ubiquitination
    Dong Mee Lim, Ju Young Kim, Kang Woo Lee, Keun Young Park, Byung Joon Kim
    Endocrinology and Metabolism.2011; 26(2): 142.     CrossRef
  • Exendin-4 Protects Oxidative Stress-Induced β-Cell Apoptosis through Reduced JNK and GSK3β Activity
    Ju-Young Kim, Dong-Mee Lim, Chan Il Moon, Kyung-Jin Jo, Seong-Kyu Lee, Haing-Woon Baik, Ki-Ho Lee, Kang-Woo Lee, Keun-Young Park, Byung-Joon Kim
    Journal of Korean Medical Science.2010; 25(11): 1626.     CrossRef
Transcriptional Regulation of Insulin and CXCL10 Gene by Peroxisome Proliferator Activated Receptor gamma Coactivator-1alpha.
Won Gu Jang, In Kyu Lee, Eun Jung Kim, Seong Yeol Ryu, Bo Wan Kim, Jung Guk Kim
Korean Diabetes J. 2007;31(4):326-335.   Published online July 1, 2007
DOI: https://doi.org/10.4093/jkda.2007.31.4.326
  • 3,083 View
  • 25 Download
AbstractAbstract PDF
BACKGROUND
Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha), which act as a coactivator of nuclear receptors and several other transcription factors. This study was performed to evaluate the expressional regulation of insulin and inflammatory response genes by PGC-1alpha. METHODS: Transient transfection assays were performed to measure the promoter activity of the insulin and CXCL10 gene. The insulin gene expression levels in INS-1 cells were determined by Northern blot analysis. Differentially expressed genes by PGC-1alpha overexpression in HASMCs were confirmed using DNA microarray, real-time PCR and Northen blot analysis. RESULTS: Insulin promoter activity and mRNA levels were suppressed by GR and Ad-PGC-1alpha. Northern blot analysis of the INS-1 cells revealed that infection with Ad-PGC-1alpha markedly reduced the amount of insulin mRNA and treatment of Dex enhanced this effect in an additive manner. The PGC-1alpha-specific siRNA decreased insulin expression that was induced by Dex in the GR-expressing INS-1 cells was nearly restored by this siRNA treatment. We found that when vascular smooth muscle cells (VSMCs) overexpressed PGC-1alpha, immune or inflammatory response genes were highly expressed. For example, promoter activity and mRNA level of CXCL10 gene were increased by PGC-1alpha. CONCLUSION: PGC-1alpha overexpression inhibited insulin promoter activity in INS-1 cells and enhanced expressions of inflammatory response genes (CXCL10, CXCL11, TNFLSF10) in VSMCs.
gamma-glutamylcysteine Synthetase (gamma-GCS) mRNA Expression in INS-1 Cells and Patients with Type 2 Diabetes Mellitus.
Jae Hong Kim, Chan Hee Lee, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
Korean Diabetes J. 2007;31(4):302-309.   Published online July 1, 2007
DOI: https://doi.org/10.4093/jkda.2007.31.4.302
  • 3,057 View
  • 25 Download
AbstractAbstract PDF
BACKGROUND
Hyperglycemia is a well-recognized pathogenic factor of long term complications in diabetes mellitus and hyperglycemia also generates reactive oxygen species (ROS) in beta cells when ROS accumulate in excess for prolonged periods of time, they cause chronic oxidative stress and adverse effects. Unfortunately, the islet contacts low capacity of endogenous antioxidant effects. But, gamma-glutamylcysteine synthetase (gamma-GCS), the rate-limiting enzyme for glutathione synthesis, is well represented in islets. METHODS: This study is to evaluate the changes in the activity of gamma-GCS, glutathione in beta-cells exposed to high glucose, in pancreatic tissue of OLETF (Otsuka Long Evans Tokushima Fatty) and LETO (Long-Evans Tokushima Otsuka) rats, in leukocytes from patients with Korean type 2 DM (T2DM) and to disclose the effects of high blood glucose on this impairment in patients with T2DM. We divided our patients into 3 groups by HbA1c (controls: n = 20, well controls diabetes: n=24, poorly controlled diabetes: n = 36). RESULTS: We observed that decreased glutathione level, gamma-GCS expression, glucose-stimulated (GSIS) and increased intracellular peroxide level in the INS-1 cells exposed to 30 mM glucose condition. Also decreased glutathione level at erythrocytes, gamma-GCS expression at leukocytes and increased oxidized LDL, MDA (malondialdehyde) level at plasma from patients with T2DM compared to controls (esp, poorly controlled patients). CONCLUSION: These results suggest that insufficient antioxidant defenses by the glutathione pathway may be one of the factors responsible for development of complications in T2DM.
Differentiation of Pancreatic beta Cells from Human Pancreatic Duct Cells Derived from a Partial Pancreas Tissue.
Ki Ho Song, Myung Mee Kim, Min Kyung Lee, Gyeong Ryul Ryu, Seung Hyun Ko, Sung Dae Moon, Yu Bae Ahn, Kun Ho Yoon, Bong Yun Cha, Kwang Woo Lee, Ho Young Son, Sung Koo Kang, Hyung Min Chin
Korean Diabetes J. 2007;31(3):236-242.   Published online May 1, 2007
DOI: https://doi.org/10.4093/jkda.2007.31.3.236
  • 3,264 View
  • 28 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
Despite a recent breakthrough in human islet transplantation for treating diabetes mellitus, the limited availability of insulin-producing tissue is still a major obstacle. This has led to a search for alternative sources of transplantable insulin-producing cells including pancreatic duct cells. We aimed to establish in vitro culture of pancreatic duct cells from a partial pancreas tissue in human, which could be harnessed to differentiate into pancreatic beta cells. METHODS: We isolated pancreatic duct cells from small pieces of pancreas tissue (1~3 g) derived from non-diabetic humans (n = 8) undergoing pancreatic surgery due to cancer. Pancreas tissue was finely minced after injection of collagenase P into the parenchyma. The mince was incubated in a shaking water bath at 37degrees C for 25 min and passed through a 150 micrometer mesh. The released cells were recovered, washed, and plated in a dish containing CMRL culture medium with serum. RESULTS: Isolated pancreatic cells grew in monolayer and became confluent in 1~2 wks showing typical epithelial cobblestone morphology. Immunochemistry demonstrated that ~90% of the cultured cells were cytokeratin7-positive duct cells. To induce beta cell differentiation, the cells were incubated in DMEM/F12 culture medium without serum. In addition, treatment with Matrigel overlay, exendin-4, cholera toxin or forskolin was done. Though beta cell differentiation was found by immunostaining and RT-PCR, the differentiation efficiency was very low. Over-expression of neurogenin-3 by recombinant adenovirus did not increase beta cell differentiation of the cultured duct cells significantly. CONCLUSION: We established in vitro culture of pancreatic duct cells from a partial pancreas tissue in human, which differentiate into pancreatic cells. However, a strategy to optimize beta cell differentiation in this model is needed.

Citations

Citations to this article as recorded by  
  • Transdifferentiation of Enteroendocrine K-cells into Insulin-expressing Cells
    Esder Lee, Jun Mo Yu, Min Kyung Lee, Gyeong Ryul Ryu, Seung-Hyun Ko, Yu-Bae Ahn, Sung-Dae Moon, Ki-Ho Song
    Korean Diabetes Journal.2009; 33(6): 475.     CrossRef
Review
The Roles of Clusterin on Morphogenesis of Beta Cells During Pancreas Regeneration.
Seok Woo Hong, KC Ranjan, Song Lee, Yong Jae Shin, Bon Hong Min, In Sun Park
Korean Diabetes J. 2007;31(1):1-8.   Published online January 1, 2007
DOI: https://doi.org/10.4093/jkda.2007.31.1.1
  • 3,342 View
  • 45 Download
  • 1 Crossref
AbstractAbstract PDF
Clusterin is a highly glycosylated heterodimeric glycoprotein that plays diverse biological roles in various organs. The secreted clusterin has been established as a major form of the protein that exerts diverse tissue effects. For instance, clusterin is known to act in cell protection through the actions of extra-cellular molecular chaperones. In the extracellular milieu, clusterin participates in specific interactions with a diverse array of native biological molecules including LRP-2 (Lipoprotein receptor-related protein 2, also known as gp330 or megalin), which is involved in ligand endocytosis at the surfaces of certain epithelia. Clusterin is expressed transiently in developing and differentiating endocrine pancreatic cells and might be involved in pancreas development. This transient expression of clusterin at specific time points of pancreas development and cell differentiation during pancreas regeneration implies that the protein is a regulatory factor for cytodifferentiation as well as for replication. A specific action of the clusterin in the reconstruction and remodeling of the endocrine pancreas has been demonstrated. It also strongly stimulates duct cell differentiation into insulin-secreting cells under in vitro culture conditions. Clusterin appears thus as a potent regulator of insulin cell morphogenesis.

Citations

Citations to this article as recorded by  
  • Effect of African Mango (Irvingia gabonesis, IGOB 131TM) Extract on Glucose Regulation in STZ-Induced Diabetes
    Yejin Ha, Minhee Lee, Han Ol Kwon, Yoo-Hyun Lee
    Journal of the Korean Society of Food Science and Nutrition.2015; 44(11): 1607.     CrossRef
Original Article
Protective Effect of PGC-1 on Lipid Overload-induced Apoptosis in Vascular Endothelial Cell.
Eun Hee Koh, Youn Mi Kim, Ha Jung Kim, Woo Je Lee, Jong Chul Won, Min Seon Kim, Ki Up Lee, Joong Yeol Park
Korean Diabetes J. 2006;30(3):151-160.   Published online May 1, 2006
DOI: https://doi.org/10.4093/jkda.2006.30.3.151
  • 3,006 View
  • 25 Download
AbstractAbstract PDF
BACKGROUND
Fatty acids contribute to endothelial cell dysfunction and apoptosis by inducing accumulation of long chain fatty acyl CoA (LCAC), which increases oxidative stress in vascular endothelial cells. Forced expression of PGC-1 was shown to induce mitochondrial biogenesis and to control expression of mitochondrial enzymes involved in fatty acid oxidation. This study was undertaken to test the hypothesis that PGC-1 overexpression could prevent endothelial cell apoptosis by enhancing fatty acid oxidation and relieving oxidative stress in vascular endothelium. METHODS: Adenoviruses containing human PGC-1 (Ad-PGC-1) and beta-galactosidase (Ad-beta-gal) were transfected to confluent human aortic endothelial cells (HAECs). To investigate the effect of adenoviral PGC-1 gene transfer on apoptosis, combined treatment of linoleic acid (LA), an unsaturated fatty acid, was performed. RESULTS: PGC-1 overexpression inhibited the increase in ROS production and apoptosis of HAECs induced by LA. Also, PGC-1 led to a significant increase in fatty acid oxidation and decrease in triglyceride content in HAECs. LA caused the decrease of adenine nucleotide translocase (ANT) activity and transient mitochondrial hyperpolarization, which was followed by depolarization. PGC-1 overexpression prevented these processes. CONCLUSION: In summary, PGC-1 overexpression inhibited mitochondrial dysfunction and apoptosis by facilitating fatty acid oxidation and protecting against the damage from oxidative stress in HAECs. The data collectively suggest that the regulation of intracellular PGC-1 expression might play a critical role in preventing atherosclerosis.

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP